[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-7b_response": "Acrokeratosis paraneoplastica is a rare skin condition that is characterized by the development of thick, scaly, and discolored patches on the skin. These patches are most commonly found on the hands and feet, but can also appear on other areas of the body. The cause of this condition is unknown, but it has been linked to certain types of cancer. Synonyms for Acrokeratosis paraneoplastica include acrokeratotic paraneoplastic syndrome, acrokeratotic disorder of Blaschko, and Blaschko's disease.",
    "llama-7b_fact_raw": "1. Acrokeratosis paraneoplastica is a rare skin condition.\n2. Acrokeratosis paraneoplastica is characterized by thick, scaly, and discolored patches on the skin.\n3. The patches associated with Acrokeratosis paraneoplastica are most commonly found on the hands and feet.\n4. Acrokeratosis paraneoplastica has been linked to certain types of cancer.\n5. Synonyms for Acrokeratosis paraneoplastica include acrokeratotic paraneoplastic syndrome, acrokeratotic disorder of Blaschko, and Blaschko's disease.",
    "llama-7b_fact": [
      "Acrokeratosis paraneoplastica is a rare skin condition.",
      "Acrokeratosis paraneoplastica is characterized by thick, scaly, and discolored patches on the skin.",
      "The patches associated with Acrokeratosis paraneoplastica are most commonly found on the hands and feet.",
      "Acrokeratosis paraneoplastica has been linked to certain types of cancer.",
      "Synonyms for Acrokeratosis paraneoplastica include acrokeratotic paraneoplastic syndrome, acrokeratotic disorder of Blaschko, and Blaschko's disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Synonyms for Acrokeratosis paraneoplastica include Bazex syndrome, acrokeratosis neoplastica, and paraneoplastic acrokeratosis. Acrokeratotic disorder of Blaschko and Blaschko's disease are not synonyms for Acrokeratosis paraneoplastica.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-7b_response": "No, Weaver syndrome is not similar to Sotos. Weaver syndrome is a rare genetic disorder that is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features. Sotos syndrome is a rare genetic disorder that is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features, but it is not the same as Weaver syndrome. Weaver syndrome is caused by mutations in the WFS1 gene, while Sotos syndrome is caused by mutations in the NSD1 gene.",
    "llama-7b_fact_raw": "1. Weaver syndrome is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features.\n2. Sotos syndrome is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features.\n3. Weaver syndrome is caused by mutations in the EZH2 gene (not WFS1 as stated in the answer, which is incorrect).\n4. Sotos syndrome is caused by mutations in the NSD1 gene.",
    "llama-7b_fact": [
      "Weaver syndrome is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features.",
      "Sotos syndrome is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features.",
      "Weaver syndrome is caused by mutations in the EZH2 gene (not WFS1 as stated in the answer, which is incorrect).",
      "Sotos syndrome is caused by mutations in the NSD1 gene."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-7b_response": "The JASPAR database has been updated several times since its initial release in 1999. The most recent version, JASPAR 2019, was released in February 2019 and contains information on more than 4000 protein-coding transcripts from a variety of organisms. Previous versions of the database include JASPAR 2010 (released in 2010), JASPAR 2005 (released in 2005), and JASPAR 2002 (released in 2002).",
    "llama-7b_fact_raw": "1. The JASPAR database was initially released in 1999.\n2. JASPAR 2019 was released in February 2019.\n3. JASPAR 2019 contains information on more than 4000 protein-coding transcripts.\n4. JASPAR 2010 was released in 2010.\n5. JASPAR 2005 and JASPAR 2002 were released in 2005 and 2002, respectively.",
    "llama-7b_fact": [
      "The JASPAR database was initially released in 1999.",
      "JASPAR 2019 was released in February 2019.",
      "JASPAR 2019 contains information on more than 4000 protein-coding transcripts.",
      "JASPAR 2010 was released in 2010.",
      "JASPAR 2005 and JASPAR 2002 were released in 2005 and 2002, respectively."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The JASPAR database was initially released in 2004.\n2. TRUE\n3. FALSE [correction]: JASPAR 2019 contains information on transcription factor binding profiles, not protein-coding transcripts.\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-7b_response": "The viral KP4 protein is a small, non-structural protein found in certain picornaviruses, including poliovirus. It is believed to play a role in the replication and assembly of the virus, as well as in the modulation of the host cell's gene expression. KP4 has also been shown to interact with cellular proteins, such as RNA polymerase II, which may help the virus to evade the host cell's immune system.",
    "llama-7b_fact_raw": "1. The KP4 protein is found in certain picornaviruses, including poliovirus.\n2. KP4 is involved in the replication and assembly of the virus.\n3. KP4 plays a role in the modulation of the host cell's gene expression.\n4. The KP4 protein interacts with cellular proteins such as RNA polymerase II.\n5. The interaction of KP4 with cellular proteins may help the virus evade the host cell's immune system.",
    "llama-7b_fact": [
      "The KP4 protein is found in certain picornaviruses, including poliovirus.",
      "KP4 is involved in the replication and assembly of the virus.",
      "KP4 plays a role in the modulation of the host cell's gene expression.",
      "The KP4 protein interacts with cellular proteins such as RNA polymerase II.",
      "The interaction of KP4 with cellular proteins may help the virus evade the host cell's immune system."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The KP4 protein is not associated with picornaviruses like poliovirus. KP4 is a fungal toxin produced by the corn smut fungus Ustilago maydis.\n2. FALSE [correction]: Since KP4 is not a viral protein, it is not involved in the replication and assembly of viruses. It is a toxin that affects insect pests.\n3. UNKNOWN: Without specific context, it's unclear whether KP4 modulates the host cell's gene expression, especially since KP4 is a fungal toxin and not a viral protein.\n4. UNKNOWN: There is no information provided about KP4 interacting with cellular proteins such as RNA polymerase II, and given that KP4 is a fungal toxin, this statement would not be applicable in the context of viral proteins.\n5. UNKNOWN: The statement about KP4 helping a virus evade the host cell's immune system is not applicable since KP4 is not a viral protein but a fungal toxin.",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-7b_response": "DITPA (3,5-diiodothyronine) is a thyroid hormone analog that is utilized in both experimental and clinical studies. It is a potent thyroid hormone agonist that has been studied for its potential to treat a variety of thyroid-related disorders, including hypothyroidism, hyperthyroidism, and thyroid cancer. DITPA is more potent than thyroid hormones such as triiodothyronine (T3) and thyroxine (T4) and has a longer half-life than these hormones, allowing for once-daily administration. DITPA has also been studied for its potential to improve cognitive function in patients with hypothyroidism.",
    "llama-7b_fact_raw": "1. DITPA stands for 3,5-diiodothyronine.\n2. DITPA is used in both experimental and clinical studies.\n3. DITPA has been studied for its potential to treat thyroid-related disorders such as hypothyroidism, hyperthyroidism, and thyroid cancer.\n4. DITPA is more potent than thyroid hormones like triiodothyronine (T3) and thyroxine (T4).\n5. DITPA has a longer half-life than triiodothyronine (T3) and thyroxine (T4), which allows for once-daily administration.",
    "llama-7b_fact": [
      "DITPA stands for 3,5-diiodothyronine.",
      "DITPA is used in both experimental and clinical studies.",
      "DITPA has been studied for its potential to treat thyroid-related disorders such as hypothyroidism, hyperthyroidism, and thyroid cancer.",
      "DITPA is more potent than thyroid hormones like triiodothyronine (T3) and thyroxine (T4).",
      "DITPA has a longer half-life than triiodothyronine (T3) and thyroxine (T4), which allows for once-daily administration."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: DITPA stands for 3,5-diiodothyropropionic acid.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DITPA is less potent than thyroid hormones like triiodothyronine (T3) and thyroxine (T4).\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-7b_response": "The COUGER tool is a software tool developed by Microsoft to help developers build and test applications on the Windows platform. It provides a graphical user interface that allows developers to quickly and easily create, debug, and deploy applications. It also provides a wide range of debugging and testing features, such as breakpoints, code stepping, and memory dumps.",
    "llama-7b_fact_raw": "1. The COUGER tool is a software tool developed by Microsoft.\n2. The COUGER tool is designed to assist developers in building and testing applications on the Windows platform.\n3. It offers a graphical user interface for developers to create, debug, and deploy applications.\n4. The COUGER tool includes debugging features like breakpoints and code stepping.\n5. It also includes testing features such as memory dumps.",
    "llama-7b_fact": [
      "The COUGER tool is a software tool developed by Microsoft.",
      "The COUGER tool is designed to assist developers in building and testing applications on the Windows platform.",
      "It offers a graphical user interface for developers to create, debug, and deploy applications.",
      "The COUGER tool includes debugging features like breakpoints and code stepping.",
      "It also includes testing features such as memory dumps."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There is no widely recognized software tool named COUGER developed by Microsoft. It's possible that the statement refers to a different tool or is simply incorrect.\n2. UNKNOWN: Since the existence of the COUGER tool is not established, its purpose cannot be confirmed.\n3. UNKNOWN: Without confirmation of the COUGER tool's existence, the features it offers cannot be determined.\n4. UNKNOWN: The specifics of debugging features such as breakpoints and code stepping cannot be confirmed for the COUGER tool.\n5. UNKNOWN: Similarly, the inclusion of testing features such as memory dumps in the COUGER tool cannot be confirmed.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-7b_response": "Yes, there are drugs available to treat Tick-borne Encephalitis. These include antiviral medications such as oseltamivir and zanamivir, as well as immunoglobulin therapy which can help reduce the severity of symptoms.",
    "llama-7b_fact_raw": "1. Drugs are available to treat Tick-borne Encephalitis.\n2. Antiviral medications such as oseltamivir and zanamivir can be used to treat Tick-borne Encephalitis.\n3. Immunoglobulin therapy can help reduce the severity of symptoms of Tick-borne Encephalitis.",
    "llama-7b_fact": [
      "Drugs are available to treat Tick-borne Encephalitis.",
      "Antiviral medications such as oseltamivir and zanamivir can be used to treat Tick-borne Encephalitis.",
      "Immunoglobulin therapy can help reduce the severity of symptoms of Tick-borne Encephalitis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Antiviral medications such as oseltamivir and zanamivir are used to treat influenza, not Tick-borne Encephalitis. There are no specific antiviral medications for Tick-borne Encephalitis.\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-7b_response": "The Genome Browser database for DNA shape annotations is available through the UCSC Genome Browser.",
    "llama-7b_fact_raw": "1. A genome browser database for DNA shape annotations is available through the UCSC Genome Browser.",
    "llama-7b_fact": [
      "A genome browser database for DNA shape annotations is available through the UCSC Genome Browser."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-7b_response": "Syndromes associated with mutations in the EZH2 gene include Beckwith-Wiedemann Syndrome, Silver-Russell Syndrome, Proteus Syndrome, and Juvenile Polyposis Syndrome.",
    "llama-7b_fact_raw": "1. Beckwith-Wiedemann Syndrome is associated with mutations in the EZH2 gene.\n2. Silver-Russell Syndrome is associated with mutations in the EZH2 gene.\n3. Proteus Syndrome is associated with mutations in the EZH2 gene.\n4. Juvenile Polyposis Syndrome is associated with mutations in the EZH2 gene.",
    "llama-7b_fact": [
      "Beckwith-Wiedemann Syndrome is associated with mutations in the EZH2 gene.",
      "Silver-Russell Syndrome is associated with mutations in the EZH2 gene.",
      "Proteus Syndrome is associated with mutations in the EZH2 gene.",
      "Juvenile Polyposis Syndrome is associated with mutations in the EZH2 gene."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Beckwith-Wiedemann Syndrome is commonly associated with changes in the imprinted region on chromosome 11p15, involving genes such as IGF2 and H19, not mutations in the EZH2 gene.\n2. FALSE [correction]: Silver-Russell Syndrome is typically associated with genetic changes affecting chromosome 7 or the imprinted region on chromosome 11p15, not mutations in the EZH2 gene.\n3. FALSE [correction]: Proteus Syndrome is caused by a somatic mutation in the AKT1 gene, not mutations in the EZH2 gene.\n4. FALSE [correction]: Juvenile Polyposis Syndrome is associated with mutations in the BMPR1A or SMAD4 genes, not mutations in the EZH2 gene.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-7b_response": "The human proteins that are subject to a dimer-to-tetramer transition are the transcription factors Oct4, Sox2, Klf4, and c-Myc. These proteins form dimers in the cytoplasm and undergo a dimer-to-tetramer transition upon entry into the nucleus, where they bind to DNA and regulate gene expression.",
    "llama-7b_fact_raw": "1. The transcription factors Oct4, Sox2, Klf4, and c-Myc can form dimers.\n2. Oct4, Sox2, Klf4, and c-Myc undergo a dimer-to-tetramer transition.\n3. The dimer-to-tetramer transition of these proteins occurs upon their entry into the nucleus.\n4. Once in the nucleus, Oct4, Sox2, Klf4, and c-Myc bind to DNA.\n5. The purpose of Oct4, Sox2, Klf4, and c-Myc binding to DNA is to regulate gene expression.",
    "llama-7b_fact": [
      "The transcription factors Oct4, Sox2, Klf4, and c-Myc can form dimers.",
      "Oct4, Sox2, Klf4, and c-Myc undergo a dimer-to-tetramer transition.",
      "The dimer-to-tetramer transition of these proteins occurs upon their entry into the nucleus.",
      "Once in the nucleus, Oct4, Sox2, Klf4, and c-Myc bind to DNA.",
      "The purpose of Oct4, Sox2, Klf4, and c-Myc binding to DNA is to regulate gene expression."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: The statement is vague as it does not specify which dimers are formed between the transcription factors. While Oct4 and Sox2 are known to interact, the statement about all four forming dimers is not specific enough without additional context.\n2. FALSE [correction]: Oct4, Sox2, Klf4, and c-Myc are known as Yamanaka factors and are used to induce pluripotency in somatic cells. They do not undergo a dimer-to-tetramer transition as described; instead, they function as individual transcription factors or in complexes, but not as a single tetrameric unit.\n3. UNKNOWN: The entry of these transcription factors into the nucleus is a part of their function, but the statement about a dimer-to-tetramer transition upon entry is not accurate, as corrected in the previous statement. The process of their nuclear entry is not typically described in terms of dimer-to-tetramer transitions.\n4. TRUE: Oct4, Sox2, Klf4, and c-Myc are transcription factors that, once in the nucleus, bind to DNA to regulate gene expression.\n5. TRUE: The purpose of Oct4, Sox2, Klf4, and c-Myc binding to DNA is indeed to regulate gene expression, specifically to maintain pluripotency or to induce pluripotent stem cell states in the case of somatic cell reprogramming.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-7b_response": "The protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is Bcl-2.",
    "llama-7b_fact_raw": "1. Bcl-2 is a protein that interacts with phospholamban (PLN).\n2. Bcl-2 is an anti-apoptotic protein.",
    "llama-7b_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-7b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. A systematic review and meta-analysis of randomized controlled trials found that vitamin D supplementation significantly reduced the risk of falls in older people by 22-37%. Additionally, a 2019 Cochrane review found that vitamin D supplementation can reduce the risk of falls in older people by 19%.",
    "llama-7b_fact_raw": "1. Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.\n2. A systematic review and meta-analysis found that vitamin D supplementation reduced the risk of falls in older people by 22-37%.\n3. A 2019 Cochrane review concluded that vitamin D supplementation can reduce the risk of falls in older people by 19%.",
    "llama-7b_fact": [
      "Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.",
      "A systematic review and meta-analysis found that vitamin D supplementation reduced the risk of falls in older people by 22-37%.",
      "A 2019 Cochrane review concluded that vitamin D supplementation can reduce the risk of falls in older people by 19%."
    ],
    "llama-7b_judge_raw": "1. TRUE: Vitamin D supplementation has been shown in some clinical trials to reduce the incidence of falls in older people, although the evidence is mixed and some studies have not found a significant effect.\n2. UNKNOWN: Without a specific reference to the systematic review and meta-analysis mentioned, it is difficult to verify the accuracy of the 22-37% reduction in the risk of falls. The results of such analyses can vary based on the included studies and their methodologies.\n3. FALSE [correction]: A 2019 Cochrane review concluded that vitamin D supplementation does not reduce the risk of falls in older people by a statistically significant amount. The review suggested that vitamin D supplementation may not prevent falls and that further research is needed to confirm its role.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-7b_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Studies have shown that miR-155 is upregulated in Th17 cells and that Jarid2 is a direct target of miR-155. This suggests that the expression of Jarid2 is negatively regulated by miR-155 in Th17 cells.",
    "llama-7b_fact_raw": "1. miR-155 is upregulated in Th17 cells.\n2. Jarid2 is a direct target of miR-155.\n3. The expression of Jarid2 is negatively regulated by miR-155 in Th17 cells.",
    "llama-7b_fact": [
      "miR-155 is upregulated in Th17 cells.",
      "Jarid2 is a direct target of miR-155.",
      "The expression of Jarid2 is negatively regulated by miR-155 in Th17 cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n\nExplanation:\n1. miR-155 is known to be upregulated in various cell types, including Th17 cells, which are a subset of T cells involved in inflammatory responses.\n3. If miR-155 is upregulated and Jarid2 is a direct target of miR-155, it would be consistent with the mechanism of microRNAs that they negatively regulate the expression of their target genes. However, without specific evidence or a reference to confirm that Jarid2 is a direct target of miR-155, the second statement remains UNKNOWN.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-7b_response": "The human hoxD cluster contains 11 genes.",
    "llama-7b_fact_raw": "1. The human hoxD cluster contains 11 genes.",
    "llama-7b_fact": [
      "The human hoxD cluster contains 11 genes."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The human HOXD cluster contains 9 genes.",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-7b_response": "The phosphorylation consensus motifs for Casein Kinase 1 (CK1) are:\n\n1. S/T-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-7b_response": "The ASPH gene encodes three different proteins/isoforms in humans: aspartate beta-hydroxylase, aspartate beta-semialdehyde dehydrogenase, and aspartate beta-semialdehyde transaminase.",
    "llama-7b_fact_raw": "1. The ASPH gene encodes the aspartate beta-hydroxylase protein/isoform in humans.\n2. The ASPH gene encodes the aspartate beta-semialdehyde dehydrogenase protein/isoform in humans.\n3. The ASPH gene encodes the aspartate beta-semialdehyde transaminase protein/isoform in humans.",
    "llama-7b_fact": [
      "The ASPH gene encodes the aspartate beta-hydroxylase protein/isoform in humans.",
      "The ASPH gene encodes the aspartate beta-semialdehyde dehydrogenase protein/isoform in humans.",
      "The ASPH gene encodes the aspartate beta-semialdehyde transaminase protein/isoform in humans."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ALDH4A1 gene encodes the aspartate beta-semialdehyde dehydrogenase protein/isoform in humans.\n3. FALSE [correction]: The GOT1 gene encodes the aspartate aminotransferase, cytoplasmic protein/isoform in humans, which is also known as aspartate transaminase. There is no protein specifically named aspartate beta-semialdehyde transaminase associated with the ASPH gene.",
    "llama-7b_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-7b_response": "Empagliflozin was approved by the FDA in August 2014 for the treatment of adults with type 2 diabetes.",
    "llama-7b_fact_raw": "1. Empagliflozin was approved by the FDA in August 2014.\n2. The FDA approved empagliflozin for the treatment of adults with type 2 diabetes.",
    "llama-7b_fact": [
      "Empagliflozin was approved by the FDA in August 2014.",
      "The FDA approved empagliflozin for the treatment of adults with type 2 diabetes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-7b_response": "Loss of the protein Lon1 in the plant Arabidopsis results in a decrease in the lifespan of the plant. This is because Lon1 is a protein that is involved in the regulation of the cell cycle and its absence leads to an increase in the number of cells in the plant, which can cause premature aging and death.",
    "llama-7b_fact_raw": "1. Loss of the protein Lon1 in Arabidopsis results in a decreased lifespan of the plant.\n2. Lon1 is involved in the regulation of the cell cycle in Arabidopsis.\n3. The absence of Lon1 leads to an increase in the number of cells in Arabidopsis.\n4. An increase in the number of cells due to the absence of Lon1 can cause premature aging and death in Arabidopsis.",
    "llama-7b_fact": [
      "Loss of the protein Lon1 in Arabidopsis results in a decreased lifespan of the plant.",
      "Lon1 is involved in the regulation of the cell cycle in Arabidopsis.",
      "The absence of Lon1 leads to an increase in the number of cells in Arabidopsis.",
      "An increase in the number of cells due to the absence of Lon1 can cause premature aging and death in Arabidopsis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-7b_response": "Yes, a linker histone exists in the yeast genome. It is encoded by the Htz1 gene and is involved in the formation of nucleosomes, which are the basic building blocks of chromatin.",
    "llama-7b_fact_raw": "1. A linker histone exists in the yeast genome.\n2. The Htz1 gene encodes for the linker histone in yeast.\n3. The linker histone is involved in the formation of nucleosomes.\n4. Nucleosomes are the basic building blocks of chromatin.",
    "llama-7b_fact": [
      "A linker histone exists in the yeast genome.",
      "The Htz1 gene encodes for the linker histone in yeast.",
      "The linker histone is involved in the formation of nucleosomes.",
      "Nucleosomes are the basic building blocks of chromatin."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Yeast genomes typically do not contain linker histones. Linker histones are found in other eukaryotes and are involved in the further compaction of chromatin.\n2. FALSE [correction]: The Htz1 gene in yeast encodes for the histone variant H2A.Z, not a linker histone.\n3. TRUE: Linker histones are indeed involved in the formation and stabilization of nucleosomes by binding to the DNA between nucleosomes, although this is not applicable to yeast as stated in the first correction.\n4. TRUE: Nucleosomes are indeed the basic building blocks of chromatin, consisting of DNA wrapped around a histone octamer.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-7b_response": "Yes, there is evidence that tomato juice can lower cholesterol levels. A study published in the American Journal of Clinical Nutrition found that drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce total cholesterol and low-density lipoprotein (LDL) cholesterol levels. The study also found that the juice had no effect on HDL cholesterol levels.",
    "llama-7b_fact_raw": "1. A study published in the American Journal of Clinical Nutrition found that tomato juice can lower cholesterol levels.\n2. Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce total cholesterol levels.\n3. Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce low-density lipoprotein (LDL) cholesterol levels.\n4. The study found that tomato juice had no effect on high-density lipoprotein (HDL) cholesterol levels.",
    "llama-7b_fact": [
      "A study published in the American Journal of Clinical Nutrition found that tomato juice can lower cholesterol levels.",
      "Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce total cholesterol levels.",
      "Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce low-density lipoprotein (LDL) cholesterol levels.",
      "The study found that tomato juice had no effect on high-density lipoprotein (HDL) cholesterol levels."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific details about the study from the American Journal of Clinical Nutrition, such as the title, authors, or publication date, it is not possible to verify the accuracy of these statements. Therefore, the truthfulness of the claims regarding the effects of tomato juice on cholesterol levels cannot be determined from the information provided.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-7b_response": "Hsp70 and Hsp110 are molecular chaperones that help to fold and stabilize proteins. They are also involved in the regulation of mRNA stability. Hsp70 binds to the 5' untranslated region of mRNAs and helps to prevent their degradation, while Hsp110 binds to the 3' untranslated region and promotes the stability of mRNAs. Both Hsp70 and Hsp110 are important for the proper expression of genes and the maintenance of cell homeostasis.",
    "llama-7b_fact_raw": "1. Hsp70 and Hsp110 are molecular chaperones that assist in protein folding and stabilization.\n2. Hsp70 and Hsp110 play a role in the regulation of mRNA stability.\n3. Hsp70 binds to the 5' untranslated region of mRNAs to help prevent their degradation.\n4. Hsp110 binds to the 3' untranslated region of mRNAs to promote their stability.\n5. Both Hsp70 and Hsp110 are important for gene expression and maintaining cell homeostasis.",
    "llama-7b_fact": [
      "Hsp70 and Hsp110 are molecular chaperones that assist in protein folding and stabilization.",
      "Hsp70 and Hsp110 play a role in the regulation of mRNA stability.",
      "Hsp70 binds to the 5' untranslated region of mRNAs to help prevent their degradation.",
      "Hsp110 binds to the 3' untranslated region of mRNAs to promote their stability.",
      "Both Hsp70 and Hsp110 are important for gene expression and maintaining cell homeostasis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Hsp70 does not typically bind to the 5' untranslated region of mRNAs to prevent their degradation; this function is not commonly associated with Hsp70.\n4. FALSE [correction]: There is no widely recognized role of Hsp110 binding specifically to the 3' untranslated region of mRNAs to promote their stability. Hsp110 primarily functions as a molecular chaperone assisting in protein folding and stabilization.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-7b_response": "Two deiodinases are present in skeletal muscle: DIO1 and DIO2. DIO1 is responsible for the conversion of T4 to T3, while DIO2 is responsible for the conversion of T3 to rT3.",
    "llama-7b_fact_raw": "1. Two deiodinases, DIO1 and DIO2, are present in skeletal muscle.\n2. DIO1 is responsible for the conversion of T4 to T3.\n3. DIO2 is responsible for the conversion of T3 to rT3.",
    "llama-7b_fact": [
      "Two deiodinases, DIO1 and DIO2, are present in skeletal muscle.",
      "DIO1 is responsible for the conversion of T4 to T3.",
      "DIO2 is responsible for the conversion of T3 to rT3."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DIO2 is responsible for the conversion of T4 to T3, not T3 to rT3. It is DIO3 that typically catalyzes the conversion of T3 to rT3 (reverse T3).",
    "llama-7b_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-7b_response": "Caspase-1, -2, -3, -4, -5, -6, -7, -8, -9, and -11.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-7b_response": "Yes, there is a known link between the aurora B kinase and the polycomb protein ring1B. The aurora B kinase phosphorylates the ring1B protein, which is a component of the polycomb repressive complex 1 (PRC1). This phosphorylation leads to the dissociation of PRC1 from chromatin, resulting in the activation of target genes.",
    "llama-7b_fact_raw": "1. Aurora B kinase phosphorylates the ring1B protein.\n2. Ring1B is a component of the polycomb repressive complex 1 (PRC1).\n3. The phosphorylation of ring1B by aurora B kinase leads to the dissociation of PRC1 from chromatin.\n4. The dissociation of PRC1 from chromatin results in the activation of target genes.",
    "llama-7b_fact": [
      "Aurora B kinase phosphorylates the ring1B protein.",
      "Ring1B is a component of the polycomb repressive complex 1 (PRC1).",
      "The phosphorylation of ring1B by aurora B kinase leads to the dissociation of PRC1 from chromatin.",
      "The dissociation of PRC1 from chromatin results in the activation of target genes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nThe first two statements are factual and can be verified in scientific literature. Aurora B kinase is known to phosphorylate various proteins, including those involved in chromatin regulation, and Ring1B is indeed a component of the polycomb repressive complex 1 (PRC1). However, without specific context or a reference to a particular study, the effects of Ring1B phosphorylation by Aurora B kinase on PRC1's association with chromatin (statement 3) and the subsequent activation of target genes (statement 4) cannot be determined as true or false. These processes can be complex and context-dependent, and the outcomes might vary depending on the cell type, the state of the cell, or other interacting proteins and modifications.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are known as dinucleotides, which are composed of two nucleotides. The most common dinucleotides at the donor splice site are AG and GT, while the most common dinucleotides at the acceptor splice site are GU and CT. These motifs are important for the recognition of the splice sites by the U1 and U2 small nuclear ribonucleoproteins (snRNPs).",
    "llama-7b_fact_raw": "1. Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are known as dinucleotides.\n2. Dinucleotides are composed of two nucleotides.\n3. The most common dinucleotides at the donor splice site are AG and GT.\n4. The most common dinucleotides at the acceptor splice site are GU and CT.\n5. The U1 and U2 small nuclear ribonucleoproteins (snRNPs) are involved in the recognition of the splice sites.",
    "llama-7b_fact": [
      "Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are known as dinucleotides.",
      "Dinucleotides are composed of two nucleotides.",
      "The most common dinucleotides at the donor splice site are AG and GT.",
      "The most common dinucleotides at the acceptor splice site are GU and CT.",
      "The U1 and U2 small nuclear ribonucleoproteins (snRNPs) are involved in the recognition of the splice sites."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are not known as dinucleotides; they are known as non-canonical splice sites or splice site variants.\n2. TRUE\n3. FALSE [correction]: The most common dinucleotides at the donor splice site are GT and AG, not AG and GT. The order matters because GT is at the 5' end and AG is at the 3' end of the intron.\n4. FALSE [correction]: The most common dinucleotide at the acceptor splice site is AG, not GU and CT. GU and CT are not associated with the acceptor splice site.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-7b_response": "The acetylation of S6K1 is catalyzed by the p300 histone acetyltransferase, which is activated by the phosphorylation of S6K1 by the protein kinase Akt.",
    "llama-7b_fact_raw": "1. The acetylation of S6K1 is catalyzed by the p300 histone acetyltransferase.\n2. The p300 histone acetyltransferase is activated by the phosphorylation of S6K1.\n3. The protein kinase Akt is responsible for the phosphorylation of S6K1.",
    "llama-7b_fact": [
      "The acetylation of S6K1 is catalyzed by the p300 histone acetyltransferase.",
      "The p300 histone acetyltransferase is activated by the phosphorylation of S6K1.",
      "The protein kinase Akt is responsible for the phosphorylation of S6K1."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n\nThe acetylation of specific proteins by p300 histone acetyltransferase and the activation mechanisms of p300 are complex and can vary depending on the context and the specific substrates involved. Without specific information from the passage regarding the acetylation of S6K1 by p300, it is not possible to determine the truth of statement 1.\n\nSimilarly, the activation of p300 can be influenced by various factors, and it is not typically described as being directly activated by the phosphorylation of S6K1. Therefore, the truth of statement 2 cannot be determined without additional context.\n\nStatement 3 is generally true as the protein kinase Akt (also known as Protein Kinase B) is known to phosphorylate S6K1 (ribosomal protein S6 kinase beta-1), which is part of the mTOR signaling pathway.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-7b_response": "The cause of episodic ataxia type 6 is a mutation in the CACNA1A gene. This gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel. The alpha-1A subunit is one of the proteins that make up the calcium channel, a protein complex that regulates the flow of calcium ions into the cell. The mutation that causes episodic ataxia type 6 results in a change in the amino acid sequence of the alpha-1A subunit, which disrupts the function of the calcium channel and leads to the symptoms of the disorder.",
    "llama-7b_fact_raw": "1. Episodic ataxia type 6 is caused by a mutation in the CACNA1A gene.\n2. The CACNA1A gene provides instructions for making the alpha-1A subunit of the voltage-gated calcium channel.\n3. The alpha-1A subunit is part of the protein complex that makes up the calcium channel.\n4. The mutation in the CACNA1A gene changes the amino acid sequence of the alpha-1A subunit.\n5. The disrupted function of the calcium channel due to the mutation leads to the symptoms of episodic ataxia type 6.",
    "llama-7b_fact": [
      "Episodic ataxia type 6 is caused by a mutation in the CACNA1A gene.",
      "The CACNA1A gene provides instructions for making the alpha-1A subunit of the voltage-gated calcium channel.",
      "The alpha-1A subunit is part of the protein complex that makes up the calcium channel.",
      "The mutation in the CACNA1A gene changes the amino acid sequence of the alpha-1A subunit.",
      "The disrupted function of the calcium channel due to the mutation leads to the symptoms of episodic ataxia type 6."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-7b_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that catalyze the transfer of a methyl group from one molecule to another. They are involved in a variety of biochemical reactions, including the methylation of DNA, RNA, and proteins. Chromomethylases have been found in the genomes of many animals, including humans.",
    "llama-7b_fact_raw": "1. Chromomethylases are present in animal genomes.\n2. Chromomethylases are enzymes that catalyze the transfer of a methyl group from one molecule to another.\n3. Chromomethylases are involved in the methylation of DNA, RNA, and proteins.\n4. Chromomethylases have been found in the genomes of humans.",
    "llama-7b_fact": [
      "Chromomethylases are present in animal genomes.",
      "Chromomethylases are enzymes that catalyze the transfer of a methyl group from one molecule to another.",
      "Chromomethylases are involved in the methylation of DNA, RNA, and proteins.",
      "Chromomethylases have been found in the genomes of humans."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Chromomethylases are not present in animal genomes; they are typically found in plants.\n2. TRUE\n3. FALSE [correction]: Chromomethylases are specifically involved in the methylation of DNA, not RNA or proteins.\n4. FALSE [correction]: Chromomethylases have not been found in the genomes of humans; they are associated with plants.",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-7b_response": "The following packages are available in R/Bioconductor for transcription factor binding site (TFBS) analysis: \n\n1. Arabidopsis Transcription Factor Binding Site Database (ATFBSD) \n2. ChIPPeakAnnotator \n3. ChIPseeker \n4. DNase-seq PeakAnnotator \n5. FAIRE-seq PeakAnnotator \n6. Genomic Regions Enrichment of Transcription Factor (GREAT) \n7. Homer \n8. MotifSampler \n9. PFAM Transcription Factor Binding Sites \n10. Transfac \n11. Transcription Factor Binding Site Search Utility (TFBSeq) \n12. Transcription Factor Binding Site Search Utility (TFBSeq) 2.0 \n13. Transcription Factor Binding Site Search Utility (TFBSeq) 3.0 \n14. Transcription Factor Binding Site Search Utility (TFBSeq) 4.0 \n15. Transcription Factor Binding Site Search Utility (TFBSeq) 5.0 \n16. Transcription Factor Binding Site Search Utility (TFBSeq) 6.0 \n17. Transcription Factor Binding Site Search Utility (TFBSeq) 7.0 \n18. Transcription Factor Binding Site Search Utility (TFBSeq) 8.0 \n19. Transcription Factor Binding Site Search Utility (TFBSeq) 9.0 \n20. Transcription Factor Binding Site Search Utility (TFBSeq) 10.0 \n21. Transcription Factor Binding Site Search Utility (TFBSeq) 11.0 \n22. Transcription Factor Binding Site Search Utility (TFBSeq) 12.0 \n23. Transcription Factor Binding Site Search Utility (TFBSeq) 13.0 \n24. Transcription Factor Binding Site Search Utility (TFBSeq) 14.0 \n25. Transcription Factor Binding Site Search Utility (TFBSeq) 15.0 \n26. Transcription Factor Binding Site Search Utility (TF",
    "llama-7b_fact_raw": "1. Arabidopsis Transcription Factor Binding Site Database (ATFBSD) is available in R/Bioconductor for TFBS analysis.\n2. ChIPPeakAnnotator is a package available in R/Bioconductor for TFBS analysis.\n3. ChIPseeker is a package available in R/Bioconductor for TFBS analysis.\n4. DNase-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis.\n5. FAIRE-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis.",
    "llama-7b_fact": [
      "Arabidopsis Transcription Factor Binding Site Database (ATFBSD) is available in R/Bioconductor for TFBS analysis.",
      "ChIPPeakAnnotator is a package available in R/Bioconductor for TFBS analysis.",
      "ChIPseeker is a package available in R/Bioconductor for TFBS analysis.",
      "DNase-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis.",
      "FAIRE-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Arabidopsis Transcription Factor Binding Site Database (ATFBSD) is not a package in R/Bioconductor; it is a database. Tools for TFBS analysis in R/Bioconductor include packages like TFBSTools.\n2. UNKNOWN: ChIPPeakAnnotator is not a well-known package in R/Bioconductor for TFBS analysis. It is possible that the statement refers to a different or less common tool, or it could be a mistake. Without more information, the accuracy of this statement cannot be determined.\n3. TRUE: ChIPseeker is indeed a package available in R/Bioconductor for annotating ChIP-seq data, which includes TFBS analysis.\n4. FALSE [correction]: There is no package specifically named \"DNase-seq PeakAnnotator\" in R/Bioconductor for TFBS analysis. However, there are other tools available for analyzing DNase-seq data, such as the \"DiffBind\" package.\n5. FALSE [correction]: There is no package specifically named \"FAIRE-seq PeakAnnotator\" in R/Bioconductor for TFBS analysis. FAIRE-seq data can be analyzed using various other packages in R/Bioconductor, such as \"csaw\" or \"DiffBind\".",
    "llama-7b_judge": [
      "false",
      "unknown",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-7b_response": "Clinical trials for the prevention of sarcopenia include the Sarcopenia Prevention Evaluation (SARPREV) trial, the Sarcopenia Prevention Evaluation (SARPREV-2) trial, the Sarcopenia Prevention Evaluation (SARPREV-3) trial, the Sarcopenia Prevention Evaluation (SARPREV-4) trial, the Sarcopenia Prevention Evaluation (SARPREV-5) trial, the Sarcopenia Prevention Evaluation (SARPREV-6) trial, the Sarcopenia Prevention Evaluation (SARPREV-7) trial, the Sarcopenia Prevention Evaluation (SARPREV-8) trial, the Sarcopenia Prevention Evaluation (SARPREV-9) trial, the Sarcopenia Prevention Evaluation (SARPREV-10) trial, the Sarcopenia Prevention Evaluation (SARPREV-11) trial, the Sarcopenia Prevention Evaluation (SARPREV-12) trial, the Sarcopenia Prevention Evaluation (SARPREV-13) trial, the Sarcopenia Prevention Evaluation (SARPREV-14) trial, the Sarcopenia Prevention Evaluation (SARPREV-15) trial, the Sarcopenia Prevention Evaluation (SARPREV-16) trial, the Sarcopenia Prevention Evaluation (SARPREV-17) trial, the Sarcopenia Prevention Evaluation (SARPREV-18) trial, the Sarcopenia Prevention Evaluation (SARPREV-19) trial, the Sarcopenia Prevention Evaluation (SARPREV-20) trial, the Sarcopenia Prevention Evaluation (SARPREV-21) trial, the Sarcopenia Prevention Evaluation (SARPREV-22) trial, the Sarcopenia Prevention Evaluation (SARPREV-23) trial, the Sarcopenia Prevention Evaluation (SARPREV-24) trial, the Sarcopen",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-7b_response": "The Database of Molecular Recognition Features in Membrane Proteins (DMRM) is a comprehensive database that provides information about molecular recognition features in membrane proteins. It contains information about the types of features, their locations, and the amino acid residues involved in the recognition process. The database also provides a platform for researchers to share their data and insights.",
    "llama-7b_fact_raw": "1. The Database of Molecular Recognition Features in Membrane Proteins (DMRM) provides information about molecular recognition features in membrane proteins.\n2. The DMRM contains information about the types of features, their locations, and the amino acid residues involved in the recognition process.\n3. The DMRM serves as a platform for researchers to share their data and insights.",
    "llama-7b_fact": [
      "The Database of Molecular Recognition Features in Membrane Proteins (DMRM) provides information about molecular recognition features in membrane proteins.",
      "The DMRM contains information about the types of features, their locations, and the amino acid residues involved in the recognition process.",
      "The DMRM serves as a platform for researchers to share their data and insights."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. It is cleared primarily by the cytochrome P450 2C9 (CYP2C9) enzyme, which is primarily located in the liver and kidneys. The metabolites of rivaroxaban are mainly excreted in the urine. Therefore, kidney function is an important factor in the elimination of rivaroxaban from the body.",
    "llama-7b_fact_raw": "1. Rivaroxaban is metabolized in the kidneys.\n2. The cytochrome P450 2C9 (CYP2C9) enzyme is involved in the clearance of rivaroxaban.\n3. The CYP2C9 enzyme is located primarily in the liver and kidneys.\n4. The metabolites of rivaroxaban are mainly excreted in the urine.\n5. Kidney function is an important factor in the elimination of rivaroxaban from the body.",
    "llama-7b_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "The cytochrome P450 2C9 (CYP2C9) enzyme is involved in the clearance of rivaroxaban.",
      "The CYP2C9 enzyme is located primarily in the liver and kidneys.",
      "The metabolites of rivaroxaban are mainly excreted in the urine.",
      "Kidney function is an important factor in the elimination of rivaroxaban from the body."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Rivaroxaban is primarily metabolized in the liver, not the kidneys.\n2. FALSE [correction]: The cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) are the primary enzymes involved in the metabolism and clearance of rivaroxaban, not CYP2C9.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-7b_response": "TRalpha2 is a nuclear receptor that plays an important role in the development and function of the heart. Studies have shown that TRalpha2 is involved in the regulation of genes that are important for cardiac growth and development, including genes that code for proteins involved in cardiac muscle contraction, electrical conduction, and heart rhythm regulation. Additionally, TRalpha2 has been shown to regulate genes involved in the development of cardiac hypertrophy and heart failure.",
    "llama-7b_fact_raw": "1. TRalpha2 is a nuclear receptor that is involved in heart development and function.\n2. TRalpha2 regulates genes important for cardiac growth and development.\n3. TRalpha2 influences genes that code for proteins involved in cardiac muscle contraction.\n4. TRalpha2 affects genes related to electrical conduction and heart rhythm regulation.\n5. TRalpha2 has been shown to regulate genes involved in the development of cardiac hypertrophy and heart failure.",
    "llama-7b_fact": [
      "TRalpha2 is a nuclear receptor that is involved in heart development and function.",
      "TRalpha2 regulates genes important for cardiac growth and development.",
      "TRalpha2 influences genes that code for proteins involved in cardiac muscle contraction.",
      "TRalpha2 affects genes related to electrical conduction and heart rhythm regulation.",
      "TRalpha2 has been shown to regulate genes involved in the development of cardiac hypertrophy and heart failure."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with the known functions of nuclear receptors related to heart development and function. TRalpha2, a variant of the thyroid hormone receptor, is known to regulate genes important for cardiac growth and development, including those involved in muscle contraction and potentially those related to electrical conduction and heart rhythm. It can also be involved in pathological processes such as cardiac hypertrophy and heart failure. However, without specific references to scientific literature, these statements are assumed to be true based on general knowledge of the role of thyroid hormone receptors in the heart.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-7b_response": "There are several biomedical question answering systems available, including PubMedQA, MEDQA, BioASQ, and Biocreative III. PubMedQA is a question answering system for biomedical literature, MEDQA is a question answering system for medical textbooks, BioASQ is a question answering system for genomics data, and Biocreative III is a question answering system for biomedical research papers.",
    "llama-7b_fact_raw": "1. PubMedQA is a question answering system for biomedical literature.\n2. MEDQA is a question answering system for medical textbooks.\n3. BioASQ is a question answering system for genomics data.\n4. Biocreative III is a question answering system for biomedical research papers.",
    "llama-7b_fact": [
      "PubMedQA is a question answering system for biomedical literature.",
      "MEDQA is a question answering system for medical textbooks.",
      "BioASQ is a question answering system for genomics data.",
      "Biocreative III is a question answering system for biomedical research papers."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: PubMedQA is a dataset for biomedical question answering, not a question answering system itself.\n2. UNKNOWN\n3. FALSE [correction]: BioASQ is a challenge on biomedical semantic indexing and question answering, not specifically for genomics data.\n4. FALSE [correction]: Biocreative III is a challenge that involves tasks such as gene mention recognition and protein-protein interaction, not a question answering system.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-7b_response": "The trancription factor that activates the betalain pathway is the Betaine-Homocysteine S-Methyltransferase 2 (BHMT2) protein. BHMT2 is a key regulator of the betalain pathway, which is responsible for the synthesis of the pigments that give beets and other plants their red and yellow colors. BHMT2 binds to the promoter region of the genes that code for the enzymes involved in the betalain pathway and activates their transcription, thereby initiating the pathway.",
    "llama-7b_fact_raw": "1. The transcription factor that activates the betalain pathway is Betaine-Homocysteine S-Methyltransferase 2 (BHMT2).\n2. BHMT2 is a key regulator of the betalain pathway.\n3. The betalain pathway is responsible for the synthesis of pigments that give beets and other plants their red and yellow colors.\n4. BHMT2 binds to the promoter region of the genes coding for enzymes involved in the betalain pathway.\n5. BHMT2 activates the transcription of genes involved in the betalain pathway.",
    "llama-7b_fact": [
      "The transcription factor that activates the betalain pathway is Betaine-Homocysteine S-Methyltransferase 2 (BHMT2).",
      "BHMT2 is a key regulator of the betalain pathway.",
      "The betalain pathway is responsible for the synthesis of pigments that give beets and other plants their red and yellow colors.",
      "BHMT2 binds to the promoter region of the genes coding for enzymes involved in the betalain pathway.",
      "BHMT2 activates the transcription of genes involved in the betalain pathway."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The transcription factor that activates the betalain pathway is not Betaine-Homocysteine S-Methyltransferase 2 (BHMT2); it is more likely to be a transcription factor specifically involved in pigment synthesis, such as MYB or bHLH transcription factors.\n2. FALSE [correction]: BHMT2 is not a key regulator of the betalain pathway; it is an enzyme involved in homocysteine metabolism.\n3. TRUE\n4. FALSE [correction]: BHMT2 does not bind to the promoter region of genes coding for enzymes involved in the betalain pathway; it is not a transcription factor.\n5. FALSE [correction]: BHMT2 does not activate the transcription of genes involved in the betalain pathway; it is involved in a different metabolic process.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-7b_response": "The preferred technologies for the enrichment of phosphorylated peptides are titanium dioxide (TiO2), immobilized metal affinity chromatography (IMAC), and metal-chelate affinity chromatography (MCA).",
    "llama-7b_fact_raw": "1. Titanium dioxide (TiO2) is a preferred technology for the enrichment of phosphorylated peptides.\n2. Immobilized metal affinity chromatography (IMAC) is a preferred technology for the enrichment of phosphorylated peptides.\n3. Metal-chelate affinity chromatography (MCA) is a preferred technology for the enrichment of phosphorylated peptides.",
    "llama-7b_fact": [
      "Titanium dioxide (TiO2) is a preferred technology for the enrichment of phosphorylated peptides.",
      "Immobilized metal affinity chromatography (IMAC) is a preferred technology for the enrichment of phosphorylated peptides.",
      "Metal-chelate affinity chromatography (MCA) is a preferred technology for the enrichment of phosphorylated peptides."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Titanium dioxide (TiO2) is a preferred technology for the enrichment of phosphorylated proteins, not peptides.\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-7b_response": "The disorder rated by the Palmini classification is Obsessive Compulsive Disorder (OCD).",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-7b_response": "Yes, viruses are involved in the etiology of human subacute thyroiditis. Several studies have suggested that viruses, such as the rubella virus and the human papillomavirus, can cause subacute thyroiditis. These viruses can cause inflammation and destruction of the thyroid gland, leading to the clinical features of subacute thyroiditis.",
    "llama-7b_fact_raw": "1. Viruses are involved in the etiology of human subacute thyroiditis.\n2. Studies have suggested that the rubella virus can cause subacute thyroiditis.\n3. Studies have suggested that the human papillomavirus can cause subacute thyroiditis.\n4. Viral involvement in subacute thyroiditis can lead to inflammation and destruction of the thyroid gland.",
    "llama-7b_fact": [
      "Viruses are involved in the etiology of human subacute thyroiditis.",
      "Studies have suggested that the rubella virus can cause subacute thyroiditis.",
      "Studies have suggested that the human papillomavirus can cause subacute thyroiditis.",
      "Viral involvement in subacute thyroiditis can lead to inflammation and destruction of the thyroid gland."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Studies have suggested that the mumps virus, not the rubella virus, can cause subacute thyroiditis.\n3. FALSE [correction]: There is no strong evidence to suggest that the human papillomavirus (HPV) causes subacute thyroiditis. HPV is primarily associated with conditions such as warts and cervical cancer.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-7b_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. STAT3 is a transcription factor that plays an important role in the regulation of cell growth and metabolism. It has been reported that STAT3 binds to the promoter region of EIF2AK2 and inhibits its expression, leading to the suppression of autophagy.",
    "llama-7b_fact_raw": "1. STAT3 is involved in EIF2AK2-dependent suppression of autophagy.\n2. STAT3 is a transcription factor that regulates cell growth and metabolism.\n3. STAT3 binds to the promoter region of EIF2AK2.\n4. STAT3 inhibits the expression of EIF2AK2.\n5. The inhibition of EIF2AK2 expression by STAT3 leads to the suppression of autophagy.",
    "llama-7b_fact": [
      "STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
      "STAT3 is a transcription factor that regulates cell growth and metabolism.",
      "STAT3 binds to the promoter region of EIF2AK2.",
      "STAT3 inhibits the expression of EIF2AK2.",
      "The inhibition of EIF2AK2 expression by STAT3 leads to the suppression of autophagy."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided are specific to molecular biology and the interactions between proteins and genes. Without specific scientific evidence or studies to reference, it is not possible to accurately confirm or correct these statements. They require specialized knowledge and access to current scientific research data.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-7b_response": "The Theatre software tool is used for genomic analysis and is designed to facilitate the analysis of large-scale genomic data sets. It provides a graphical user interface (GUI) that allows users to quickly and easily visualize, navigate, and analyze their genomic data. It also provides a range of analysis tools, such as alignment, annotation, and comparison tools, which can be used to gain insights into the structure and function of genomes.",
    "llama-7b_fact_raw": "1. The Theatre software tool is used for genomic analysis.\n2. It is designed to handle large-scale genomic data sets.\n3. The Theatre software tool provides a graphical user interface (GUI).\n4. The software includes tools for alignment, annotation, and comparison of genomic data.\n5. The Theatre software tool helps users visualize, navigate, and analyze genomic data.",
    "llama-7b_fact": [
      "The Theatre software tool is used for genomic analysis.",
      "It is designed to handle large-scale genomic data sets.",
      "The Theatre software tool provides a graphical user interface (GUI).",
      "The software includes tools for alignment, annotation, and comparison of genomic data.",
      "The Theatre software tool helps users visualize, navigate, and analyze genomic data."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The correct name of the software tool is the Integrative Genomics Viewer (IGV), not Theatre.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNote: The correction in statement 1 assumes that the intended software tool is IGV, which is a commonly used tool for genomic analysis. If \"Theatre\" is a fictional or less well-known software tool, the truth value of statement 1 could be different, but based on the information provided, it is assumed to be a mistake.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-7b_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(m*n), where m and n are the lengths of the two sequences.",
    "llama-7b_fact_raw": "1. The execution time (complexity) of the Smith-Waterman algorithm is O(m*n).\n2. The complexity of the Smith-Waterman algorithm depends on the lengths of the two sequences being aligned.\n3. The variables m and n represent the lengths of the two sequences in the Smith-Waterman algorithm's complexity expression.",
    "llama-7b_fact": [
      "The execution time (complexity) of the Smith-Waterman algorithm is O(m*n).",
      "The complexity of the Smith-Waterman algorithm depends on the lengths of the two sequences being aligned.",
      "The variables m and n represent the lengths of the two sequences in the Smith-Waterman algorithm's complexity expression."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-7b_response": "FLVCR1 is a member of the SLC family.",
    "llama-7b_fact_raw": "1. FLVCR1 is a member of the SLC family.",
    "llama-7b_fact": [
      "FLVCR1 is a member of the SLC family."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: FLVCR1 is not a member of the SLC (Solute Carrier) family. It is a member of the Major Facilitator Superfamily (MFS).",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-7b_response": "GATA-1 interacting partners that have been discovered with the help of the biotinylation tagging approach include transcription factors such as GATA-2, GATA-3, GATA-4, and GATA-5; transcriptional co-activators such as p300, CBP, and PCAF; and transcriptional co-repressors such as SMRT and N-CoR. Additionally, GATA-1 has been shown to interact with several proteins involved in cell growth and proliferation, including c-Myc, cyclin D1, and CDK4.",
    "llama-7b_fact_raw": "1. GATA-1 interacts with other transcription factors including GATA-2, GATA-3, GATA-4, and GATA-5.\n2. GATA-1 interacts with transcriptional co-activators such as p300, CBP, and PCAF.\n3. GATA-1 interacts with transcriptional co-repressors including SMRT and N-CoR.\n4. GATA-1 has been shown to interact with proteins involved in cell growth and proliferation such as c-Myc.\n5. GATA-1 has been shown to interact with cyclin D1 and CDK4.",
    "llama-7b_fact": [
      "GATA-1 interacts with other transcription factors including GATA-2, GATA-3, GATA-4, and GATA-5.",
      "GATA-1 interacts with transcriptional co-activators such as p300, CBP, and PCAF.",
      "GATA-1 interacts with transcriptional co-repressors including SMRT and N-CoR.",
      "GATA-1 has been shown to interact with proteins involved in cell growth and proliferation such as c-Myc.",
      "GATA-1 has been shown to interact with cyclin D1 and CDK4."
    ],
    "llama-7b_judge_raw": "1. TRUE: GATA-1 is known to interact with other members of the GATA family of transcription factors, which includes GATA-2, GATA-3, GATA-4, and GATA-5.\n2. TRUE: GATA-1 does interact with transcriptional co-activators such as p300, CBP (CREB-binding protein), and PCAF (p300/CBP-associated factor).\n3. TRUE: GATA-1 is known to interact with transcriptional co-repressors, including SMRT (Silencing Mediator for Retinoid and Thyroid hormone receptors) and N-CoR (Nuclear receptor Co-Repressor).\n4. TRUE: GATA-1 has been shown to interact with proteins involved in cell growth and proliferation, such as c-Myc, which is a well-known regulator of these processes.\n5. UNKNOWN: While GATA-1 is involved in the regulation of cell proliferation and differentiation, the specific interaction with cyclin D1 and CDK4 (Cyclin-Dependent Kinase 4) is not as well-established in the literature as the other interactions mentioned. Without specific context or references, the interaction with cyclin D1 and CDK4 cannot be confirmed as true or false.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-7b_response": "The interaction of TAF10 with the GATA1 transcription factor leads to the activation of GATA1-dependent genes, which are involved in the development and function of the cardiovascular system. This interaction also plays a role in the differentiation of embryonic stem cells and the formation of the heart, blood vessels, and other organs.",
    "llama-7b_fact_raw": "1. TAF10 interaction with the GATA1 transcription factor leads to the activation of GATA1-dependent genes.\n2. GATA1-dependent genes are involved in the development and function of the cardiovascular system.\n3. The interaction between TAF10 and GATA1 plays a role in the differentiation of embryonic stem cells.\n4. The interaction is involved in the formation of the heart and blood vessels.\n5. The interaction contributes to the formation of other organs.",
    "llama-7b_fact": [
      "TAF10 interaction with the GATA1 transcription factor leads to the activation of GATA1-dependent genes.",
      "GATA1-dependent genes are involved in the development and function of the cardiovascular system.",
      "The interaction between TAF10 and GATA1 plays a role in the differentiation of embryonic stem cells.",
      "The interaction is involved in the formation of the heart and blood vessels.",
      "The interaction contributes to the formation of other organs."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-7b_response": "Yes, there are several Decision support systems for chronic pain management. These systems are designed to help healthcare providers and patients make informed decisions about the best treatment options for chronic pain. For example, the Pain Management Decision Support System (PM-DSS) is a web-based tool that provides evidence-based recommendations for the management of chronic pain. The system takes into account the patient's medical history, current medications, and other factors to generate personalized treatment plans.",
    "llama-7b_fact_raw": "1. There are Decision support systems designed for chronic pain management.\n2. These systems assist healthcare providers and patients in making decisions about chronic pain treatment options.\n3. The Pain Management Decision Support System (PM-DSS) is a web-based tool.\n4. PM-DSS provides evidence-based recommendations for managing chronic pain.\n5. PM-DSS generates personalized treatment plans considering the patient's medical history and current medications.",
    "llama-7b_fact": [
      "There are Decision support systems designed for chronic pain management.",
      "These systems assist healthcare providers and patients in making decisions about chronic pain treatment options.",
      "The Pain Management Decision Support System (PM-DSS) is a web-based tool.",
      "PM-DSS provides evidence-based recommendations for managing chronic pain.",
      "PM-DSS generates personalized treatment plans considering the patient's medical history and current medications."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-7b_response": "Angiogenin is a secreted protein that localizes to the extracellular space.",
    "llama-7b_fact_raw": "1. Angiogenin is a secreted protein.\n2. Angiogenin localizes to the extracellular space.",
    "llama-7b_fact": [
      "Angiogenin is a secreted protein.",
      "Angiogenin localizes to the extracellular space."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-7b_response": "Ranolazine is a novel anti-angina drug that inhibits the voltage-gated potassium channel Kv1.5. This leads to an increase in the concentration of extracellular potassium, which in turn inhibits the activity of protein kinase A (PKA) and protein kinase C (PKC). As a result, ranolazine reduces the activity of protein kinase-dependent signaling pathways, such as the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways, which are important in the regulation of cardiac hypertrophy and remodeling. By inhibiting these kinase signaling pathways, ranolazine reduces myocardial ischemia and angina pectoris.",
    "llama-7b_fact_raw": "1. Ranolazine inhibits the voltage-gated potassium channel Kv1.5.\n2. Inhibition of Kv1.5 by ranolazine leads to an increase in the concentration of extracellular potassium.\n3. Increased extracellular potassium concentration inhibits the activity of protein kinase A (PKA) and protein kinase C (PKC).\n4. Ranolazine reduces the activity of protein kinase-dependent signaling pathways, including the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways.\n5. Ranolazine is used to reduce myocardial ischemia and angina pectoris.",
    "llama-7b_fact": [
      "Ranolazine inhibits the voltage-gated potassium channel Kv1.5.",
      "Inhibition of Kv1.5 by ranolazine leads to an increase in the concentration of extracellular potassium.",
      "Increased extracellular potassium concentration inhibits the activity of protein kinase A (PKA) and protein kinase C (PKC).",
      "Ranolazine reduces the activity of protein kinase-dependent signaling pathways, including the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways.",
      "Ranolazine is used to reduce myocardial ischemia and angina pectoris."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Ranolazine inhibits the late sodium current (I_Na) in cardiac cells, not the voltage-gated potassium channel Kv1.5.\n2. FALSE [correction]: Inhibition of Kv1.5 would lead to a decrease in the repolarization current in cardiac cells, but since ranolazine inhibits the late sodium current, not Kv1.5, this statement is not applicable to the action of ranolazine.\n3. UNKNOWN: The statement is a general claim about the effects of increased extracellular potassium concentration on protein kinases, but without specific context or evidence, it's difficult to determine its accuracy.\n4. UNKNOWN: While ranolazine may have effects on various signaling pathways, the statement is too specific without context or evidence to support the direct inhibition of these pathways by ranolazine.\n5. TRUE: Ranolazine is used clinically to treat chronic angina and may help to reduce symptoms of myocardial ischemia.",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-7b_response": "Yes, the regulation of Vsr endonuclease is independent of the growth phase of bacteria. This means that the enzyme's activity is not affected by the stage of bacterial growth. Vsr endonuclease is an RNA-specific endonuclease that plays a role in the bacterial stress response. It is activated in response to the presence of double-stranded RNA and is involved in the degradation of mRNAs that contain viral-like sequences.",
    "llama-7b_fact_raw": "1. The regulation of Vsr endonuclease is independent of the growth phase of bacteria.\n2. Vsr endonuclease is an RNA-specific endonuclease.\n3. Vsr endonuclease plays a role in the bacterial stress response.\n4. Vsr endonuclease is activated in response to the presence of double-stranded RNA.\n5. Vsr endonuclease is involved in the degradation of mRNAs that contain viral-like sequences.",
    "llama-7b_fact": [
      "The regulation of Vsr endonuclease is independent of the growth phase of bacteria.",
      "Vsr endonuclease is an RNA-specific endonuclease.",
      "Vsr endonuclease plays a role in the bacterial stress response.",
      "Vsr endonuclease is activated in response to the presence of double-stranded RNA.",
      "Vsr endonuclease is involved in the degradation of mRNAs that contain viral-like sequences."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Vsr endonuclease is a DNA-specific endonuclease, not RNA-specific.\n3. UNKNOWN\n4. FALSE [correction]: Vsr endonuclease is not known to be activated in response to the presence of double-stranded RNA; it recognizes and cleaves specific DNA sequences.\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-7b_response": "Computational tools for the prediction of beta-barrel transmembrane proteins include the beta-barrel prediction algorithm of TMHMM, the beta-barrel assembly line (BARL) algorithm, and the beta-barrel topology predictor (BTP). TMHMM is a Hidden Markov Model (HMM) based method that uses a training dataset of beta-barrel proteins to predict the beta-barrel topology of a given protein. BARL is an algorithm that uses a combination of HMMs and threading to predict the beta-barrel topology of a given protein. BTP is a web server that uses a combination of HMMs and neural networks to predict the beta-barrel topology of a given protein.",
    "llama-7b_fact_raw": "1. TMHMM is a computational tool that uses a Hidden Markov Model to predict the beta-barrel topology of proteins.\n2. The beta-barrel assembly line (BARL) algorithm combines Hidden Markov Models and threading to predict beta-barrel topology.\n3. The beta-barrel topology predictor (BTP) is a web server that employs both Hidden Markov Models and neural networks for prediction purposes.\n4. TMHMM, BARL, and BTP are tools specifically designed for the prediction of beta-barrel transmembrane proteins.",
    "llama-7b_fact": [
      "TMHMM is a computational tool that uses a Hidden Markov Model to predict the beta-barrel topology of proteins.",
      "The beta-barrel assembly line (BARL) algorithm combines Hidden Markov Models and threading to predict beta-barrel topology.",
      "The beta-barrel topology predictor (BTP) is a web server that employs both Hidden Markov Models and neural networks for prediction purposes.",
      "TMHMM, BARL, and BTP are tools specifically designed for the prediction of beta-barrel transmembrane proteins."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: TMHMM is a computational tool that uses a Hidden Markov Model to predict the transmembrane helices in proteins, not the beta-barrel topology.\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: TMHMM is not specifically designed for the prediction of beta-barrel transmembrane proteins; it is designed for predicting transmembrane helices. Without additional context, the specificity of BARL and BTP for beta-barrel transmembrane proteins cannot be confirmed.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-7b_response": "Galassi classification is used to classify epileptic seizures.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-7b_response": "Common features of Shapiro syndrome include short stature, intellectual disability, distinctive facial features such as a broad forehead, epicanthal folds, and a short, upturned nose, and speech and language delays. People with Shapiro syndrome may also have hearing loss, heart defects, and kidney abnormalities.",
    "llama-7b_fact_raw": "1. Shapiro syndrome is associated with short stature.\n2. Intellectual disability is a common feature of Shapiro syndrome.\n3. Distinctive facial features of Shapiro syndrome include a broad forehead, epicanthal folds, and a short, upturned nose.\n4. Speech and language delays are common in individuals with Shapiro syndrome.\n5. People with Shapiro syndrome may experience hearing loss, heart defects, and kidney abnormalities.",
    "llama-7b_fact": [
      "Shapiro syndrome is associated with short stature.",
      "Intellectual disability is a common feature of Shapiro syndrome.",
      "Distinctive facial features of Shapiro syndrome include a broad forehead, epicanthal folds, and a short, upturned nose.",
      "Speech and language delays are common in individuals with Shapiro syndrome.",
      "People with Shapiro syndrome may experience hearing loss, heart defects, and kidney abnormalities."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is characterized by the triad of recurrent episodes of spontaneous hypothermia, hyperhidrosis, and agenesis of the corpus callosum; it is not typically associated with short stature.\n2. UNKNOWN: While some individuals with Shapiro syndrome may experience developmental delays or intellectual disability, it is not stated as a common feature in the literature, and the variability of the syndrome makes it difficult to confirm as a common feature without specific context.\n3. FALSE [correction]: The distinctive facial features described are not associated with Shapiro syndrome. These features may be associated with other genetic conditions, but Shapiro syndrome is primarily characterized by the triad mentioned earlier.\n4. UNKNOWN: Speech and language delays can occur in individuals with various neurological conditions, but without specific context, it is not possible to confirm this as a common feature of Shapiro syndrome.\n5. FALSE [correction]: Hearing loss, heart defects, and kidney abnormalities are not typically associated with Shapiro syndrome. The primary features of Shapiro syndrome are the triad of hypothermia, hyperhidrosis, and agenesis of the corpus callosum. Other symptoms may vary widely among individuals.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-7b_response": "BRAG1-related cancer is linked to mutations in the BRAG1 gene. These mutations can cause changes in the protein produced by the BRAG1 gene, which can lead to uncontrolled cell growth and the development of cancer.",
    "llama-7b_fact_raw": "1. BRAG1-related cancer is associated with mutations in the BRAG1 gene.\n2. Mutations in the BRAG1 gene can cause changes in the protein it produces.\n3. The changes in the protein produced by the BRAG1 gene can lead to uncontrolled cell growth.\n4. Uncontrolled cell growth due to mutations in the BRAG1 gene can result in the development of cancer.",
    "llama-7b_fact": [
      "BRAG1-related cancer is associated with mutations in the BRAG1 gene.",
      "Mutations in the BRAG1 gene can cause changes in the protein it produces.",
      "The changes in the protein produced by the BRAG1 gene can lead to uncontrolled cell growth.",
      "Uncontrolled cell growth due to mutations in the BRAG1 gene can result in the development of cancer."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n\nNote: While statements 2, 3, and 4 are generally true for genes associated with cancer, the specificity of \"BRAG1-related cancer\" cannot be confirmed without additional context or scientific literature that specifically discusses the BRAG1 gene and its association with cancer. If \"BRAG1\" is a hypothetical or less commonly known gene, the information might not be readily available, hence the \"UNKNOWN\" status for statement 1. If \"BRAG1\" is a typographical error or a misrepresentation of a known cancer-related gene (e.g., BRCA1), then the statement would need to be corrected accordingly.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-7b_response": "The protein that is the main inhibitor of protein phosphatase 1 (PP1) is PP1 catalytic subunit inhibitor 1 (PPI1). PPI1 is a protein that binds to and inhibits the activity of the PP1 catalytic subunit, preventing it from dephosphorylating other proteins.",
    "llama-7b_fact_raw": "1. PP1 catalytic subunit inhibitor 1 (PPI1) is the main inhibitor of protein phosphatase 1 (PP1).\n2. PPI1 binds to and inhibits the activity of the PP1 catalytic subunit.\n3. The inhibition by PPI1 prevents PP1 from dephosphorylating other proteins.",
    "llama-7b_fact": [
      "PP1 catalytic subunit inhibitor 1 (PPI1) is the main inhibitor of protein phosphatase 1 (PP1).",
      "PPI1 binds to and inhibits the activity of the PP1 catalytic subunit.",
      "The inhibition by PPI1 prevents PP1 from dephosphorylating other proteins."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The main inhibitor of protein phosphatase 1 (PP1) is not known as PP1 catalytic subunit inhibitor 1 (PPI1). The primary regulatory subunits that control PP1 activity are often referred to as \"inhibitor-1\" (I-1) and \"inhibitor-2\" (I-2), among others.\n2. UNKNOWN: Without specific information on \"PPI1,\" it is unclear whether this entity binds to and inhibits the activity of the PP1 catalytic subunit. If \"PPI1\" is a typographical error for \"I-1\" (inhibitor-1), then the statement would be true for I-1, but as it stands, the accuracy of the statement cannot be determined.\n3. UNKNOWN: Similarly, without clear information on \"PPI1,\" it is not possible to confirm whether the inhibition by this entity prevents PP1 from dephosphorylating other proteins. If \"PPI1\" is intended to refer to a known inhibitor of PP1 such as I-1, then the statement would be true for I-1. However, the statement's accuracy is uncertain with the given context.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-7b_response": "Adaptive mutagenesis in Bacillus subtilis, also known as stationary-phase mutagenesis, is a process by which the bacteria undergoes a series of genetic changes that allow it to better survive in its environment. This process is initiated when the bacteria enters a stationary phase, which is a dormant state where the bacteria is not actively growing. During this phase, the bacteria undergoes a series of genetic changes, such as point mutations, deletions, and insertions, which allow it to better survive in its environment. These changes are then passed on to the next generation, allowing the bacteria to better adapt to its environment.",
    "llama-7b_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis is also known as stationary-phase mutagenesis.\n2. Bacillus subtilis undergoes genetic changes to better survive in its environment during adaptive mutagenesis.\n3. The bacteria enters a stationary phase, which is a dormant state where it is not actively growing.\n4. During the stationary phase, Bacillus subtilis may undergo point mutations, deletions, and insertions.\n5. The genetic changes that occur during adaptive mutagenesis are passed on to the next generation of Bacillus subtilis.",
    "llama-7b_fact": [
      "Adaptive mutagenesis in Bacillus subtilis is also known as stationary-phase mutagenesis.",
      "Bacillus subtilis undergoes genetic changes to better survive in its environment during adaptive mutagenesis.",
      "The bacteria enters a stationary phase, which is a dormant state where it is not actively growing.",
      "During the stationary phase, Bacillus subtilis may undergo point mutations, deletions, and insertions.",
      "The genetic changes that occur during adaptive mutagenesis are passed on to the next generation of Bacillus subtilis."
    ],
    "llama-7b_judge_raw": "1. TRUE: Adaptive mutagenesis in Bacillus subtilis is often associated with stationary-phase mutagenesis, which occurs when the bacteria are in a nutrient-depleted, non-growing state.\n2. TRUE: During adaptive mutagenesis, Bacillus subtilis can undergo genetic changes that may enhance its survival in stressful environments.\n3. TRUE: The stationary phase is characterized by a cessation of growth due to a lack of nutrients or other unfavorable conditions, and the bacteria are not actively dividing, though they are not necessarily dormant.\n4. TRUE: During the stationary phase, genetic changes such as point mutations, deletions, and insertions can occur in Bacillus subtilis.\n5. TRUE: The genetic changes that occur during adaptive mutagenesis can be heritable and thus passed on to subsequent generations of Bacillus subtilis if the mutations confer a survival advantage and are not lethal.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-7b_response": "Erucism is caused by a deficiency of alpha-linolenic acid (an omega-3 fatty acid) in the diet. This deficiency can be due to a diet that is low in plant sources of omega-3 fatty acids, such as flaxseed, chia seed, and walnut, or to a diet that is low in overall fat. It can also be caused by certain medical conditions, such as cystic fibrosis, that affect fat absorption.",
    "llama-7b_fact_raw": "1. Erucism is caused by a deficiency of alpha-linolenic acid, an omega-3 fatty acid.\n2. A diet low in plant sources of omega-3 fatty acids can lead to erucism.\n3. Flaxseed, chia seed, and walnut are plant sources of omega-3 fatty acids.\n4. A diet low in overall fat can contribute to the development of erucism.\n5. Certain medical conditions, such as cystic fibrosis, can affect fat absorption and lead to erucism.",
    "llama-7b_fact": [
      "Erucism is caused by a deficiency of alpha-linolenic acid, an omega-3 fatty acid.",
      "A diet low in plant sources of omega-3 fatty acids can lead to erucism.",
      "Flaxseed, chia seed, and walnut are plant sources of omega-3 fatty acids.",
      "A diet low in overall fat can contribute to the development of erucism.",
      "Certain medical conditions, such as cystic fibrosis, can affect fat absorption and lead to erucism."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Erucism is not caused by a deficiency of alpha-linolenic acid, an omega-3 fatty acid. Erucism is a condition resulting from contact with the irritating hairs or spines of certain caterpillars.\n2. FALSE [correction]: Since erucism is not related to dietary deficiencies, a diet low in plant sources of omega-3 fatty acids does not lead to erucism.\n3. TRUE\n4. FALSE [correction]: A diet low in overall fat can contribute to various health issues, but it does not lead to erucism, which is caused by contact with certain caterpillars.\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-7b_response": "Hydrochlorothiazide is indicated for the treatment of hypertension, fluid retention, and swelling due to congestive heart failure, and for the prevention of kidney stones. It can also be used to treat mild to moderate edema in patients with heart, liver, or kidney disease.",
    "llama-7b_fact_raw": "1. Hydrochlorothiazide is used for the treatment of hypertension.\n2. Hydrochlorothiazide is indicated for the treatment of fluid retention and swelling due to congestive heart failure.\n3. Hydrochlorothiazide can be used for the prevention of kidney stones.\n4. Hydrochlorothiazide is used to treat mild to moderate edema in patients with heart, liver, or kidney disease.",
    "llama-7b_fact": [
      "Hydrochlorothiazide is used for the treatment of hypertension.",
      "Hydrochlorothiazide is indicated for the treatment of fluid retention and swelling due to congestive heart failure.",
      "Hydrochlorothiazide can be used for the prevention of kidney stones.",
      "Hydrochlorothiazide is used to treat mild to moderate edema in patients with heart, liver, or kidney disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-7b_response": "Yes, silicon has been used in the treatment of incontinence. It is a common material used in the construction of urinary catheters, which are inserted into the urethra to help manage urinary incontinence. Silicon is also used in the construction of sling procedures, which are used to support the urethra and bladder to help reduce incontinence.",
    "llama-7b_fact_raw": "1. Silicon has been used in the treatment of incontinence.\n2. Silicon is a common material used in the construction of urinary catheters.\n3. Urinary catheters are inserted into the urethra to help manage urinary incontinence.\n4. Silicon is used in the construction of sling procedures.\n5. Sling procedures are used to support the urethra and bladder to help reduce incontinence.",
    "llama-7b_fact": [
      "Silicon has been used in the treatment of incontinence.",
      "Silicon is a common material used in the construction of urinary catheters.",
      "Urinary catheters are inserted into the urethra to help manage urinary incontinence.",
      "Silicon is used in the construction of sling procedures.",
      "Sling procedures are used to support the urethra and bladder to help reduce incontinence."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Silicone, not silicon, has been used in the treatment of incontinence.\n2. FALSE [correction]: Silicone, a polymer, is a common material used in the construction of urinary catheters, not elemental silicon.\n3. TRUE\n4. FALSE [correction]: Silicone is used in the construction of sling procedures, not elemental silicon.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-7b_response": "The association between the moon cycle and rupture risk of intracranial aneurysms is controversial. Some studies have suggested that the risk of rupture is higher during the full moon, while others have found no correlation between the moon cycle and rupture risk. It is believed that the lunar cycle may affect the pressure in the brain, which could affect the risk of rupture. Further research is needed to better understand the relationship between the moon cycle and rupture risk of intracranial aneurysms.",
    "llama-7b_fact_raw": "1. Some studies suggest that the risk of rupture of intracranial aneurysms is higher during the full moon.\n2. Other studies have found no correlation between the moon cycle and the rupture risk of intracranial aneurysms.\n3. It is believed that the lunar cycle may affect the pressure in the brain.\n4. Further research is needed to understand the relationship between the moon cycle and rupture risk of intracranial aneurysms.",
    "llama-7b_fact": [
      "Some studies suggest that the risk of rupture of intracranial aneurysms is higher during the full moon.",
      "Other studies have found no correlation between the moon cycle and the rupture risk of intracranial aneurysms.",
      "It is believed that the lunar cycle may affect the pressure in the brain.",
      "Further research is needed to understand the relationship between the moon cycle and rupture risk of intracranial aneurysms."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-7b_response": "Yes, HuR protein has been shown to regulate the splicing process. HuR is a nuclear protein that binds to unspliced pre-mRNA and stimulates the splicing of the mRNA. It also binds to spliced mRNA and promotes the export of the mature mRNA from the nucleus. In addition, HuR has been shown to regulate the stability of mRNA, suggesting that it may play a role in the post-transcriptional regulation of gene expression.",
    "llama-7b_fact_raw": "1. HuR protein regulates the splicing process.\n2. HuR is a nuclear protein that binds to unspliced pre-mRNA.\n3. HuR stimulates the splicing of mRNA.\n4. HuR promotes the export of mature mRNA from the nucleus.\n5. HuR has been shown to regulate the stability of mRNA.",
    "llama-7b_fact": [
      "HuR protein regulates the splicing process.",
      "HuR is a nuclear protein that binds to unspliced pre-mRNA.",
      "HuR stimulates the splicing of mRNA.",
      "HuR promotes the export of mature mRNA from the nucleus.",
      "HuR has been shown to regulate the stability of mRNA."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: HuR protein primarily regulates mRNA stability and translation, not the splicing process.\n2. TRUE\n3. FALSE [correction]: HuR does not stimulate the splicing of mRNA; it is involved in regulating mRNA stability and translation.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-7b_response": "The prothymosin alpha c-terminal peptide has been found to have a variety of functions. It has been shown to play a role in the regulation of cell growth, differentiation, and apoptosis, as well as in the regulation of the actin cytoskeleton. Additionally, it has been found to interact with a variety of proteins, including kinases, phosphatases, and transcription factors.",
    "llama-7b_fact_raw": "1. The prothymosin alpha c-terminal peptide plays a role in the regulation of cell growth.\n2. The prothymosin alpha c-terminal peptide is involved in cell differentiation.\n3. The prothymosin alpha c-terminal peptide has a role in the regulation of apoptosis.\n4. The prothymosin alpha c-terminal peptide is involved in the regulation of the actin cytoskeleton.\n5. The prothymosin alpha c-terminal peptide interacts with various proteins, including kinases, phosphatases, and transcription factors.",
    "llama-7b_fact": [
      "The prothymosin alpha c-terminal peptide plays a role in the regulation of cell growth.",
      "The prothymosin alpha c-terminal peptide is involved in cell differentiation.",
      "The prothymosin alpha c-terminal peptide has a role in the regulation of apoptosis.",
      "The prothymosin alpha c-terminal peptide is involved in the regulation of the actin cytoskeleton.",
      "The prothymosin alpha c-terminal peptide interacts with various proteins, including kinases, phosphatases, and transcription factors."
    ],
    "llama-7b_judge_raw": "1. TRUE: Prothymosin alpha is known to be involved in cell proliferation and regulation of cell growth.\n2. TRUE: Prothymosin alpha has been implicated in cell differentiation processes.\n3. TRUE: Prothymosin alpha is involved in the regulation of apoptosis, as it has anti-apoptotic properties.\n4. UNKNOWN: While prothymosin alpha has various roles in the cell, its direct involvement in the regulation of the actin cytoskeleton is not well-established or may not be a primary function, so without specific context, this statement is difficult to confirm.\n5. TRUE: Prothymosin alpha is known to interact with various proteins, including those involved in signaling pathways such as kinases and phosphatases, as well as transcription factors, which are crucial for its role in cell proliferation and survival.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-7b_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the C-terminal domain (CTD) of cystatin C. The CTD of cystatin C is a highly conserved region that is responsible for the formation of the fibrils that are found in the nephrocytes of the kidney. It is believed that the CTD of cystatin C interacts with other cystatin C molecules to form the fibrils.",
    "llama-7b_fact_raw": "1. The C-terminal domain (CTD) of cystatin C plays a pivotal role in human cystatin C fibrillization.\n2. The CTD of cystatin C is a highly conserved region.\n3. The CTD of cystatin C is responsible for the formation of fibrils found in the nephrocytes of the kidney.\n4. The CTD of cystatin C interacts with other cystatin C molecules to form fibrils.",
    "llama-7b_fact": [
      "The C-terminal domain (CTD) of cystatin C plays a pivotal role in human cystatin C fibrillization.",
      "The CTD of cystatin C is a highly conserved region.",
      "The CTD of cystatin C is responsible for the formation of fibrils found in the nephrocytes of the kidney.",
      "The CTD of cystatin C interacts with other cystatin C molecules to form fibrils."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The C-terminal domain (CTD) of cystatin C is not a highly conserved region; it is the N-terminal domain that is typically more conserved.\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-7b_response": "Yes, the concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol). This is due to the fact that amifostine (ethyol) is a prodrug that is metabolized in the body to the active form of the drug, which is a potent inhibitor of the enzyme cytochrome P450 2B4. This enzyme is responsible for the degradation of HIF-1, and by inhibiting it, the concentration of HIF-1 increases.",
    "llama-7b_fact_raw": "1. The concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).\n2. Amifostine (ethyol) is metabolized in the body to its active form.\n3. The active form of amifostine is a potent inhibitor of the enzyme cytochrome P450 2B4.\n4. The enzyme cytochrome P450 2B4 is responsible for the degradation of HIF-1.\n5. Inhibition of cytochrome P450 2B4 leads to an increase in the concentration of HIF-1.",
    "llama-7b_fact": [
      "The concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).",
      "Amifostine (ethyol) is metabolized in the body to its active form.",
      "The active form of amifostine is a potent inhibitor of the enzyme cytochrome P450 2B4.",
      "The enzyme cytochrome P450 2B4 is responsible for the degradation of HIF-1.",
      "Inhibition of cytochrome P450 2B4 leads to an increase in the concentration of HIF-1."
    ],
    "llama-7b_judge_raw": "1. TRUE: The concentration of HIF-1 (hypoxia-inducible factor 1-alpha) can increase in response to various protective stimuli, and it is plausible that the cytoprotective prodrug amifostine could have such an effect, although the specific mechanism may not be directly linked to amifostine's known actions.\n2. TRUE: Amifostine is indeed metabolized in the body to its active form, which is known as WR-1065.\n3. FALSE [correction]: The active form of amifostine, WR-1065, is not known to be a potent inhibitor of the enzyme cytochrome P450 2B4. Instead, it is primarily known for its role as a cytoprotective agent, particularly in protecting against the toxic effects of chemotherapy and radiation therapy.\n4. UNKNOWN: The specific role of cytochrome P450 2B4 in the degradation of HIF-1 is not well-established in the literature, and it is unclear whether this enzyme is directly responsible for HIF-1 degradation.\n5. UNKNOWN: Since the role of cytochrome P450 2B4 in the degradation of HIF-1 is not clearly established, it is also unknown whether inhibition of this enzyme would lead to an increase in the concentration of HIF-1.",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-7b_response": "Set7 is a histone methyltransferase that deposits H3K79me2 and H3K27me3 histone marks.",
    "llama-7b_fact_raw": "1. Set7 is a histone methyltransferase.\n2. Set7 deposits the H3K79me2 histone mark.\n3. Set7 deposits the H3K27me3 histone mark.",
    "llama-7b_fact": [
      "Set7 is a histone methyltransferase.",
      "Set7 deposits the H3K79me2 histone mark.",
      "Set7 deposits the H3K27me3 histone mark."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Set7 (also known as Set7/9 or SETD7) is a histone methyltransferase, but it specifically methylates lysine 4 on histone H3 (H3K4), not histone in general.\n2. FALSE [correction]: Set7 is known for depositing the H3K4me1 histone mark, not H3K79me2.\n3. FALSE [correction]: Set7 does not deposit the H3K27me3 histone mark; this modification is associated with the Polycomb group of proteins, such as EZH2.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-7b_response": "Hepcidin has two disulfide bridges.",
    "llama-7b_fact_raw": "1. The protein hepcidin has two disulfide bridges.",
    "llama-7b_fact": [
      "The protein hepcidin has two disulfide bridges."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-7b_response": "The protein encoded by the gene DNAJC11 is localized to the endoplasmic reticulum.",
    "llama-7b_fact_raw": "1. The protein encoded by the gene DNAJC11 is localized to the endoplasmic reticulum.",
    "llama-7b_fact": [
      "The protein encoded by the gene DNAJC11 is localized to the endoplasmic reticulum."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n\nWithout additional context or specific scientific references, it is not possible to verify the localization of the protein encoded by the gene DNAJC11. Localization of proteins can often be determined through experimental studies such as immunofluorescence or subcellular fractionation, but without access to such data, the statement's accuracy cannot be confirmed.",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-7b_response": "Yes, ultraconserved elements (UCEs) are depleted among copy number variants (CNVs). UCEs are short segments of DNA that are highly conserved across species and are usually located in the introns of genes. CNVs are large segments of DNA that are present in more than one copy and can contain UCEs. Studies have shown that CNVs are more likely to contain UCEs than expected by chance, suggesting that UCEs are depleted among CNVs.",
    "llama-7b_fact_raw": "1. Ultraconserved elements (UCEs) are short segments of DNA that are highly conserved across species.\n2. UCEs are usually located in the introns of genes.\n3. Copy number variants (CNVs) are large segments of DNA that are present in more than one copy.\n4. CNVs can contain ultraconserved elements (UCEs).\n5. Studies have shown that CNVs are less likely to contain UCEs than expected by chance, indicating that UCEs are depleted among CNVs.",
    "llama-7b_fact": [
      "Ultraconserved elements (UCEs) are short segments of DNA that are highly conserved across species.",
      "UCEs are usually located in the introns of genes.",
      "Copy number variants (CNVs) are large segments of DNA that are present in more than one copy.",
      "CNVs can contain ultraconserved elements (UCEs).",
      "Studies have shown that CNVs are less likely to contain UCEs than expected by chance, indicating that UCEs are depleted among CNVs."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Ultraconserved elements (UCEs) are often found in non-coding regions of the genome, which can include introns, but they are also found in exons and regulatory regions.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-7b_response": "The haspin kinase substrate during mitosis is histone H3.",
    "llama-7b_fact_raw": "1. Haspin kinase has a substrate during mitosis.\n2. Histone H3 is the substrate of haspin kinase during mitosis.",
    "llama-7b_fact": [
      "Haspin kinase has a substrate during mitosis.",
      "Histone H3 is the substrate of haspin kinase during mitosis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-7b_response": "Viroid replication is a process by which viroids, a class of small, non-coding, circular, single-stranded molecules of RNA, are able to reproduce themselves. The mechanism of viroid replication involves the formation of a replication complex, which consists of the viroid molecule and a helper virus. The replication complex is then able to hijack the cell's replication machinery and use it to replicate the viroid molecule. This process results in the production of a complementary strand of the viroid molecule, which is then released from the cell.",
    "llama-7b_fact_raw": "1. Viroids are a class of small, non-coding, circular, single-stranded molecules of RNA.\n2. Viroid replication involves the formation of a replication complex with a helper virus.\n3. The replication complex hijacks the cell's replication machinery to replicate the viroid molecule.\n4. The replication process results in the production of a complementary strand of the viroid molecule.\n5. The newly produced viroid molecule is released from the cell after replication.",
    "llama-7b_fact": [
      "Viroids are a class of small, non-coding, circular, single-stranded molecules of RNA.",
      "Viroid replication involves the formation of a replication complex with a helper virus.",
      "The replication complex hijacks the cell's replication machinery to replicate the viroid molecule.",
      "The replication process results in the production of a complementary strand of the viroid molecule.",
      "The newly produced viroid molecule is released from the cell after replication."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Viroids do not require a helper virus for replication; they replicate autonomously in the host cell.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The newly produced viroid molecules do not necessarily get released from the cell after replication; they can accumulate within the cell, potentially causing disease.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-7b_response": "Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy. Studies have shown that fibronectin levels are significantly elevated in the serum of patients with Duchenne muscular dystrophy compared to healthy controls. Additionally, fibronectin levels have been found to be correlated with the severity of the disease. These findings suggest that fibronectin may be a useful biomarker for the diagnosis and monitoring of Duchenne muscular dystrophy.",
    "llama-7b_fact_raw": "1. Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy.\n2. Studies have indicated that fibronectin levels are significantly elevated in the serum of patients with Duchenne muscular dystrophy compared to healthy controls.\n3. Fibronectin levels have been found to correlate with the severity of Duchenne muscular dystrophy.",
    "llama-7b_fact": [
      "Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy.",
      "Studies have indicated that fibronectin levels are significantly elevated in the serum of patients with Duchenne muscular dystrophy compared to healthy controls.",
      "Fibronectin levels have been found to correlate with the severity of Duchenne muscular dystrophy."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-7b_response": "The DeepBlue epigenomic data server contains data from the ENCODE, Roadmap Epigenomics, and FANTOM5 projects.",
    "llama-7b_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE project.\n2. The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics project.\n3. The DeepBlue epigenomic data server contains data from the FANTOM5 project.",
    "llama-7b_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE project.",
      "The DeepBlue epigenomic data server contains data from the Roadmap Epigenomics project.",
      "The DeepBlue epigenomic data server contains data from the FANTOM5 project."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n\nThe DeepBlue epigenomic data server is known to contain data from various epigenomic projects, including ENCODE and the Roadmap Epigenomics project. However, without specific information about the inclusion of data from the FANTOM5 project in the DeepBlue server, the status of that statement remains unknown.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-7b_response": "The tool that employs self organizing maps for analyzing synonymous codon usage is CodonOptimizer.",
    "llama-7b_fact_raw": "1. CodonOptimizer is a tool that employs self organizing maps for analyzing synonymous codon usage.",
    "llama-7b_fact": [
      "CodonOptimizer is a tool that employs self organizing maps for analyzing synonymous codon usage."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-7b_response": "MINDY-1 is an AI chatbot developed by OpenAI to help humans with common language-based tasks and provide suggestions. It is trained on AI-generated dialogue data with 8 A100 GPUs and is capable of understanding and responding to questions in both English and Chinese.",
    "llama-7b_fact_raw": "1. MINDY-1 is an AI chatbot developed by OpenAI.\n2. MINDY-1 is designed to assist with common language-based tasks and provide suggestions.\n3. It is trained on AI-generated dialogue data.\n4. MINDY-1 uses 8 A100 GPUs for its operations.\n5. MINDY-1 can understand and respond to questions in both English and Chinese.",
    "llama-7b_fact": [
      "MINDY-1 is an AI chatbot developed by OpenAI.",
      "MINDY-1 is designed to assist with common language-based tasks and provide suggestions.",
      "It is trained on AI-generated dialogue data.",
      "MINDY-1 uses 8 A100 GPUs for its operations.",
      "MINDY-1 can understand and respond to questions in both English and Chinese."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: As of my knowledge cutoff in 2023, there is no AI chatbot named MINDY-1 developed by OpenAI. OpenAI has developed chatbots like ChatGPT.\n2. UNKNOWN: Since MINDY-1 does not exist as per my knowledge, I cannot confirm its design purpose.\n3. UNKNOWN: Without confirmation of MINDY-1's existence, the training data cannot be determined.\n4. UNKNOWN: The hardware specifications such as the use of 8 A100 GPUs cannot be confirmed for a non-existent AI.\n5. UNKNOWN: The language capabilities of MINDY-1 cannot be confirmed.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-7b_response": "The software package available for the analysis of conserved genomic loci is BLAT (BLAST-like Alignment Tool). BLAT is a fast, flexible, and accurate alignment tool that compares genomic sequences to a reference sequence and identifies regions of similarity. It is particularly useful for identifying conserved non-coding elements in the genome.",
    "llama-7b_fact_raw": "1. BLAT stands for BLAST-like Alignment Tool.\n2. BLAT is used for the analysis of conserved genomic loci.\n3. BLAT compares genomic sequences to a reference sequence to identify regions of similarity.\n4. BLAT is designed to be fast, flexible, and accurate.\n5. BLAT is particularly useful for identifying conserved non-coding elements in the genome.",
    "llama-7b_fact": [
      "BLAT stands for BLAST-like Alignment Tool.",
      "BLAT is used for the analysis of conserved genomic loci.",
      "BLAT compares genomic sequences to a reference sequence to identify regions of similarity.",
      "BLAT is designed to be fast, flexible, and accurate.",
      "BLAT is particularly useful for identifying conserved non-coding elements in the genome."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-7b_response": "Diseases associated with the PIEZO2 gene include hereditary haemorrhagic telangiectasia (HHT), Sturge-Weber syndrome, and Klippel-Trenaunay syndrome.",
    "llama-7b_fact_raw": "1. Hereditary haemorrhagic telangiectasia (HHT) is associated with the PIEZO2 gene.\n2. Sturge-Weber syndrome is associated with the PIEZO2 gene.\n3. Klippel-Trenaunay syndrome is associated with the PIEZO2 gene.",
    "llama-7b_fact": [
      "Hereditary haemorrhagic telangiectasia (HHT) is associated with the PIEZO2 gene.",
      "Sturge-Weber syndrome is associated with the PIEZO2 gene.",
      "Klippel-Trenaunay syndrome is associated with the PIEZO2 gene."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Hereditary haemorrhagic telangiectasia (HHT) is associated with mutations in genes such as ENG, ACVRL1, and SMAD4, not the PIEZO2 gene.\n2. FALSE [correction]: Sturge-Weber syndrome is associated with a somatic mutation in the GNAQ gene, not the PIEZO2 gene.\n3. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-7b_response": "ERAP1-ERAP2 dimerization is important for the processing and presentation of antigen by the major histocompatibility complex (MHC) class I pathway. It is believed that the dimerization of ERAP1 and ERAP2 facilitates the transfer of peptides from the ER to the cell surface, where they can be loaded onto MHC class I molecules for presentation to CD8+ T cells.",
    "llama-7b_fact_raw": "1. ERAP1-ERAP2 dimerization is involved in the processing and presentation of antigen by the MHC class I pathway.\n2. The dimerization of ERAP1 and ERAP2 is believed to facilitate the transfer of peptides from the ER to the cell surface.\n3. Peptides transferred to the cell surface can be loaded onto MHC class I molecules.\n4. MHC class I molecules present peptides to CD8+ T cells.",
    "llama-7b_fact": [
      "ERAP1-ERAP2 dimerization is involved in the processing and presentation of antigen by the MHC class I pathway.",
      "The dimerization of ERAP1 and ERAP2 is believed to facilitate the transfer of peptides from the ER to the cell surface.",
      "Peptides transferred to the cell surface can be loaded onto MHC class I molecules.",
      "MHC class I molecules present peptides to CD8+ T cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The dimerization of ERAP1 and ERAP2 is believed to facilitate the trimming of peptides within the ER so that they can fit into the MHC class I molecules, not the transfer of peptides from the ER to the cell surface.\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-7b_response": "R-spondin 1 and noggin are both involved in the formation of the gallbladder. R-spondin 1 is a growth factor that is essential for the development of the gallbladder, while noggin is an inhibitory protein that helps to regulate the activity of R-spondin 1. In non-damaged gallbladders, R-spondin 1 and noggin work together to promote the formation and maintenance of the gallbladder.",
    "llama-7b_fact_raw": "1. R-spondin 1 is a growth factor essential for the development of the gallbladder.\n2. Noggin is an inhibitory protein that helps to regulate the activity of R-spondin 1.\n3. R-spondin 1 and noggin work together to promote the formation and maintenance of the gallbladder in non-damaged gallbladders.",
    "llama-7b_fact": [
      "R-spondin 1 is a growth factor essential for the development of the gallbladder.",
      "Noggin is an inhibitory protein that helps to regulate the activity of R-spondin 1.",
      "R-spondin 1 and noggin work together to promote the formation and maintenance of the gallbladder in non-damaged gallbladders."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: R-spondin 1 is a growth factor that is important for the development of various organs, but it is not specifically essential for the development of the gallbladder. It is more commonly associated with the development and regeneration of the intestinal epithelium.\n2. FALSE [correction]: Noggin is an inhibitory protein that specifically antagonizes members of the TGF-beta superfamily, such as BMPs (Bone Morphogenetic Proteins), not R-spondin 1.\n3. FALSE [correction]: Since the previous statements are incorrect regarding the specific roles of R-spondin 1 and noggin, this statement is also false. R-spondin 1 is involved in Wnt signaling, which is important for various developmental processes, while noggin inhibits BMP signaling. They do not work together specifically to promote the formation and maintenance of the gallbladder.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-7b_response": "No, NADPH oxidase 5 does not require any subunit for its function. NADPH oxidase 5 is an enzyme that catalyzes the oxidation of NADPH to generate reactive oxygen species (ROS). It is a homodimer composed of two catalytic subunits, p22phox and p40phox, and two regulatory subunits, p67phox and p47phox. The regulatory subunits are required for the enzyme to be activated, but the catalytic subunits are not. Therefore, NADPH oxidase 5 can function without any of its subunits.",
    "llama-7b_fact_raw": "1. NADPH oxidase 5 is an enzyme that catalyzes the oxidation of NADPH to generate reactive oxygen species (ROS).\n2. NADPH oxidase 5 is composed of two catalytic subunits, p22phox and p40phox.\n3. NADPH oxidase 5 also has two regulatory subunits, p67phox and p47phox.\n4. The regulatory subunits of NADPH oxidase 5 are required for the enzyme to be activated.\n5. NADPH oxidase 5 can function without any of its subunits.",
    "llama-7b_fact": [
      "NADPH oxidase 5 is an enzyme that catalyzes the oxidation of NADPH to generate reactive oxygen species (ROS).",
      "NADPH oxidase 5 is composed of two catalytic subunits, p22phox and p40phox.",
      "NADPH oxidase 5 also has two regulatory subunits, p67phox and p47phox.",
      "The regulatory subunits of NADPH oxidase 5 are required for the enzyme to be activated.",
      "NADPH oxidase 5 can function without any of its subunits."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: NADPH oxidase 5 (NOX5) does not contain the p22phox or p40phox subunits. These subunits are associated with other NOX family members, such as NOX1, NOX2, and NOX3.\n3. FALSE [correction]: NADPH oxidase 5 (NOX5) does not have the regulatory subunits p67phox and p47phox. These subunits are associated with NOX2 but not with NOX5.\n4. UNKNOWN: The statement is vague because it does not specify which regulatory subunits are being referred to. NOX5 has different regulatory mechanisms compared to other NOX family members and does not require p67phox and p47phox for activation.\n5. FALSE [correction]: NADPH oxidase 5 requires its own structural domains for proper function, but it does not require the p22phox, p40phox, p67phox, or p47phox subunits. However, it cannot function without any of its essential components or domains.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-7b_response": "Furin and hepcidin are both proteins that are involved in the regulation of iron metabolism. Furin is an iron-regulatory protein that binds to hepcidin and helps to regulate the amount of iron available for absorption in the body. Hepcidin, on the other hand, is a peptide hormone that is produced by the liver and is the primary regulator of body iron homeostasis. It works by binding to the ferroportin receptor on the surface of cells and inhibiting the export of iron out of the cell, thus controlling the amount of iron available for absorption.",
    "llama-7b_fact_raw": "1. Furin is a protein involved in the regulation of iron metabolism.\n2. Hepcidin is a peptide hormone produced by the liver.\n3. Hepcidin is the primary regulator of body iron homeostasis.\n4. Furin binds to hepcidin to help regulate iron absorption in the body.\n5. Hepcidin controls iron availability by binding to the ferroportin receptor and inhibiting iron export out of the cell.",
    "llama-7b_fact": [
      "Furin is a protein involved in the regulation of iron metabolism.",
      "Hepcidin is a peptide hormone produced by the liver.",
      "Hepcidin is the primary regulator of body iron homeostasis.",
      "Furin binds to hepcidin to help regulate iron absorption in the body.",
      "Hepcidin controls iron availability by binding to the ferroportin receptor and inhibiting iron export out of the cell."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Furin is a protein that is involved in the activation of other proteins by cleaving them at specific sites, not in the regulation of iron metabolism.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Furin does not bind to hepcidin to regulate iron absorption. Furin is involved in the activation of various proteins through proteolytic cleavage.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-7b_response": "The largest metabolic gene cluster in yeast is the gluconeogenesis gene cluster, which is responsible for the synthesis of glucose molecules from non-carbohydrate sources. This cluster consists of 13 genes and is located on the left arm of chromosome XII.",
    "llama-7b_fact_raw": "1. The largest metabolic gene cluster in yeast is the gluconeogenesis gene cluster.\n2. The gluconeogenesis gene cluster is responsible for the synthesis of glucose molecules from non-carbohydrate sources.\n3. This gene cluster consists of 13 genes.\n4. It is located on the left arm of chromosome XII in yeast.",
    "llama-7b_fact": [
      "The largest metabolic gene cluster in yeast is the gluconeogenesis gene cluster.",
      "The gluconeogenesis gene cluster is responsible for the synthesis of glucose molecules from non-carbohydrate sources.",
      "This gene cluster consists of 13 genes.",
      "It is located on the left arm of chromosome XII in yeast."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nThe correctness of statements 1, 3, and 4 would require specific scientific knowledge or data about yeast genetics that is not commonly known or may vary depending on the species of yeast and current research data. Without additional context or reference to specific scientific literature, it is not possible to confirm the accuracy of these statements. Statement 2 is a general description of gluconeogenesis, which is a true metabolic pathway.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-7b_response": "LIMT is a long non-coding RNA (lncRNA) that has been shown to play a role in the regulation of cell growth and metabolism. LIMT has been found to be upregulated in a variety of cancers, and its overexpression has been linked to poor prognosis. LIMT has been shown to interact with and regulate the expression of a number of genes, including those involved in cell growth, metabolism, and epithelial-to-mesenchymal transition. These findings suggest that LIMT may be a potential therapeutic target for certain cancers.",
    "llama-7b_fact_raw": "1. LIMT is a long non-coding RNA (lncRNA).\n2. LIMT plays a role in the regulation of cell growth and metabolism.\n3. LIMT has been found to be upregulated in a variety of cancers.\n4. Overexpression of LIMT has been linked to poor prognosis in cancers.\n5. LIMT interacts with and regulates the expression of genes involved in cell growth, metabolism, and epithelial-to-mesenchymal transition.",
    "llama-7b_fact": [
      "LIMT is a long non-coding RNA (lncRNA).",
      "LIMT plays a role in the regulation of cell growth and metabolism.",
      "LIMT has been found to be upregulated in a variety of cancers.",
      "Overexpression of LIMT has been linked to poor prognosis in cancers.",
      "LIMT interacts with and regulates the expression of genes involved in cell growth, metabolism, and epithelial-to-mesenchymal transition."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nPlease note that while these statements are generally consistent with the characteristics of many long non-coding RNAs (lncRNAs), the specific details about LIMT (such as its role in cancer and its interactions with other genes) would require validation from scientific research. If LIMT is a hypothetical or less-studied lncRNA, the truth of these statements may not be fully established in the scientific literature as of my knowledge cutoff date. However, assuming these statements are based on research findings available up to early 2023, the responses are given as true.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-7b_response": "The R / bioconductor package used for performing SNP enrichment analysis is GREAT.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-7b_response": "The key players in radial glial specification to ependymal cells are the Sonic Hedgehog (Shh) protein, the Indian Hedgehog (Ihh) protein, and the Wnt/beta-catenin signaling pathway. Shh is a secreted protein that binds to the Patched (Ptc) receptor and activates the Indian Hedgehog (Ihh) protein. Ihh then binds to the fibroblast growth factor receptor 1 (Fgfr1) and activates the Wnt/beta-catenin signaling pathway, which is essential for radial glial specification and ependymal cell formation.",
    "llama-7b_fact_raw": "1. Sonic Hedgehog (Shh) protein is a key player in radial glial specification to ependymal cells.\n2. Indian Hedgehog (Ihh) protein is involved in the specification of radial glial cells to ependymal cells.\n3. The Wnt/beta-catenin signaling pathway is essential for radial glial specification and ependymal cell formation.\n4. Shh binds to the Patched (Ptc) receptor and activates Ihh protein.\n5. Ihh binds to the fibroblast growth factor receptor 1 (Fgfr1) and activates the Wnt/beta-catenin signaling pathway.",
    "llama-7b_fact": [
      "Sonic Hedgehog (Shh) protein is a key player in radial glial specification to ependymal cells.",
      "Indian Hedgehog (Ihh) protein is involved in the specification of radial glial cells to ependymal cells.",
      "The Wnt/beta-catenin signaling pathway is essential for radial glial specification and ependymal cell formation.",
      "Shh binds to the Patched (Ptc) receptor and activates Ihh protein.",
      "Ihh binds to the fibroblast growth factor receptor 1 (Fgfr1) and activates the Wnt/beta-catenin signaling pathway."
    ],
    "llama-7b_judge_raw": "1. TRUE: Sonic Hedgehog (Shh) protein is indeed a key signaling molecule in various developmental processes, including the specification of radial glial cells to ependymal cells in the central nervous system.\n2. FALSE [correction]: Indian Hedgehog (Ihh) protein is not primarily involved in the specification of radial glial cells to ependymal cells. Ihh is more commonly associated with bone growth and differentiation.\n3. TRUE: The Wnt/beta-catenin signaling pathway plays a crucial role in numerous developmental processes, including the specification of radial glial cells and the formation of ependymal cells.\n4. FALSE [correction]: Shh binds to the Patched (Ptc) receptor, which in turn relieves the inhibition on the Smoothened (Smo) protein, leading to the activation of the downstream signaling pathway. Ihh is a different protein and is not activated by Shh binding to Ptc.\n5. FALSE [correction]: Ihh does not bind to the fibroblast growth factor receptor 1 (Fgfr1). Ihh typically binds to its own receptors, Patched 1 (Ptch1) or Patched 2 (Ptch2), and plays a role in bone development and other processes. The Wnt/beta-catenin signaling pathway is activated through interactions with Wnt proteins, not Ihh.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-7b_response": "Triple negative gliomas (TNGs) are characterized by the absence of three key proteins found in other gliomas: the epidermal growth factor receptor (EGFR), the anaplastic lymphoma kinase (ALK), and the platelet-derived growth factor receptor (PDGFR). These proteins are important for the growth and survival of glioma cells and their absence in TNGs makes them particularly aggressive and difficult to treat.",
    "llama-7b_fact_raw": "1. Triple negative gliomas are characterized by the absence of the epidermal growth factor receptor (EGFR).\n2. Triple negative gliomas lack the anaplastic lymphoma kinase (ALK) protein.\n3. The platelet-derived growth factor receptor (PDGFR) is not present in triple negative gliomas.\n4. The absence of EGFR, ALK, and PDGFR proteins makes triple negative gliomas particularly aggressive.\n5. Triple negative gliomas are difficult to treat due to the lack of these three key proteins.",
    "llama-7b_fact": [
      "Triple negative gliomas are characterized by the absence of the epidermal growth factor receptor (EGFR).",
      "Triple negative gliomas lack the anaplastic lymphoma kinase (ALK) protein.",
      "The platelet-derived growth factor receptor (PDGFR) is not present in triple negative gliomas.",
      "The absence of EGFR, ALK, and PDGFR proteins makes triple negative gliomas particularly aggressive.",
      "Triple negative gliomas are difficult to treat due to the lack of these three key proteins."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Triple negative gliomas are not characterized by the absence of the epidermal growth factor receptor (EGFR); instead, triple-negative usually refers to breast cancer and involves the lack of estrogen receptors, progesterone receptors, and HER2.\n2. UNKNOWN: Without specific context, it's unclear whether triple negative gliomas lack the anaplastic lymphoma kinase (ALK) protein, as the term \"triple negative\" is not standard for gliomas.\n3. UNKNOWN: Similar to statement 2, without specific context, it's unclear whether triple negative gliomas lack the platelet-derived growth factor receptor (PDGFR), as the term \"triple negative\" is not standard for gliomas.\n4. UNKNOWN: The aggressiveness of triple negative gliomas cannot be determined without more context and a clear definition of what \"triple negative\" refers to in gliomas.\n5. UNKNOWN: The difficulty in treating triple negative gliomas cannot be determined without more context and a clear definition of what \"triple negative\" refers to in gliomas.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-7b_response": "TOPAZ1 is a cryptographic algorithm developed by the National Security Agency (NSA) for encrypting and decrypting data. It is a symmetric-key algorithm that uses the Advanced Encryption Standard (AES) as its core. TOPAZ1 is designed to be fast and secure, making it suitable for use in high-performance computing applications.",
    "llama-7b_fact_raw": "1. TOPAZ1 is a cryptographic algorithm developed by the National Security Agency (NSA).\n2. TOPAZ1 is used for encrypting and decrypting data.\n3. It is a symmetric-key algorithm.\n4. TOPAZ1 uses the Advanced Encryption Standard (AES) as its core.\n5. TOPAZ1 is designed for use in high-performance computing applications.",
    "llama-7b_fact": [
      "TOPAZ1 is a cryptographic algorithm developed by the National Security Agency (NSA).",
      "TOPAZ1 is used for encrypting and decrypting data.",
      "It is a symmetric-key algorithm.",
      "TOPAZ1 uses the Advanced Encryption Standard (AES) as its core.",
      "TOPAZ1 is designed for use in high-performance computing applications."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation: Without specific information about a cryptographic algorithm named TOPAZ1, it is not possible to determine the truth of these statements. TOPAZ1 is not a widely recognized or standard cryptographic algorithm in the public domain as of my knowledge cutoff date. If TOPAZ1 is a classified or less-known algorithm developed by the NSA, details about its use, type, core, and design purpose may not be publicly available.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-7b_response": "The gene that controls the expression of GATA-1 isoforms is GATA-1 itself. GATA-1 is a transcription factor that encodes multiple isoforms due to alternative splicing of its mRNA. The different isoforms have different expression patterns and functions. For example, GATA-1 isoform 1 is mainly expressed in the heart and skeletal muscle, while GATA-1 isoform 2 is mainly expressed in the liver and kidney.",
    "llama-7b_fact_raw": "1. The GATA-1 gene controls the expression of its own isoforms.\n2. GATA-1 is a transcription factor.\n3. GATA-1 encodes multiple isoforms through alternative splicing of its mRNA.\n4. GATA-1 isoform 1 is mainly expressed in the heart and skeletal muscle.\n5. GATA-1 isoform 2 is mainly expressed in the liver and kidney.",
    "llama-7b_fact": [
      "The GATA-1 gene controls the expression of its own isoforms.",
      "GATA-1 is a transcription factor.",
      "GATA-1 encodes multiple isoforms through alternative splicing of its mRNA.",
      "GATA-1 isoform 1 is mainly expressed in the heart and skeletal muscle.",
      "GATA-1 isoform 2 is mainly expressed in the liver and kidney."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: GATA-1 is mainly expressed in erythroid cells and megakaryocytes, not specifically in the heart and skeletal muscle.\n5. FALSE [correction]: GATA-1 is not known for being mainly expressed in the liver and kidney; it is primarily involved in the regulation of genes in erythroid and megakaryocytic lineages.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-7b_response": "MIRA-seq is a method of single-molecule sequencing developed by researchers at the Broad Institute of Harvard and MIT. It is a form of nanopore sequencing, which involves passing a single molecule of DNA or RNA through a nanopore in a membrane and measuring the electrical current that flows through the pore as the molecule passes by. The current is then used to determine the nucleotide sequence of the molecule. MIRA-seq is more accurate and faster than traditional sequencing methods, and can be used to sequence large amounts of DNA or RNA in a short amount of time.",
    "llama-7b_fact_raw": "1. MIRA-seq is a method of single-molecule sequencing.\n2. Researchers at the Broad Institute of Harvard and MIT developed MIRA-seq.\n3. MIRA-seq is a form of nanopore sequencing.\n4. Nanopore sequencing involves passing a single molecule of DNA or RNA through a nanopore and measuring the electrical current.\n5. MIRA-seq is claimed to be more accurate and faster than traditional sequencing methods.",
    "llama-7b_fact": [
      "MIRA-seq is a method of single-molecule sequencing.",
      "Researchers at the Broad Institute of Harvard and MIT developed MIRA-seq.",
      "MIRA-seq is a form of nanopore sequencing.",
      "Nanopore sequencing involves passing a single molecule of DNA or RNA through a nanopore and measuring the electrical current.",
      "MIRA-seq is claimed to be more accurate and faster than traditional sequencing methods."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: MIRA-seq (Methylation Interaction-Resistant Amplification sequencing) is not a method of single-molecule sequencing; it is a method for sequencing DNA while preserving information about DNA methylation.\n2. UNKNOWN\n3. FALSE [correction]: MIRA-seq is not a form of nanopore sequencing; it is a method that involves amplification of DNA while preserving methylation status, which is different from the principle of nanopore sequencing.\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-7b_response": "ARCALYST is indicated for the treatment of cryopyrin-associated periodic syndromes (CAPS) in adults and children 6 years of age and older.",
    "llama-7b_fact_raw": "1. ARCALYST is used for the treatment of cryopyrin-associated periodic syndromes (CAPS).\n2. ARCALYST can be prescribed to both adults and children.\n3. The minimum age for a child to be treated with ARCALYST is 6 years old.",
    "llama-7b_fact": [
      "ARCALYST is used for the treatment of cryopyrin-associated periodic syndromes (CAPS).",
      "ARCALYST can be prescribed to both adults and children.",
      "The minimum age for a child to be treated with ARCALYST is 6 years old."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The minimum age for a child to be treated with ARCALYST is 12 years old.",
    "llama-7b_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-7b_response": "The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13, 14, 21, and 22.",
    "llama-7b_fact_raw": "1. Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 13.\n2. Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 14.\n3. Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 21.\n4. Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 22.",
    "llama-7b_fact": [
      "Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 13.",
      "Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 14.",
      "Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 21.",
      "Human acrocentric chromosomes involved in Robertsonian translocation include chromosome 22."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nAcrocentric chromosomes in humans are chromosomes 13, 14, 15, 21, and 22. These chromosomes have a centromere near one end, creating a long arm and a very short arm. Robertsonian translocations can occur between any two acrocentric chromosomes, which can lead to inherited disorders or have other clinical significance.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-7b_response": "The R package that could be used for the identification of pediatric brain tumors is the rpart package. This package provides a range of functions for the classification and clustering of data, including the identification of pediatric brain tumors.",
    "llama-7b_fact_raw": "1. The rpart package in R can be used for the identification of pediatric brain tumors.\n2. The rpart package provides functions for classification and clustering of data.",
    "llama-7b_fact": [
      "The rpart package in R can be used for the identification of pediatric brain tumors.",
      "The rpart package provides functions for classification and clustering of data."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-7b_response": "Yes, NEMO is a zinc finger protein.",
    "llama-7b_fact_raw": "1. NEMO is a zinc finger protein.",
    "llama-7b_fact": [
      "NEMO is a zinc finger protein."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-7b_response": "Yes, TFIIS affects nucleosome positioning. TFIIS is a transcription factor that binds to the core promoter of genes and helps to recruit other transcription factors, RNA polymerase II, and other components of the transcriptional machinery. TFIIS also helps to position nucleosomes at the core promoter, which is important for proper transcriptional activation.",
    "llama-7b_fact_raw": "1. TFIIS is a transcription factor.\n2. TFIIS binds to the core promoter of genes.\n3. TFIIS helps to recruit other transcription factors and RNA polymerase II.\n4. TFIIS assists in positioning nucleosomes at the core promoter.\n5. The positioning of nucleosomes at the core promoter is important for proper transcriptional activation.",
    "llama-7b_fact": [
      "TFIIS is a transcription factor.",
      "TFIIS binds to the core promoter of genes.",
      "TFIIS helps to recruit other transcription factors and RNA polymerase II.",
      "TFIIS assists in positioning nucleosomes at the core promoter.",
      "The positioning of nucleosomes at the core promoter is important for proper transcriptional activation."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: TFIIS is not a transcription factor; it is a transcription elongation factor that helps RNA polymerase II overcome transcriptional arrest.\n2. FALSE [correction]: TFIIS does not bind to the core promoter of genes; it interacts with RNA polymerase II during the elongation phase of transcription.\n3. FALSE [correction]: TFIIS does not help to recruit other transcription factors and RNA polymerase II; it acts after RNA polymerase II has been recruited and has initiated transcription.\n4. FALSE [correction]: TFIIS does not assist in positioning nucleosomes at the core promoter; its main role is in the elongation phase of transcription, not in the assembly of the transcriptional machinery at the promoter.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-7b_response": "The origins of replication that are close to yeast centromeres have been shown to fire early in the cell cycle. This is in contrast to origins of replication that are further away from the centromere, which tend to fire late in the cell cycle.",
    "llama-7b_fact_raw": "1. Origins of replication close to yeast centromeres fire early in the cell cycle.\n2. Origins of replication further away from the centromere tend to fire late in the cell cycle.",
    "llama-7b_fact": [
      "Origins of replication close to yeast centromeres fire early in the cell cycle.",
      "Origins of replication further away from the centromere tend to fire late in the cell cycle."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-7b_response": "Mammalian GA-sequences have a length of 18-20 nucleotides and are composed of three exons separated by two introns. The first exon encodes the first two amino acids of the protein, the second exon encodes the remaining amino acids, and the third exon contains the stop codon. GA-sequences are highly conserved among mammals and are important for the post-transcriptional regulation of gene expression.",
    "llama-7b_fact_raw": "1. Mammalian GA-sequences have a length of 18-20 nucleotides.\n2. They are composed of three exons separated by two introns.\n3. The first exon encodes the first two amino acids of the protein.\n4. The second exon encodes the remaining amino acids of the protein.\n5. The third exon contains the stop codon.",
    "llama-7b_fact": [
      "Mammalian GA-sequences have a length of 18-20 nucleotides.",
      "They are composed of three exons separated by two introns.",
      "The first exon encodes the first two amino acids of the protein.",
      "The second exon encodes the remaining amino acids of the protein.",
      "The third exon contains the stop codon."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Mammalian GA-sequences, if referring to gene sequences, do not have a defined length of 18-20 nucleotides. Gene sequences can vary greatly in length. GA-sequences could refer to a specific short sequence motif, but without more context, the statement is too vague to be deemed true.\n2. FALSE [correction]: Genes are composed of exons and introns, but there is no rule that they are composed of three exons separated by two introns. The number of exons and introns can vary widely between different genes.\n3. UNKNOWN: Without specific context about which gene or protein is being referred to, it is impossible to determine if the first exon encodes the first two amino acids of a protein.\n4. UNKNOWN: Similar to the previous statement, without context about which gene or protein is being referred to, it is impossible to determine if the second exon encodes the remaining amino acids of a protein.\n5. UNKNOWN: The statement could be true for some genes, as the stop codon is typically found at the end of the coding sequence, which could be in the last exon. However, without specific context, it is not possible to confirm this as a general truth for all mammalian genes.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-7b_response": "Four Groucho-related genes (GRG1-4) are contained in the mouse genome.",
    "llama-7b_fact_raw": "1. There are four Groucho-related genes (GRG1-4) in the mouse genome.",
    "llama-7b_fact": [
      "There are four Groucho-related genes (GRG1-4) in the mouse genome."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-7b_response": "The RNA polymerase II subunit that carries RNA cleavage activity is the C-terminal domain of the polymerase itself. This domain is responsible for the cleavage and polyadenylation of transcripts during the elongation phase of transcription.",
    "llama-7b_fact_raw": "1. RNA polymerase II has a subunit with RNA cleavage activity.\n2. The C-terminal domain of RNA polymerase II is responsible for RNA cleavage.\n3. The cleavage and polyadenylation of transcripts occur during the elongation phase of transcription.",
    "llama-7b_fact": [
      "RNA polymerase II has a subunit with RNA cleavage activity.",
      "The C-terminal domain of RNA polymerase II is responsible for RNA cleavage.",
      "The cleavage and polyadenylation of transcripts occur during the elongation phase of transcription."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: RNA polymerase II itself does not have a subunit with RNA cleavage activity. RNA cleavage is carried out by separate protein complexes during RNA processing.\n2. FALSE [correction]: The C-terminal domain (CTD) of RNA polymerase II is involved in the process of transcription initiation and elongation, as well as in the recruitment of processing factors for capping, splicing, and polyadenylation, but it is not responsible for RNA cleavage itself.\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-7b_response": "Ohdo syndrome is a rare genetic disorder caused by mutations in the POLD1 gene. The POLD1 gene provides instructions for making an enzyme called poly(ADP-ribose) polymerase 1, which is involved in the repair of DNA damage. Mutations in the POLD1 gene lead to an impaired ability to repair DNA damage, which can cause cellular changes that can lead to the development of Ohdo syndrome.",
    "llama-7b_fact_raw": "1. Ohdo syndrome is a rare genetic disorder.\n2. Mutations in the POLD1 gene cause Ohdo syndrome.\n3. The POLD1 gene is responsible for making an enzyme called poly(ADP-ribose) polymerase 1.\n4. Poly(ADP-ribose) polymerase 1 is involved in the repair of DNA damage.\n5. Mutations in the POLD1 gene can impair the ability to repair DNA damage, leading to the development of Ohdo syndrome.",
    "llama-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder.",
      "Mutations in the POLD1 gene cause Ohdo syndrome.",
      "The POLD1 gene is responsible for making an enzyme called poly(ADP-ribose) polymerase 1.",
      "Poly(ADP-ribose) polymerase 1 is involved in the repair of DNA damage.",
      "Mutations in the POLD1 gene can impair the ability to repair DNA damage, leading to the development of Ohdo syndrome."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in the SALL1 or KAT6B gene cause Ohdo syndrome.\n3. FALSE [correction]: The POLD1 gene is responsible for making an enzyme involved in DNA replication and repair, but it is not poly(ADP-ribose) polymerase 1. Poly(ADP-ribose) polymerase 1 is produced by the PARP1 gene.\n4. TRUE\n5. FALSE [correction]: While mutations in the POLD1 gene can impair the ability to repair DNA damage, they are not associated with the development of Ohdo syndrome. Instead, mutations in the SALL1 or KAT6B gene are associated with Ohdo syndrome.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-7b_response": "The R/Bioconductor package \"psychiatric-disease-genes\" has been developed for the analysis of psychiatric disease genes.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-7b_response": "Swirl sign is a characteristic finding on computed tomography (CT) scans of intracerebral hemorrhages. It is caused by the rapid flow of blood within the hemorrhage, which creates a swirling pattern that looks like a tornado. This sign is highly specific for intracerebral hemorrhage and can help differentiate it from other causes of stroke.",
    "llama-7b_fact_raw": "1. Swirl sign is a finding on computed tomography (CT) scans.\n2. Swirl sign is associated with intracerebral hemorrhages.\n3. The swirl sign appears due to the rapid flow of blood within the hemorrhage.\n4. The pattern created by swirl sign resembles a tornado.\n5. Swirl sign is highly specific for intracerebral hemorrhage and aids in differentiating it from other causes of stroke.",
    "llama-7b_fact": [
      "Swirl sign is a finding on computed tomography (CT) scans.",
      "Swirl sign is associated with intracerebral hemorrhages.",
      "The swirl sign appears due to the rapid flow of blood within the hemorrhage.",
      "The pattern created by swirl sign resembles a tornado.",
      "Swirl sign is highly specific for intracerebral hemorrhage and aids in differentiating it from other causes of stroke."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The swirl sign appears due to the presence of mixed density within a hematoma, indicating active bleeding or the layering of blood products, not necessarily the rapid flow of blood.\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-7b_response": "ROF1 expression in Arabidopsis thaliana is induced by abscisic acid (ABA), a phytohormone involved in the response to environmental stress. ABA binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter, leading to transcriptional activation of the ROF1 gene. Other environmental stresses, such as high salinity, also induce ROF1 expression.",
    "llama-7b_fact_raw": "1. ROF1 expression in Arabidopsis thaliana is induced by abscisic acid (ABA).\n2. Abscisic acid is a phytohormone involved in the response to environmental stress.\n3. ABA binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter.\n4. The activation of the ABRE leads to transcriptional activation of the ROF1 gene.\n5. High salinity is an environmental stress that induces ROF1 expression.",
    "llama-7b_fact": [
      "ROF1 expression in Arabidopsis thaliana is induced by abscisic acid (ABA).",
      "Abscisic acid is a phytohormone involved in the response to environmental stress.",
      "ABA binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter.",
      "The activation of the ABRE leads to transcriptional activation of the ROF1 gene.",
      "High salinity is an environmental stress that induces ROF1 expression."
    ],
    "llama-7b_judge_raw": "1. TRUE: ROF1 (AtFKBP62) expression in Arabidopsis thaliana is known to be induced by abscisic acid (ABA), which is consistent with the role of ABA in stress responses.\n2. TRUE: Abscisic acid is indeed a phytohormone that plays a crucial role in plant responses to environmental stress, including drought, cold, and salinity.\n3. UNKNOWN: Without specific scientific literature or experimental evidence provided, it is difficult to confirm whether ABA directly binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter. This is a specific molecular interaction that would need to be verified by research data.\n4. UNKNOWN: Similar to statement 3, the activation of the ABRE leading to transcriptional activation of the ROF1 gene is a specific molecular mechanism that would require experimental evidence to confirm as true or false.\n5. TRUE: High salinity is a type of environmental stress that can induce the expression of stress-responsive genes in plants, including those regulated by abscisic acid (ABA). It is reasonable to infer that ROF1 expression could be induced under high salinity conditions, given its association with ABA and stress responses.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-7b_response": "The most common cause of hereditary renal amyloidosis is a mutation in the transthyretin (TTR) gene. TTR is a plasma protein that is involved in the transport of thyroid hormones and vitamin A throughout the body. When the TTR gene is mutated, it can cause the production of an abnormal, misfolded protein that accumulates in the kidneys, resulting in renal amyloidosis.",
    "llama-7b_fact_raw": "1. A mutation in the transthyretin (TTR) gene is the most common cause of hereditary renal amyloidosis.\n2. Transthyretin (TTR) is a plasma protein involved in the transport of thyroid hormones and vitamin A.\n3. Mutations in the TTR gene can lead to the production of an abnormal, misfolded protein.\n4. The accumulation of misfolded protein in the kidneys can result in renal amyloidosis.",
    "llama-7b_fact": [
      "A mutation in the transthyretin (TTR) gene is the most common cause of hereditary renal amyloidosis.",
      "Transthyretin (TTR) is a plasma protein involved in the transport of thyroid hormones and vitamin A.",
      "Mutations in the TTR gene can lead to the production of an abnormal, misfolded protein.",
      "The accumulation of misfolded protein in the kidneys can result in renal amyloidosis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: A mutation in the transthyretin (TTR) gene is the most common cause of hereditary ATTR (transthyretin amyloidosis), which primarily affects the nervous system and the heart, not specifically the kidneys.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-7b_response": "Yes, the proteome of mice hippocampus has been analysed. A study published in 2013 by the journal Molecular and Cellular Proteomics reported the results of a proteomic analysis of the hippocampus of mice. The study identified over 11,000 proteins and characterized the expression of over 5,600 of them.",
    "llama-7b_fact_raw": "1. The proteome of mice hippocampus has been analysed.\n2. A study reporting the proteomic analysis of the hippocampus of mice was published in 2013.\n3. The study was published by the journal Molecular and Cellular Proteomics.\n4. The study identified over 11,000 proteins in the hippocampus of mice.\n5. The study characterized the expression of over 5,600 proteins in the hippocampus of mice.",
    "llama-7b_fact": [
      "The proteome of mice hippocampus has been analysed.",
      "A study reporting the proteomic analysis of the hippocampus of mice was published in 2013.",
      "The study was published by the journal Molecular and Cellular Proteomics.",
      "The study identified over 11,000 proteins in the hippocampus of mice.",
      "The study characterized the expression of over 5,600 proteins in the hippocampus of mice."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific references to the study or studies in question, it is not possible to verify the publication year, the journal, or the exact findings regarding the number of proteins identified or characterized in the hippocampus of mice.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-7b_response": "No, mouse chromosomes are not acrocentric.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-7b_response": "The siRNA based drug currently in clinical trials for the treatment of pancreatic cancer is GEN-1, which is being developed by Genocea Biosciences. GEN-1 is an investigational RNA interference (RNAi) therapeutic that is designed to silence the genes that cause pancreatic cancer. It is believed that by silencing these genes, the growth of pancreatic cancer cells can be stopped. GEN-1 is currently in Phase I/II clinical trials.",
    "llama-7b_fact_raw": "1. GEN-1 is an siRNA based drug in clinical trials for the treatment of pancreatic cancer.\n2. Genocea Biosciences is developing GEN-1.\n3. GEN-1 is an investigational RNA interference (RNAi) therapeutic.\n4. The purpose of GEN-1 is to silence the genes that cause pancreatic cancer.\n5. GEN-1 is currently in Phase I/II clinical trials.",
    "llama-7b_fact": [
      "GEN-1 is an siRNA based drug in clinical trials for the treatment of pancreatic cancer.",
      "Genocea Biosciences is developing GEN-1.",
      "GEN-1 is an investigational RNA interference (RNAi) therapeutic.",
      "The purpose of GEN-1 is to silence the genes that cause pancreatic cancer.",
      "GEN-1 is currently in Phase I/II clinical trials."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Celsion Corporation is developing GEN-1.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe correctness of statements 1, 4, and 5 would require up-to-date information on the clinical trials and the specific mechanism of action of GEN-1. As of my last update, I cannot confirm the current phase of clinical trials for GEN-1 or its specific targets in pancreatic cancer treatment without current data.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-7b_response": "The HPG pore is a small hole in the cell membrane of plant cells that is used for the transport of materials in and out of the cell. It is located in the plasma membrane of the cell and is responsible for the movement of water, minerals, and other nutrients in and out of the cell. It is also responsible for the movement of certain molecules, such as hormones and signalling molecules, which are important for the communication between cells.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-7b_response": "The 959 Nematode Genomes initiative is a research project that aims to sequence and analyze the genomes of 959 species of roundworms, or nematodes. This project is being conducted by the Nematode Genomics Consortium, a collaboration of researchers from around the world, and is funded by the National Institutes of Health. The goal of the project is to gain a better understanding of the diversity of nematodes and their role in the environment, as well as to identify potential new treatments for human diseases.",
    "llama-7b_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of nematodes.\n2. The project is conducted by the Nematode Genomics Consortium.\n3. Researchers from around the world are collaborating on the 959 Nematode Genomes initiative.\n4. The National Institutes of Health is funding the 959 Nematode Genomes initiative.\n5. The goal of the initiative includes gaining a better understanding of nematode diversity and their environmental role, as well as identifying potential new treatments for human diseases.",
    "llama-7b_fact": [
      "The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of nematodes.",
      "The project is conducted by the Nematode Genomics Consortium.",
      "Researchers from around the world are collaborating on the 959 Nematode Genomes initiative.",
      "The National Institutes of Health is funding the 959 Nematode Genomes initiative.",
      "The goal of the initiative includes gaining a better understanding of nematode diversity and their environmental role, as well as identifying potential new treatments for human diseases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-7b_response": "The R package 'NIPT' has been developed for analyzing Non-invasive prenatal testing (NIPT) data. It provides functions for data pre-processing, quality control, and statistical analysis of NIPT data.",
    "llama-7b_fact_raw": "1. The R package 'NIPT' is developed for analyzing Non-invasive prenatal testing (NIPT) data.\n2. The 'NIPT' package includes functions for data pre-processing.\n3. The 'NIPT' package includes functions for quality control.\n4. The 'NIPT' package includes functions for statistical analysis of NIPT data.",
    "llama-7b_fact": [
      "The R package 'NIPT' is developed for analyzing Non-invasive prenatal testing (NIPT) data.",
      "The 'NIPT' package includes functions for data pre-processing.",
      "The 'NIPT' package includes functions for quality control.",
      "The 'NIPT' package includes functions for statistical analysis of NIPT data."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nThe R package 'NIPT' is indeed developed for analyzing Non-invasive prenatal testing (NIPT) data, and typically such packages include functions for data pre-processing, quality control, and statistical analysis. Without specific details about the 'NIPT' package's functionality, it is reasonable to assume that it includes these features, as they are common components of bioinformatics software designed for data analysis.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachs syndrome.",
    "llama-7b_response": "Achenbach's syndrome is a rare genetic disorder that affects the skin, hair, and nails. It is characterized by abnormal pigmentation of the skin, white patches on the skin, sparse and broken hair, and brittle and discolored nails. It is caused by mutations in the MC1R gene and is inherited in an autosomal dominant manner.",
    "llama-7b_fact_raw": "1. Achenbach's syndrome affects the skin, hair, and nails.\n2. The syndrome is characterized by abnormal pigmentation of the skin.\n3. White patches on the skin are a characteristic of Achenbach's syndrome.\n4. Achenbach's syndrome can cause sparse and broken hair.\n5. Brittle and discolored nails are symptoms of Achenbach's syndrome.",
    "llama-7b_fact": [
      "Achenbach's syndrome affects the skin, hair, and nails.",
      "The syndrome is characterized by abnormal pigmentation of the skin.",
      "White patches on the skin are a characteristic of Achenbach's syndrome.",
      "Achenbach's syndrome can cause sparse and broken hair.",
      "Brittle and discolored nails are symptoms of Achenbach's syndrome."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is a rare condition primarily affecting the hands, causing bruising or bleeding under the skin.\n2. FALSE [correction]: Achenbach's syndrome is not characterized by abnormal pigmentation of the skin; it is characterized by spontaneous bruising of the hands or fingers.\n3. FALSE [correction]: White patches on the skin are not a characteristic of Achenbach's syndrome; spontaneous bruising is.\n4. FALSE [correction]: Achenbach's syndrome does not typically cause sparse and broken hair; it involves paroxysmal hand hematoma.\n5. FALSE [correction]: Brittle and discolored nails are not symptoms of Achenbach's syndrome; the syndrome is associated with bruising of the hands or fingers without an obvious cause.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-7b_response": "The algorithm used for detection of long repeat expansions is the Sliding Window Algorithm. This algorithm is used to detect the presence of a long repeat expansion in a given sequence of nucleotides. It works by scanning the sequence for the presence of a given number of identical nucleotides in a window of a given size. If the window contains the given number of identical nucleotides, then a repeat expansion is detected.",
    "llama-7b_fact_raw": "1. The Sliding Window Algorithm is used for detection of long repeat expansions.\n2. The Sliding Window Algorithm scans a sequence for the presence of a given number of identical nucleotides in a window of a given size.\n3. A repeat expansion is detected if the window contains the given number of identical nucleotides.",
    "llama-7b_fact": [
      "The Sliding Window Algorithm is used for detection of long repeat expansions.",
      "The Sliding Window Algorithm scans a sequence for the presence of a given number of identical nucleotides in a window of a given size.",
      "A repeat expansion is detected if the window contains the given number of identical nucleotides."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-7b_response": "Neuroligin-3 has been found to promote the growth of low-grade gliomas, such as astrocytomas and oligodendrogliomas, as well as medulloblastomas.",
    "llama-7b_fact_raw": "1. Neuroligin-3 promotes the growth of low-grade gliomas.\n2. Neuroligin-3 is associated with the promotion of astrocytomas.\n3. Neuroligin-3 is associated with the promotion of oligodendrogliomas.\n4. Neuroligin-3 promotes the growth of medulloblastomas.",
    "llama-7b_fact": [
      "Neuroligin-3 promotes the growth of low-grade gliomas.",
      "Neuroligin-3 is associated with the promotion of astrocytomas.",
      "Neuroligin-3 is associated with the promotion of oligodendrogliomas.",
      "Neuroligin-3 promotes the growth of medulloblastomas."
    ],
    "llama-7b_judge_raw": "1. TRUE: Neuroligin-3 has been shown to promote the growth of low-grade gliomas, including in pediatric cases.\n2. TRUE: Astrocytomas are a type of glioma, and given that neuroligin-3 promotes the growth of low-grade gliomas, it is associated with the promotion of astrocytomas.\n3. TRUE: Oligodendrogliomas are another type of glioma, and neuroligin-3's role in promoting low-grade glioma growth would include oligodendrogliomas.\n4. FALSE [correction]: Neuroligin-3 has been shown to promote the growth of gliomas, but there is no clear consensus or direct evidence linking it to the promotion of medulloblastomas, which are a different type of brain tumor. Medulloblastomas are not classified as gliomas.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-7b_response": "The approximate size of gas vesicles varies depending on the species, but they are typically around 1-2 m in diameter.",
    "llama-7b_fact_raw": "1. Gas vesicles are typically around 1-2 m in diameter.",
    "llama-7b_fact": [
      "Gas vesicles are typically around 1-2 m in diameter."
    ],
    "llama-7b_judge_raw": "UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-7b_response": "BET proteins are a family of proteins that are involved in the regulation of transcription. The BET proteins are composed of three subunits, BET1, BET2, and BET3. BET1 and BET3 form a homodimer, while BET2 binds to BET1 and BET3 to form a heterodimer. The BET proteins are involved in the regulation of gene expression by recognizing acetylated histones and other nuclear factors. They are also involved in the transcriptional activation of genes involved in cell growth, differentiation, and development.",
    "llama-7b_fact_raw": "1. BET proteins are involved in the regulation of transcription.\n2. The BET protein family includes three subunits: BET1, BET2, and BET3.\n3. BET1 and BET3 can form a homodimer.\n4. BET2 binds to BET1 and BET3 to form a heterodimer.\n5. BET proteins play a role in the transcriptional activation of genes involved in cell growth, differentiation, and development.",
    "llama-7b_fact": [
      "BET proteins are involved in the regulation of transcription.",
      "The BET protein family includes three subunits: BET1, BET2, and BET3.",
      "BET1 and BET3 can form a homodimer.",
      "BET2 binds to BET1 and BET3 to form a heterodimer.",
      "BET proteins play a role in the transcriptional activation of genes involved in cell growth, differentiation, and development."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The BET protein family includes BRD2, BRD3, BRD4, and BRDT, not BET1, BET2, and BET3.\n3. FALSE [correction]: BET1 and BET3 are not BET proteins; they are unrelated to the BET family, which includes BRD2, BRD3, BRD4, and BRDT. Therefore, the statement about BET1 and BET3 forming a homodimer is incorrect.\n4. FALSE [correction]: Since BET2 is not a member of the BET protein family, it does not bind to BET1 and BET3 to form a heterodimer. BET proteins typically contain bromodomains that can bind acetylated lysines on histone tails.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-7b_response": "The algorithm for prediction of protein subcellular localization using deep learning is called Deep Subcellular Localization (DSL). It was developed by Zhang et al. in 2018 and uses a deep convolutional neural network (CNN) to predict the subcellular localization of a protein from its amino acid sequence.",
    "llama-7b_fact_raw": "1. An algorithm called Deep Subcellular Localization (DSL) has been developed for prediction of protein subcellular localization using deep learning.\n2. The DSL algorithm was developed by Zhang et al. in 2018.\n3. The DSL algorithm uses a deep convolutional neural network (CNN) for prediction.\n4. The DSL algorithm predicts the subcellular localization of a protein from its amino acid sequence.",
    "llama-7b_fact": [
      "An algorithm called Deep Subcellular Localization (DSL) has been developed for prediction of protein subcellular localization using deep learning.",
      "The DSL algorithm was developed by Zhang et al. in 2018.",
      "The DSL algorithm uses a deep convolutional neural network (CNN) for prediction.",
      "The DSL algorithm predicts the subcellular localization of a protein from its amino acid sequence."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-7b_response": "MULTOVL is an AI-powered virtual assistant that helps humans by performing common language-based tasks and providing suggestions. It is trained on AI-generated dialogue data with 8 A100 GPUs and is capable of understanding and responding to questions in both English and Chinese.",
    "llama-7b_fact_raw": "1. MULTOVL is a virtual assistant powered by artificial intelligence.\n2. MULTOVL performs common language-based tasks and provides suggestions.\n3. It is trained on AI-generated dialogue data.\n4. MULTOVL uses 8 A100 GPUs for its training.\n5. MULTOVL is capable of understanding and responding to questions in both English and Chinese.",
    "llama-7b_fact": [
      "MULTOVL is a virtual assistant powered by artificial intelligence.",
      "MULTOVL performs common language-based tasks and provides suggestions.",
      "It is trained on AI-generated dialogue data.",
      "MULTOVL uses 8 A100 GPUs for its training.",
      "MULTOVL is capable of understanding and responding to questions in both English and Chinese."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about \"MULTOVL,\" it is not possible to confirm the details provided in statements 1, 3, 4, and 5. Statement 2 is generally true for virtual assistants powered by artificial intelligence.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-7b_response": "GDF15 is a biomarker that can be used to measure the effectiveness of metformin treatment. Metformin is an anti-diabetic drug that has been shown to reduce levels of GDF15 in patients with type 2 diabetes. Therefore, measuring the level of GDF15 in a patient's blood can be used as a biomarker to determine whether the patient is responding to metformin treatment.",
    "llama-7b_fact_raw": "1. GDF15 can be used as a biomarker to measure the effectiveness of metformin treatment.\n2. Metformin is an anti-diabetic drug.\n3. Metformin has been shown to reduce levels of GDF15 in patients with type 2 diabetes.\n4. The level of GDF15 in a patient's blood can indicate the patient's response to metformin treatment.",
    "llama-7b_fact": [
      "GDF15 can be used as a biomarker to measure the effectiveness of metformin treatment.",
      "Metformin is an anti-diabetic drug.",
      "Metformin has been shown to reduce levels of GDF15 in patients with type 2 diabetes.",
      "The level of GDF15 in a patient's blood can indicate the patient's response to metformin treatment."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Metformin has been shown to increase levels of GDF15 in patients with type 2 diabetes.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-7b_response": "Recursive splicing is more common in short introns than in long introns. This is because short introns are more likely to contain exonic splicing enhancers (ESEs) and intronic splicing enhancers (ISEs), which are elements that help promote the recruitment of the splicing machinery and thus increase the likelihood of recursive splicing. Additionally, short introns are more likely to contain splicing regulatory elements (SREs) which can also promote recursive splicing.",
    "llama-7b_fact_raw": "1. Recursive splicing is more common in short introns than in long introns.\n2. Short introns are more likely to contain exonic splicing enhancers (ESEs).\n3. Short introns are more likely to contain intronic splicing enhancers (ISEs).\n4. Exonic splicing enhancers and intronic splicing enhancers help promote the recruitment of the splicing machinery.\n5. Short introns are more likely to contain splicing regulatory elements (SREs) which can promote recursive splicing.",
    "llama-7b_fact": [
      "Recursive splicing is more common in short introns than in long introns.",
      "Short introns are more likely to contain exonic splicing enhancers (ESEs).",
      "Short introns are more likely to contain intronic splicing enhancers (ISEs).",
      "Exonic splicing enhancers and intronic splicing enhancers help promote the recruitment of the splicing machinery.",
      "Short introns are more likely to contain splicing regulatory elements (SREs) which can promote recursive splicing."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Recursive splicing is more common in long introns than in short introns.\n2. TRUE\n3. UNKNOWN: The presence of intronic splicing enhancers (ISEs) can vary, and there is no clear consensus that short introns are more likely to contain ISEs compared to long introns.\n4. TRUE\n5. UNKNOWN: While short introns may contain splicing regulatory elements (SREs), there is no specific evidence provided that these SREs promote recursive splicing, which is typically associated with long introns.",
    "llama-7b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-7b_response": "The TALE-iD method is used to identify and characterize transcription factor binding sites in a genome. It is an acronym for Transcription Factor Binding Site Identification by Integrated Discovery. This method uses a combination of data sources, such as ChIP-seq, RNA-seq, and genome-wide association studies, to identify and characterize transcription factor binding sites in a genome.",
    "llama-7b_fact_raw": "1. The TALE-iD method is used to identify and characterize transcription factor binding sites in a genome.\n2. TALE-iD stands for Transcription Factor Binding Site Identification by Integrated Discovery.\n3. The TALE-iD method utilizes data from ChIP-seq.\n4. The TALE-iD method utilizes data from RNA-seq.\n5. The TALE-iD method utilizes data from genome-wide association studies.",
    "llama-7b_fact": [
      "The TALE-iD method is used to identify and characterize transcription factor binding sites in a genome.",
      "TALE-iD stands for Transcription Factor Binding Site Identification by Integrated Discovery.",
      "The TALE-iD method utilizes data from ChIP-seq.",
      "The TALE-iD method utilizes data from RNA-seq.",
      "The TALE-iD method utilizes data from genome-wide association studies."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: TALE-iD stands for Transcription Activator-Like Effector Nuclease Identification.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe TALE-iD method indeed involves identifying transcription factor binding sites, but the acronym stands for Transcription Activator-Like Effector Nuclease Identification, not \"Transcription Factor Binding Site Identification by Integrated Discovery.\" The use of ChIP-seq, RNA-seq, and genome-wide association studies data in the TALE-iD method is not specified in the provided statements, so their involvement cannot be confirmed or denied without additional context.",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-7b_response": "The Common Lisp Image Processing (CLISP) framework has been developed for image processing. CLISP is a portable, object-oriented image processing library written in Common Lisp. It provides a wide range of functions for image manipulation, including image loading, image conversion, image filtering, and image analysis.",
    "llama-7b_fact_raw": "1. The Common Lisp Image Processing (CLISP) framework is developed for image processing.\n2. CLISP is written in Common Lisp.\n3. CLISP is a portable, object-oriented image processing library.\n4. CLISP offers functions for image loading, image conversion, image filtering, and image analysis.",
    "llama-7b_fact": [
      "The Common Lisp Image Processing (CLISP) framework is developed for image processing.",
      "CLISP is written in Common Lisp.",
      "CLISP is a portable, object-oriented image processing library.",
      "CLISP offers functions for image loading, image conversion, image filtering, and image analysis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Common Lisp Interface Manager (CLIM) is a framework for developing user interfaces, not specifically for image processing. If CLISP refers to the Common Lisp implementation, it is not a framework developed for image processing but an implementation of the Common Lisp language.\n2. TRUE (assuming CLISP refers to the Common Lisp implementation, which is indeed written in Common Lisp)\n3. FALSE [correction]: If CLISP is taken to mean the Common Lisp implementation, it is not an image processing library but an implementation of the Common Lisp language. If CLISP is mistakenly used instead of CLIM, then the statement is still false because CLIM is not an image processing library but a user interface management system.\n4. UNKNOWN (without a clear definition of what CLISP refers to in this context, it's not possible to confirm the accuracy of this statement)",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-7b_response": "Approximately 70% of the genes in the budding yeast Saccharomyces cerevisiae are the result of an ancient whole genome duplication event that occurred approximately 10 million years ago. This event resulted in the duplication of the entire genome, creating two identical copies of each gene.",
    "llama-7b_fact_raw": "1. Approximately 70% of the genes in Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.\n2. The whole genome duplication event in Saccharomyces cerevisiae occurred approximately 10 million years ago.\n3. The whole genome duplication event resulted in two identical copies of each gene in Saccharomyces cerevisiae.",
    "llama-7b_fact": [
      "Approximately 70% of the genes in Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.",
      "The whole genome duplication event in Saccharomyces cerevisiae occurred approximately 10 million years ago.",
      "The whole genome duplication event resulted in two identical copies of each gene in Saccharomyces cerevisiae."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The whole genome duplication event in Saccharomyces cerevisiae is estimated to have occurred about 100 million years ago, not 10 million years ago.\n3. FALSE [correction]: The whole genome duplication event initially resulted in two identical copies of each gene, but over time, many of these duplicated genes have diverged, been lost, or evolved new functions.",
    "llama-7b_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "llama-7b_response": "Estrogen-related receptor  (Esrrb) binds the estrogen receptor complex. The estrogen receptor complex is composed of estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2). ESR1 and ESR2 work together to regulate the expression of genes that are involved in the development and maintenance of the female reproductive system, as well as other tissues and organs.",
    "llama-7b_fact_raw": "1. Estrogen-related receptor  (Esrrb) binds the estrogen receptor complex.\n2. The estrogen receptor complex includes estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2).\n3. ESR1 and ESR2 regulate the expression of genes related to the development and maintenance of the female reproductive system.\n4. ESR1 and ESR2 are also involved in regulating genes for other tissues and organs.",
    "llama-7b_fact": [
      "Estrogen-related receptor  (Esrrb) binds the estrogen receptor complex.",
      "The estrogen receptor complex includes estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2).",
      "ESR1 and ESR2 regulate the expression of genes related to the development and maintenance of the female reproductive system.",
      "ESR1 and ESR2 are also involved in regulating genes for other tissues and organs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Estrogen-related receptor  (Esrrb) does not bind estrogen; it is an orphan receptor that shares a similar structure with estrogen receptors but does not bind estrogen itself.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-7b_response": "ZCCHC17 is a member of the zinc finger CCCH-type family and is involved in the regulation of transcription. It binds to the promoter region of genes and helps to activate or repress their transcription. ZCCHC17 has been shown to play a role in the development and function of the immune system, as well as in the regulation of cell growth and metabolism.",
    "llama-7b_fact_raw": "1. ZCCHC17 is a member of the zinc finger CCCH-type family.\n2. ZCCHC17 is involved in the regulation of transcription.\n3. ZCCHC17 binds to the promoter region of genes.\n4. ZCCHC17 plays a role in the development and function of the immune system.\n5. ZCCHC17 is involved in the regulation of cell growth and metabolism.",
    "llama-7b_fact": [
      "ZCCHC17 is a member of the zinc finger CCCH-type family.",
      "ZCCHC17 is involved in the regulation of transcription.",
      "ZCCHC17 binds to the promoter region of genes.",
      "ZCCHC17 plays a role in the development and function of the immune system.",
      "ZCCHC17 is involved in the regulation of cell growth and metabolism."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about ZCCHC17 being a member of the zinc finger CCCH-type family and its involvement in the regulation of transcription are consistent with the general characteristics of CCCH-type zinc finger proteins. However, without specific information about ZCCHC17's binding to promoter regions, its role in immune system development and function, or its involvement in cell growth and metabolism, those statements cannot be confirmed as true or false and are therefore marked as UNKNOWN.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-7b_response": "The proteins that form the nuclear pore basket in human cells are nucleoporins. Nucleoporins are a family of proteins that form the structural framework of the nuclear pore complex, a large protein channel in the nuclear membrane that serves as a gateway for transport of molecules between the nucleus and the cytoplasm. Nucleoporins are composed of multiple copies of a few different types of proteins, each of which has a distinct function in the assembly and maintenance of the nuclear pore complex.",
    "llama-7b_fact_raw": "1. Nucleoporins are the proteins that form the nuclear pore basket in human cells.\n2. Nucleoporins form the structural framework of the nuclear pore complex.\n3. The nuclear pore complex is a large protein channel in the nuclear membrane.\n4. The nuclear pore complex serves as a gateway for transport of molecules between the nucleus and the cytoplasm.\n5. Nucleoporins are composed of multiple copies of a few different types of proteins.",
    "llama-7b_fact": [
      "Nucleoporins are the proteins that form the nuclear pore basket in human cells.",
      "Nucleoporins form the structural framework of the nuclear pore complex.",
      "The nuclear pore complex is a large protein channel in the nuclear membrane.",
      "The nuclear pore complex serves as a gateway for transport of molecules between the nucleus and the cytoplasm.",
      "Nucleoporins are composed of multiple copies of a few different types of proteins."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Nucleoporins are proteins that are components of the nuclear pore complex, but they do not specifically form the nuclear pore basket; they are involved in various structural and functional aspects of the nuclear pore complex.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Nucleoporins are composed of multiple copies of about 30 different types of proteins, not just a few.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-7b_response": "Gepotidacin is a type of topoisomerase II inhibitor.",
    "llama-7b_fact_raw": "1. Gepotidacin is a topoisomerase II inhibitor.",
    "llama-7b_fact": [
      "Gepotidacin is a topoisomerase II inhibitor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Gepotidacin is a topoisomerase inhibitor, but it specifically targets bacterial type II topoisomerases, namely DNA gyrase (topoisomerase II) and topoisomerase IV, not human topoisomerase II.",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-7b_response": "Canvas SPW is an AI-powered platform that helps businesses automate their customer service processes. It uses natural language processing (NLP) and machine learning (ML) technologies to understand customer inquiries and provide personalized, automated responses. Canvas SPW can be integrated with existing customer service systems, such as chatbots, to provide a more comprehensive customer service experience.",
    "llama-7b_fact_raw": "1. Canvas SPW is an AI-powered platform designed to automate customer service processes.\n2. Canvas SPW utilizes natural language processing (NLP) technology.\n3. Canvas SPW employs machine learning (ML) technology.\n4. The platform can understand customer inquiries and provide automated responses.\n5. Canvas SPW can be integrated with existing customer service systems like chatbots.",
    "llama-7b_fact": [
      "Canvas SPW is an AI-powered platform designed to automate customer service processes.",
      "Canvas SPW utilizes natural language processing (NLP) technology.",
      "Canvas SPW employs machine learning (ML) technology.",
      "The platform can understand customer inquiries and provide automated responses.",
      "Canvas SPW can be integrated with existing customer service systems like chatbots."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about \"Canvas SPW,\" it is not possible to verify these statements as true or false. The statements seem plausible if \"Canvas SPW\" is indeed an AI-powered customer service platform, as many such platforms use NLP and ML and can be integrated with existing systems. However, without concrete details or a reliable source, the truthfulness of these statements cannot be determined.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-7b_response": "STING agonists are molecules that bind to and activate the Stimulator of Interferon Genes (STING) protein. Examples of STING agonists include, but are not limited to, cyclic dinucleotides (CDNs) such as cyclic di-GMP (c-di-GMP) and cyclic di-AMP (c-di-AMP), as well as synthetic small molecules, peptides, and antibodies.",
    "llama-7b_fact_raw": "1. STING agonists are molecules that activate the Stimulator of Interferon Genes (STING) protein.\n2. Cyclic dinucleotides (CDNs) are examples of STING agonists.\n3. Cyclic di-GMP (c-di-GMP) is a type of cyclic dinucleotide that acts as a STING agonist.\n4. Cyclic di-AMP (c-di-AMP) is another type of cyclic dinucleotide that serves as a STING agonist.\n5. Synthetic small molecules, peptides, and antibodies can also function as STING agonists.",
    "llama-7b_fact": [
      "STING agonists are molecules that activate the Stimulator of Interferon Genes (STING) protein.",
      "Cyclic dinucleotides (CDNs) are examples of STING agonists.",
      "Cyclic di-GMP (c-di-GMP) is a type of cyclic dinucleotide that acts as a STING agonist.",
      "Cyclic di-AMP (c-di-AMP) is another type of cyclic dinucleotide that serves as a STING agonist.",
      "Synthetic small molecules, peptides, and antibodies can also function as STING agonists."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-7b_response": "SLIC-CAGE is a method used to classify proteins based on their structure. It stands for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry. This method takes into account the secondary structure of the protein, the number of loops, the isoelectric point, and the ratio of cysteine and aspartic acid residues in order to classify proteins into distinct categories.",
    "llama-7b_fact_raw": "1. SLIC-CAGE is a method used for classifying proteins.\n2. SLIC-CAGE stands for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry.\n3. The method considers the secondary structure of proteins.\n4. The method accounts for the number of loops in a protein.\n5. The method includes the isoelectric point and the ratio of cysteine and aspartic acid residues for protein classification.",
    "llama-7b_fact": [
      "SLIC-CAGE is a method used for classifying proteins.",
      "SLIC-CAGE stands for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry.",
      "The method considers the secondary structure of proteins.",
      "The method accounts for the number of loops in a protein.",
      "The method includes the isoelectric point and the ratio of cysteine and aspartic acid residues for protein classification."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: SLIC-CAGE is not a known standard method for classifying proteins. It seems to be a fabricated acronym or is not widely recognized in the scientific community.\n2. FALSE [correction]: Since SLIC-CAGE is not a recognized method for classifying proteins, the given expansion of the acronym is also not accurate.\n3. UNKNOWN: Without valid information on SLIC-CAGE, it cannot be determined if the method considers the secondary structure of proteins.\n4. UNKNOWN: Without valid information on SLIC-CAGE, it cannot be determined if the method accounts for the number of loops in a protein.\n5. UNKNOWN: Without valid information on SLIC-CAGE, it cannot be determined if the method includes the isoelectric point and the ratio of cysteine and aspartic acid residues for protein classification.",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-7b_response": "LEM-3 is a protein that plays a role in the regulation of cell growth and division. It is a member of the LIM-only protein family, which is characterized by the presence of two LIM domains. LIM domains are protein-binding domains that are involved in the regulation of a variety of cellular processes, such as cell adhesion, gene transcription, and cell growth. In particular, LEM-3 is thought to be involved in the regulation of the cell cycle, as well as in the formation of the mitotic spindle and the assembly of the mitotic apparatus.",
    "llama-7b_fact_raw": "1. LEM-3 is a protein that is involved in the regulation of cell growth and division.\n2. LEM-3 is a member of the LIM-only protein family.\n3. The LIM-only protein family is characterized by the presence of two LIM domains.\n4. LIM domains are involved in the regulation of cellular processes including cell adhesion, gene transcription, and cell growth.\n5. LEM-3 is thought to be involved in the regulation of the cell cycle and in the formation of the mitotic spindle and the assembly of the mitotic apparatus.",
    "llama-7b_fact": [
      "LEM-3 is a protein that is involved in the regulation of cell growth and division.",
      "LEM-3 is a member of the LIM-only protein family.",
      "The LIM-only protein family is characterized by the presence of two LIM domains.",
      "LIM domains are involved in the regulation of cellular processes including cell adhesion, gene transcription, and cell growth.",
      "LEM-3 is thought to be involved in the regulation of the cell cycle and in the formation of the mitotic spindle and the assembly of the mitotic apparatus."
    ],
    "llama-7b_judge_raw": "1. TRUE: LEM-3 is a protein that is involved in the regulation of cell growth and division, particularly in the context of DNA damage response and repair.\n2. FALSE [correction]: LEM-3 is not a member of the LIM-only protein family. It is part of the LEM domain-containing protein family, which is characterized by the presence of the LEM domain, a different structural motif than the LIM domain.\n3. TRUE: The LIM-only protein family is indeed characterized by the presence of two LIM domains, which are zinc-finger structures that mediate protein-protein interactions.\n4. TRUE: LIM domains are involved in various cellular processes, including cell adhesion, gene transcription, and cell growth, among others.\n5. UNKNOWN: Without specific information on LEM-3's role in mitotic spindle formation and mitotic apparatus assembly, the statement's accuracy cannot be determined. While LEM domain proteins are generally involved in nuclear structure and integrity, their specific roles can vary, and the statement about LEM-3's involvement in these processes would require more specific scientific evidence.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-7b_response": "The releases of tmVar are: 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 1.10, 1.11, 1.12, 1.13, 1.14, 1.15, 1.16, 1.17, 1.18, 1.19, 1.20, 1.21, 1.22, 1.23, 1.24, 1.25, 1.26, 1.27, 1.28, 1.29, 1.30, 1.31, 1.32, 1.33, 1.34, 1.35, 1.36, 1.37, 1.38, 1.39, 1.40, 1.41, 1.42, 1.43, 1.44, 1.45, 1.46, 1.47, 1.48, 1.49, 1.50, 1.51, 1.52, 1.53, 1.54, 1.55, 1.56, 1.57, 1.58, 1.59, 1.60, 1.61, 1.62, 1.63, 1.64, 1.65, 1.66, 1.67, 1.68, 1.69, 1.70, 1.71, 1.72, 1.73, 1.74, 1.75, 1.76, 1.77, 1.78, 1.79, 1.80, 1.81, 1.82, 1.83, 1.84, 1.85",
    "llama-7b_fact_raw": "1. tmVar has a release version 1.0.\n2. tmVar has a release version 1.1.\n3. tmVar has a release version 1.2.\n4. tmVar has a release version 1.3.\n5. tmVar has a release version 1.4.",
    "llama-7b_fact": [
      "tmVar has a release version 1.0.",
      "tmVar has a release version 1.1.",
      "tmVar has a release version 1.2.",
      "tmVar has a release version 1.3.",
      "tmVar has a release version 1.4."
    ],
    "llama-7b_judge_raw": "UNKNOWN\n\nThe statements provided refer to different release versions of tmVar, which is a tool for annotating genetic variants in text. Without specific information about the release history of tmVar, it is not possible to verify the accuracy of these statements. Therefore, the truthfulness of statements 1 through 5 regarding the release versions of tmVar remains unknown.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-7b_response": "The database of somatic mutations in normal cells is known as the Catalog of Somatic Mutations in Cancer (COSMIC). It is a comprehensive database of somatic mutations in normal cells and cancer cells, which is maintained and updated by the Wellcome Sanger Institute. COSMIC provides detailed information about the types of mutations, their frequencies, and the tissues in which they occur.",
    "llama-7b_fact_raw": "1. The Catalog of Somatic Mutations in Cancer (COSMIC) is a database of somatic mutations in normal cells.\n2. COSMIC also includes information on somatic mutations in cancer cells.\n3. The Wellcome Sanger Institute maintains and updates the COSMIC database.\n4. COSMIC contains detailed information about the types of mutations and their frequencies.\n5. The database provides information on the tissues where the mutations occur.",
    "llama-7b_fact": [
      "The Catalog of Somatic Mutations in Cancer (COSMIC) is a database of somatic mutations in normal cells.",
      "COSMIC also includes information on somatic mutations in cancer cells.",
      "The Wellcome Sanger Institute maintains and updates the COSMIC database.",
      "COSMIC contains detailed information about the types of mutations and their frequencies.",
      "The database provides information on the tissues where the mutations occur."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Catalog of Somatic Mutations in Cancer (COSMIC) is a database of somatic mutations in cancer cells, not normal cells.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-7b_response": "Yes, there are several graph kernel libraries available that are implemented in JAVA. These include the JGraphT library, the GraphBLAS library, and the JKernel library. JGraphT is a library for the manipulation of graphs and is written in Java and C++. GraphBLAS is a library for the manipulation of graphs and is written in Java and C++. JKernel is a library for the implementation of graph kernels and is written in Java.",
    "llama-7b_fact_raw": "1. JGraphT is a library for the manipulation of graphs implemented in Java and C++.\n2. GraphBLAS is a library for the manipulation of graphs implemented in Java and C++.\n3. JKernel is a library for the implementation of graph kernels written in Java.",
    "llama-7b_fact": [
      "JGraphT is a library for the manipulation of graphs implemented in Java and C++.",
      "GraphBLAS is a library for the manipulation of graphs implemented in Java and C++.",
      "JKernel is a library for the implementation of graph kernels written in Java."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: JGraphT is a library for the manipulation of graphs implemented in Java, not C++.\n2. FALSE [correction]: GraphBLAS is a specification for building graph algorithms in the language of linear algebra, not specifically a library implemented in Java and C++. Implementations of GraphBLAS exist in various programming languages.\n3. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-7b_response": "The SHERLOCKv2 platform integrates four advances: 1) Natural Language Processing (NLP) for understanding the user's intent; 2) Natural Language Generation (NLG) for producing natural-sounding responses; 3) Machine Learning (ML) for adapting to the user's preferences; and 4) Knowledge Graphs (KG) for providing accurate and up-to-date information.",
    "llama-7b_fact_raw": "1. The SHERLOCKv2 platform integrates Natural Language Processing (NLP) for understanding user intent.\n2. The SHERLOCKv2 platform uses Natural Language Generation (NLG) to produce natural-sounding responses.\n3. Machine Learning (ML) is incorporated into the SHERLOCKv2 platform for adapting to user preferences.\n4. Knowledge Graphs (KG) are used in the SHERLOCKv2 platform to provide accurate and up-to-date information.",
    "llama-7b_fact": [
      "The SHERLOCKv2 platform integrates Natural Language Processing (NLP) for understanding user intent.",
      "The SHERLOCKv2 platform uses Natural Language Generation (NLG) to produce natural-sounding responses.",
      "Machine Learning (ML) is incorporated into the SHERLOCKv2 platform for adapting to user preferences.",
      "Knowledge Graphs (KG) are used in the SHERLOCKv2 platform to provide accurate and up-to-date information."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nNote: While the statements about the SHERLOCKv2 platform are consistent with the capabilities of advanced AI systems, without specific details about this particular platform, the responses are based on typical features of such systems. If SHERLOCKv2 is a hypothetical or proprietary platform not publicly documented, the responses would be speculative.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-7b_response": "The bartender algorithm is an algorithm used in natural language processing (NLP) to generate responses to user queries. It is based on the idea of a bartender who listens to a customer's query and responds with the most appropriate response. The algorithm works by first analyzing the user's query and then generating a list of potential responses. It then selects the most appropriate response based on the context of the query and the user's preferences. The response is then generated and presented to the user.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-7b_response": "There are several web-based pedigree editors available, including Family Tree Builder, MyHeritage, Geni, and WeRelate. Family Tree Builder is a free, user-friendly program offered by Ancestry.com. MyHeritage is a paid service that offers a wide range of features, including the ability to collaborate with others on your family tree. Geni is a free, collaborative family tree that allows users to connect with their relatives and build their family tree. WeRelate is a free, open-source family tree that is maintained by the WeRelate community.",
    "llama-7b_fact_raw": "1. Family Tree Builder is a web-based pedigree editor offered by Ancestry.com.\n2. MyHeritage is a paid web-based service that includes a pedigree editor.\n3. Geni is a free, collaborative web-based family tree platform.\n4. WeRelate is a free, open-source web-based family tree maintained by the WeRelate community.",
    "llama-7b_fact": [
      "Family Tree Builder is a web-based pedigree editor offered by Ancestry.com.",
      "MyHeritage is a paid web-based service that includes a pedigree editor.",
      "Geni is a free, collaborative web-based family tree platform.",
      "WeRelate is a free, open-source web-based family tree maintained by the WeRelate community."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Family Tree Builder is a software offered by MyHeritage, not Ancestry.com.\n2. TRUE\n3. FALSE [correction]: Geni offers a free basic account, but full access to all features requires a paid subscription.\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-7b_response": "There are several curated databases that exist for spider-venom toxins. These include the Spider Toxin Database (STD) (http://www.spidertoxins.com/), the World Spider Catalog (WSC) (http://wsc.nmbe.ch/), and the Arachnobase database (http://arachnobase.org/). All of these databases provide comprehensive information about spider-venom toxins, including their structures, activities, and biological effects.",
    "llama-7b_fact_raw": "1. The Spider Toxin Database (STD) is a curated database for spider-venom toxins.\n2. The World Spider Catalog (WSC) is a curated database for spider-venom toxins.\n3. The Arachnobase database is a curated database for spider-venom toxins.\n4. These databases include information about the structures of spider-venom toxins.\n5. These databases provide information on the biological effects of spider-venom toxins.",
    "llama-7b_fact": [
      "The Spider Toxin Database (STD) is a curated database for spider-venom toxins.",
      "The World Spider Catalog (WSC) is a curated database for spider-venom toxins.",
      "The Arachnobase database is a curated database for spider-venom toxins.",
      "These databases include information about the structures of spider-venom toxins.",
      "These databases provide information on the biological effects of spider-venom toxins."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The World Spider Catalog (WSC) is a database that provides taxonomic information about spiders, not specifically for spider-venom toxins.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-7b_response": "Axitinib, a tyrosine kinase inhibitor, has been shown to prolong survival in patients with metastatic pancreatic cancer in a randomized, double-blind, placebo-controlled phase III trial. In this trial, patients who received Axitinib had a median overall survival of 6.8 months compared to 4.7 months for those who received placebo. These results suggest that Axitinib may be an effective treatment for patients with metastatic pancreatic cancer.",
    "llama-7b_fact_raw": "1. Axitinib is a tyrosine kinase inhibitor.\n2. Axitinib has been shown to prolong survival in patients with metastatic pancreatic cancer.\n3. The evidence comes from a randomized, double-blind, placebo-controlled phase III trial.\n4. Patients who received Axitinib had a median overall survival of 6.8 months.\n5. Patients who received placebo had a median overall survival of 4.7 months.",
    "llama-7b_fact": [
      "Axitinib is a tyrosine kinase inhibitor.",
      "Axitinib has been shown to prolong survival in patients with metastatic pancreatic cancer.",
      "The evidence comes from a randomized, double-blind, placebo-controlled phase III trial.",
      "Patients who received Axitinib had a median overall survival of 6.8 months.",
      "Patients who received placebo had a median overall survival of 4.7 months."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Axitinib has been shown to be effective in treating advanced renal cell carcinoma, not metastatic pancreatic cancer.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-7b_response": "MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex. The Arp2/3 complex is a protein complex involved in the formation of branched actin filaments, which are essential for cell motility and morphology. MLP binds to the Arp2/3 complex and inhibits its activity, thus regulating F-actin dynamics.",
    "llama-7b_fact_raw": "1. MLP regulates F-actin dynamics through interaction with the Arp2/3 complex.\n2. The Arp2/3 complex is involved in the formation of branched actin filaments.\n3. Branched actin filaments are essential for cell motility and morphology.\n4. MLP binds to the Arp2/3 complex.\n5. MLP inhibits the activity of the Arp2/3 complex.",
    "llama-7b_fact": [
      "MLP regulates F-actin dynamics through interaction with the Arp2/3 complex.",
      "The Arp2/3 complex is involved in the formation of branched actin filaments.",
      "Branched actin filaments are essential for cell motility and morphology.",
      "MLP binds to the Arp2/3 complex.",
      "MLP inhibits the activity of the Arp2/3 complex."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements regarding MLP (presumably referring to Myotrophin or Muscle LIM protein) and its specific interactions with the Arp2/3 complex are highly specialized and would require specific scientific literature to confirm or refute. Without the context of the specific passage or access to the relevant scientific studies, it is not possible to accurately determine the truthfulness of statements 1, 4, and 5. However, statements 2 and 3 are general knowledge in cell biology.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-7b_response": "There are 51 pseudokinases in the human kinome.",
    "llama-7b_fact_raw": "1. There are 51 pseudokinases in the human kinome.",
    "llama-7b_fact": [
      "There are 51 pseudokinases in the human kinome."
    ],
    "llama-7b_judge_raw": "UNKNOWN\n\nThe number of pseudokinases in the human kinome is subject to scientific research and discovery, and without a specific reference to a current and reliable source, it is not possible to confirm the accuracy of the statement. The number of pseudokinases known in the human kinome can change as new discoveries are made and as the understanding of kinases evolves.",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-7b_response": "1. Apolipoprotein M (apoM)\n2. Apolipoprotein J (apoJ)\n3. Apolipoprotein S (apoS)",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-7b_response": "There are sex differences in SAMHD1 activity. In humans, SAMHD1 activity is higher in females than in males. This is due to the fact that females have two X chromosomes, while males only have one X chromosome and one Y chromosome. The X chromosome contains a gene that codes for the SAMHD1 protein, and the Y chromosome does not. Therefore, the amount of SAMHD1 protein produced is higher in females, who have two X chromosomes, than in males, who only have one X chromosome.",
    "llama-7b_fact_raw": "1. SAMHD1 activity is higher in females than in males in humans.\n2. The X chromosome contains a gene that codes for the SAMHD1 protein.\n3. The Y chromosome does not contain a gene that codes for the SAMHD1 protein.\n4. Females have two X chromosomes.\n5. Males have one X chromosome and one Y chromosome.",
    "llama-7b_fact": [
      "SAMHD1 activity is higher in females than in males in humans.",
      "The X chromosome contains a gene that codes for the SAMHD1 protein.",
      "The Y chromosome does not contain a gene that codes for the SAMHD1 protein.",
      "Females have two X chromosomes.",
      "Males have one X chromosome and one Y chromosome."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-7b_response": "RUNX2 is a transcription factor that has been shown to inhibit astrocyte differentiation in certain cell types. Studies have shown that RUNX2 can bind to the promoters of genes involved in astrocyte differentiation, such as the GFAP gene, and repress their expression. This leads to a decrease in the number of astrocytes in the cell population. Additionally, RUNX2 has been shown to interact with other transcription factors, such as SOX2, to further inhibit astrocyte differentiation.",
    "llama-7b_fact_raw": "1. RUNX2 is a transcription factor that inhibits astrocyte differentiation in certain cell types.\n2. RUNX2 can bind to the promoters of genes involved in astrocyte differentiation.\n3. The GFAP gene is one of the genes whose expression is repressed by RUNX2.\n4. The presence of RUNX2 leads to a decrease in the number of astrocytes in the cell population.\n5. RUNX2 interacts with other transcription factors, such as SOX2, to inhibit astrocyte differentiation.",
    "llama-7b_fact": [
      "RUNX2 is a transcription factor that inhibits astrocyte differentiation in certain cell types.",
      "RUNX2 can bind to the promoters of genes involved in astrocyte differentiation.",
      "The GFAP gene is one of the genes whose expression is repressed by RUNX2.",
      "The presence of RUNX2 leads to a decrease in the number of astrocytes in the cell population.",
      "RUNX2 interacts with other transcription factors, such as SOX2, to inhibit astrocyte differentiation."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: RUNX2 is a transcription factor that is primarily associated with bone development and osteoblast differentiation, not the inhibition of astrocyte differentiation.\n2. UNKNOWN: Without specific context, it is unclear whether RUNX2 can bind to the promoters of genes involved in astrocyte differentiation, as its known role is in bone development.\n3. FALSE [correction]: The GFAP gene is typically associated with the expression of glial fibrillary acidic protein in astrocytes, and there is no widely recognized evidence that RUNX2 represses this gene as its primary role is related to bone development.\n4. UNKNOWN: Given that RUNX2's known function is related to bone development, it is unclear whether its presence would lead to a decrease in the number of astrocytes in a cell population without specific experimental context.\n5. UNKNOWN: While RUNX2 is known to interact with other transcription factors, the statement about its interaction with SOX2 to inhibit astrocyte differentiation is not well-established in the context of known scientific literature and would require specific experimental evidence to confirm.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-7b_response": "The Cobb-Stainsby excision arthroplasty would be performed on the distal end of the radius, near the wrist joint.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-7b_response": "No, GRHL2 over-expression does not lead to EMT.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-7b_response": "T-UCRs that have been implicated in lung cancer include TP53, CDKN2A, RB1, and SMAD4. TP53 is the most frequently mutated gene in lung cancer and is involved in regulating cell growth and division. CDKN2A is a tumor suppressor gene that is often inactivated in lung cancer and other cancers. RB1 is a gene that encodes a protein that is important for cell growth and division, and mutations in this gene can lead to lung cancer. Lastly, SMAD4 is a gene that is involved in the tumor suppressor pathway and mutations in this gene can lead to the development of lung cancer.",
    "llama-7b_fact_raw": "1. TP53 is the most frequently mutated gene in lung cancer.\n2. TP53 is involved in regulating cell growth and division.\n3. CDKN2A is a tumor suppressor gene that is often inactivated in lung cancer.\n4. Mutations in the RB1 gene can lead to lung cancer.\n5. SMAD4 is involved in the tumor suppressor pathway and mutations in this gene can lead to the development of lung cancer.",
    "llama-7b_fact": [
      "TP53 is the most frequently mutated gene in lung cancer.",
      "TP53 is involved in regulating cell growth and division.",
      "CDKN2A is a tumor suppressor gene that is often inactivated in lung cancer.",
      "Mutations in the RB1 gene can lead to lung cancer.",
      "SMAD4 is involved in the tumor suppressor pathway and mutations in this gene can lead to the development of lung cancer."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-7b_response": "GPR151 is an orphan receptor that is highly expressed in the brain, particularly in the hippocampus and cerebellum. It is also expressed in the heart, kidney, and placenta. GPR151 is known to be a G-protein-coupled receptor, meaning it interacts with and is activated by signaling molecules known as G-proteins. Studies have shown that GPR151 is involved in the regulation of cell growth and metabolism, as well as in the modulation of inflammatory and immune responses. Additionally, GPR151 has been linked to the development of certain neurological disorders, such as Alzheimer's and Parkinson's diseases.",
    "llama-7b_fact_raw": "1. GPR151 is highly expressed in the brain, particularly in the hippocampus and cerebellum.\n2. GPR151 is also expressed in the heart, kidney, and placenta.\n3. GPR151 is a G-protein-coupled receptor.\n4. GPR151 is involved in the regulation of cell growth and metabolism.\n5. GPR151 has been linked to the development of neurological disorders such as Alzheimer's and Parkinson's diseases.",
    "llama-7b_fact": [
      "GPR151 is highly expressed in the brain, particularly in the hippocampus and cerebellum.",
      "GPR151 is also expressed in the heart, kidney, and placenta.",
      "GPR151 is a G-protein-coupled receptor.",
      "GPR151 is involved in the regulation of cell growth and metabolism.",
      "GPR151 has been linked to the development of neurological disorders such as Alzheimer's and Parkinson's diseases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: GPR151 is not significantly expressed in the heart, kidney, and placenta. It is primarily expressed in the brain.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-7b_response": "The Fluzone intradermal quadrivalent vaccine contains attenuated live virus strains of influenza A (H1N1), influenza A (H3N2), influenza B (Victoria lineage) and influenza B (Yamagata lineage).",
    "llama-7b_fact_raw": "1. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H1N1).\n2. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H3N2).\n3. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Victoria lineage).\n4. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Yamagata lineage).",
    "llama-7b_fact": [
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H1N1).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H3N2).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Victoria lineage).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Yamagata lineage)."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it contains inactivated (killed) viruses.\n2. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it contains inactivated (killed) viruses.\n3. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it contains inactivated (killed) viruses.\n4. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus; it contains inactivated (killed) viruses.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-7b_response": "The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE) due to a genetic variation in the promoter region of the gene. This variation results in decreased expression of the TNFR2 protein, which is believed to play a role in the development of SLE.",
    "llama-7b_fact_raw": "1. The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE).\n2. A genetic variation in the promoter region of the TNFR2 gene is linked to SLE.\n3. This genetic variation results in decreased expression of the TNFR2 protein.",
    "llama-7b_fact": [
      "The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE).",
      "A genetic variation in the promoter region of the TNFR2 gene is linked to SLE.",
      "This genetic variation results in decreased expression of the TNFR2 protein."
    ],
    "llama-7b_judge_raw": "1. TRUE: The TNFR2 gene, which encodes the tumor necrosis factor receptor 2, has been associated with autoimmune diseases, including Systemic Lupus Erythematosus (SLE).\n2. TRUE: Genetic variations, including those in the promoter region of genes like TNFR2, have been linked to SLE susceptibility.\n3. FALSE [correction]: The specific effect of a genetic variation in the promoter region of the TNFR2 gene on the expression of the TNFR2 protein can vary. Some variations may lead to decreased expression, while others could result in increased expression or have no effect at all. Without specifying which genetic variation, it is not possible to accurately state the effect on TNFR2 protein expression.",
    "llama-7b_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-7b_response": "Yes, there is a vaccine for peanut allergy. The vaccine, called Palforzia, was approved by the FDA in 2020. It is designed to reduce the risk of a severe allergic reaction to peanuts if the person is exposed to them. The vaccine is administered in two doses, six months apart, and can be given to children aged 4 to 17 who have a severe peanut allergy.",
    "llama-7b_fact_raw": "1. A vaccine for peanut allergy called Palforzia was approved by the FDA in 2020.\n2. Palforzia is designed to reduce the risk of a severe allergic reaction to peanuts.\n3. The vaccine is administered in two doses.\n4. The doses are given six months apart.\n5. Palforzia can be given to children aged 4 to 17 who have a severe peanut allergy.",
    "llama-7b_fact": [
      "A vaccine for peanut allergy called Palforzia was approved by the FDA in 2020.",
      "Palforzia is designed to reduce the risk of a severe allergic reaction to peanuts.",
      "The vaccine is administered in two doses.",
      "The doses are given six months apart.",
      "Palforzia can be given to children aged 4 to 17 who have a severe peanut allergy."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Palforzia is not a vaccine, but rather an oral immunotherapy treatment, and it is not administered in two doses.\n4. FALSE [correction]: Since Palforzia is not a vaccine and does not have a two-dose regimen, the statement about doses being given six months apart is incorrect. Palforzia treatment begins with escalating doses followed by maintenance therapy.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-7b_response": "The mouse Fxy gene is located on the X chromosome, which is one of the two sex chromosomes in mammals. It is particular in that it is one of the few genes located on the X chromosome that is not involved in determining sex. Instead, it is involved in the development of the embryo and is expressed in both males and females.",
    "llama-7b_fact_raw": "1. The mouse Fxy gene is located on the X chromosome.\n2. The X chromosome is one of the two sex chromosomes in mammals.\n3. The Fxy gene is not involved in determining sex.\n4. The Fxy gene is involved in the development of the embryo.\n5. The Fxy gene is expressed in both male and female mice.",
    "llama-7b_fact": [
      "The mouse Fxy gene is located on the X chromosome.",
      "The X chromosome is one of the two sex chromosomes in mammals.",
      "The Fxy gene is not involved in determining sex.",
      "The Fxy gene is involved in the development of the embryo.",
      "The Fxy gene is expressed in both male and female mice."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-7b_response": "The MPE-seq method is based on the principle of selective enrichment of methylated DNA. It uses methyl-propyl-EDTA (MPE) to bind to methylated DNA, allowing for the enrichment of methylated DNA from a genomic DNA sample. The MPE-seq method then uses next-generation sequencing (NGS) to sequence the methylated DNA and identify regions of methylation.",
    "llama-7b_fact_raw": "1. The MPE-seq method selectively enriches methylated DNA.\n2. Methyl-propyl-EDTA (MPE) is used to bind to methylated DNA in the MPE-seq method.\n3. The MPE-seq method enriches methylated DNA from a genomic DNA sample.\n4. Next-generation sequencing (NGS) is used in the MPE-seq method to sequence the methylated DNA.\n5. The MPE-seq method identifies regions of methylation in DNA.",
    "llama-7b_fact": [
      "The MPE-seq method selectively enriches methylated DNA.",
      "Methyl-propyl-EDTA (MPE) is used to bind to methylated DNA in the MPE-seq method.",
      "The MPE-seq method enriches methylated DNA from a genomic DNA sample.",
      "Next-generation sequencing (NGS) is used in the MPE-seq method to sequence the methylated DNA.",
      "The MPE-seq method identifies regions of methylation in DNA."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The \"MPE\" in MPE-seq stands for methylation-dependent restriction enzyme-based enrichment, not Methyl-propyl-EDTA.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-7b_response": "GWAR has been implemented using the Python programming language.",
    "llama-7b_fact_raw": "1. GWAR was implemented using the Python programming language.",
    "llama-7b_fact": [
      "GWAR was implemented using the Python programming language."
    ],
    "llama-7b_judge_raw": "UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-7b_response": "Xaliproden has been shown to have a positive effect on the prognosis of amyotrophic lateral sclerosis (ALS) in some studies, while others have shown no effect. ALS is a progressive neurodegenerative disease with no known cure, so any potential treatment is of great interest. Xaliproden has been shown to reduce inflammation, which may be beneficial in ALS, as inflammation has been linked to the progression of the disease. Additionally, it has been suggested that xaliproden may help to protect motor neurons, which could improve the prognosis of ALS. However, more research is needed to confirm these findings.",
    "llama-7b_fact_raw": "1. Xaliproden has been shown to have a positive effect on the prognosis of amyotrophic lateral sclerosis (ALS) in some studies.\n2. Other studies have shown no effect of xaliproden on the prognosis of ALS.\n3. ALS is a progressive neurodegenerative disease with no known cure.\n4. Xaliproden has been shown to reduce inflammation.\n5. It has been suggested that xaliproden may help to protect motor neurons.",
    "llama-7b_fact": [
      "Xaliproden has been shown to have a positive effect on the prognosis of amyotrophic lateral sclerosis (ALS) in some studies.",
      "Other studies have shown no effect of xaliproden on the prognosis of ALS.",
      "ALS is a progressive neurodegenerative disease with no known cure.",
      "Xaliproden has been shown to reduce inflammation.",
      "It has been suggested that xaliproden may help to protect motor neurons."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific references to the studies mentioned in statements 1, 2, 4, and 5, it is not possible to verify the accuracy of these claims. Therefore, the truthfulness of these statements remains unknown based on the information provided.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-7b_response": "Transgenes are inserted in the LiPS-A3S line in the X chromosome.",
    "llama-7b_fact_raw": "1. Transgenes are inserted in the X chromosome of the LiPS-A3S line.",
    "llama-7b_fact": [
      "Transgenes are inserted in the X chromosome of the LiPS-A3S line."
    ],
    "llama-7b_judge_raw": "UNKNOWN\n\nWithout additional context or specific information about the \"LiPS-A3S line,\" it is not possible to determine the accuracy of the statement regarding the insertion of transgenes in the X chromosome.",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-7b_response": "A tool for predicting drug synergy with deep learning exists in the form of SynergyNet. SynergyNet is a deep learning model that uses a combination of convolutional and recurrent neural networks to predict the synergy of drug combinations. The model is trained on a large dataset of drug combinations and is able to accurately predict the synergy of drug combinations.",
    "llama-7b_fact_raw": "1. SynergyNet is a tool for predicting drug synergy using deep learning.\n2. SynergyNet utilizes a combination of convolutional and recurrent neural networks.\n3. The model is trained on a large dataset of drug combinations.\n4. SynergyNet is designed to predict the synergy of drug combinations accurately.",
    "llama-7b_fact": [
      "SynergyNet is a tool for predicting drug synergy using deep learning.",
      "SynergyNet utilizes a combination of convolutional and recurrent neural networks.",
      "The model is trained on a large dataset of drug combinations.",
      "SynergyNet is designed to predict the synergy of drug combinations accurately."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-7b_response": "The Genome-Wide Association Study (GWAS) Comparison Platform (GCP) has been developed for comparing GWAS. It is a cloud-based platform that allows researchers to store, analyze, and compare GWAS data from multiple sources in a secure and efficient manner. GCP provides a suite of tools to facilitate the comparison of GWAS data, including data visualization, statistical analysis, and machine learning algorithms.",
    "llama-7b_fact_raw": "1. The Genome-Wide Association Study (GWAS) Comparison Platform (GCP) is developed for comparing GWAS.\n2. GCP is a cloud-based platform.\n3. GCP allows researchers to store, analyze, and compare GWAS data from multiple sources.\n4. The platform provides data visualization tools.\n5. GCP includes statistical analysis and machine learning algorithms for GWAS data comparison.",
    "llama-7b_fact": [
      "The Genome-Wide Association Study (GWAS) Comparison Platform (GCP) is developed for comparing GWAS.",
      "GCP is a cloud-based platform.",
      "GCP allows researchers to store, analyze, and compare GWAS data from multiple sources.",
      "The platform provides data visualization tools.",
      "GCP includes statistical analysis and machine learning algorithms for GWAS data comparison."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-7b_response": "CMB305 has been shown to be effective against certain types of sarcomas in preclinical studies. However, its efficacy against sarcomas has not yet been tested in clinical trials. Therefore, it is not yet known if CMB305 is an effective treatment for sarcomas.",
    "llama-7b_fact_raw": "1. CMB305 has been shown to be effective against certain types of sarcomas in preclinical studies.\n2. CMB305 has not yet been tested in clinical trials for efficacy against sarcomas.",
    "llama-7b_fact": [
      "CMB305 has been shown to be effective against certain types of sarcomas in preclinical studies.",
      "CMB305 has not yet been tested in clinical trials for efficacy against sarcomas."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nWithout specific information on the drug CMB305 and its testing history, it is not possible to determine the truthfulness of these statements. More context or data would be needed to assess their accuracy.",
    "llama-7b_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-7b_response": "The manifestations of the Saint's Triad refer to the three main aspects of a saint's life: holiness, miracles, and intercession. Holiness refers to a saint's personal piety and devotion to God, while miracles refer to the extraordinary events that are attributed to a saint's power and intercession refers to the saint's ability to intervene on behalf of those who pray to them.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-7b_response": "Overexpression of LY6K has been found to be associated with better prognosis for non-small cell lung cancer patients in some studies, while others have found no correlation between LY6K expression and patient survival. The results are inconclusive and further research is needed to determine the exact role of LY6K in non-small cell lung cancer prognosis.",
    "llama-7b_fact_raw": "1. Some studies have found that overexpression of LY6K is associated with better prognosis for non-small cell lung cancer patients.\n2. Other studies have found no correlation between LY6K expression and patient survival in non-small cell lung cancer.\n3. The results regarding the role of LY6K in non-small cell lung cancer prognosis are inconclusive.\n4. Further research is needed to determine the exact role of LY6K in non-small cell lung cancer prognosis.",
    "llama-7b_fact": [
      "Some studies have found that overexpression of LY6K is associated with better prognosis for non-small cell lung cancer patients.",
      "Other studies have found no correlation between LY6K expression and patient survival in non-small cell lung cancer.",
      "The results regarding the role of LY6K in non-small cell lung cancer prognosis are inconclusive.",
      "Further research is needed to determine the exact role of LY6K in non-small cell lung cancer prognosis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Overexpression of LY6K is generally associated with a poorer prognosis for non-small cell lung cancer patients.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-7b_response": "The Cdk targets that are dephosphorylated during cytokinesis include cyclin B, Cdc14, and Plk1. Cyclin B is dephosphorylated by the Cdc14 phosphatase, which is activated at the metaphase-to-anaphase transition. Cdc14 is also responsible for dephosphorylating Cdk1, which is necessary for the completion of cytokinesis. Finally, Plk1 is dephosphorylated by the Cdc14 phosphatase, allowing it to no longer bind to the mitotic spindle and allowing the completion of cytokinesis.",
    "llama-7b_fact_raw": "1. Cyclin B is dephosphorylated during cytokinesis.\n2. Cdc14 phosphatase is activated at the metaphase-to-anaphase transition.\n3. Cdc14 is responsible for dephosphorylating Cdk1.\n4. Dephosphorylation of Cdk1 is necessary for the completion of cytokinesis.\n5. Plk1 is dephosphorylated by the Cdc14 phosphatase during cytokinesis.",
    "llama-7b_fact": [
      "Cyclin B is dephosphorylated during cytokinesis.",
      "Cdc14 phosphatase is activated at the metaphase-to-anaphase transition.",
      "Cdc14 is responsible for dephosphorylating Cdk1.",
      "Dephosphorylation of Cdk1 is necessary for the completion of cytokinesis.",
      "Plk1 is dephosphorylated by the Cdc14 phosphatase during cytokinesis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Cyclin B is phosphorylated during mitosis and is targeted for degradation during anaphase, not dephosphorylated during cytokinesis.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Plk1 is not directly dephosphorylated by Cdc14 during cytokinesis. Cdc14 phosphatase targets Cdk1 and other substrates to trigger mitotic exit, but Plk1's regulation is more complex and involves multiple kinases and phosphatases.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-7b_response": "Xanamem is a novel, investigational medicine being studied for the treatment of mild to moderate Alzheimer's disease. It is an orally administered small molecule that has been shown in clinical trials to have a positive effect on cognition and function in patients with Alzheimer's disease. Xanamem works by increasing the levels of the neurotransmitter acetylcholine in the brain, which is decreased in Alzheimer's disease.",
    "llama-7b_fact_raw": "1. Xanamem is an investigational medicine being studied for the treatment of mild to moderate Alzheimer's disease.\n2. Xanamem is administered orally.\n3. Clinical trials have shown that Xanamem has a positive effect on cognition and function in patients with Alzheimer's disease.\n4. Xanamem works by increasing the levels of the neurotransmitter acetylcholine in the brain.\n5. Acetylcholine levels are decreased in patients with Alzheimer's disease.",
    "llama-7b_fact": [
      "Xanamem is an investigational medicine being studied for the treatment of mild to moderate Alzheimer's disease.",
      "Xanamem is administered orally.",
      "Clinical trials have shown that Xanamem has a positive effect on cognition and function in patients with Alzheimer's disease.",
      "Xanamem works by increasing the levels of the neurotransmitter acetylcholine in the brain.",
      "Acetylcholine levels are decreased in patients with Alzheimer's disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Xanamem works by blocking the production of excess cortisol by inhibiting the activity of the enzyme 11-HSD1.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-7b_response": "The Hof1-Cyk3 interaction is important for the proper functioning of the cell cycle in yeast. Cyk3 is a cyclin-dependent kinase and Hof1 is a protein that binds to and activates Cyk3. The interaction between Hof1 and Cyk3 is necessary for the activation of Cyk3 and the progression of the cell cycle. Without the Hof1-Cyk3 interaction, the cell cycle would be disrupted and the cell would not be able to divide properly.",
    "llama-7b_fact_raw": "1. The Hof1-Cyk3 interaction is important for the proper functioning of the cell cycle in yeast.\n2. Cyk3 is a cyclin-dependent kinase.\n3. Hof1 is a protein that binds to and activates Cyk3.\n4. The interaction between Hof1 and Cyk3 is necessary for the activation of Cyk3.\n5. Without the Hof1-Cyk3 interaction, the yeast cell cycle would be disrupted and the cell would not divide properly.",
    "llama-7b_fact": [
      "The Hof1-Cyk3 interaction is important for the proper functioning of the cell cycle in yeast.",
      "Cyk3 is a cyclin-dependent kinase.",
      "Hof1 is a protein that binds to and activates Cyk3.",
      "The interaction between Hof1 and Cyk3 is necessary for the activation of Cyk3.",
      "Without the Hof1-Cyk3 interaction, the yeast cell cycle would be disrupted and the cell would not divide properly."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cyk3 is not a cyclin-dependent kinase; it is a protein involved in cytokinesis, the final stage of the cell cycle.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-7b_response": "T-UCRs that have been implicated in gastric cancer include T-UCR-1, T-UCR-2, T-UCR-3, T-UCR-4, T-UCR-5, T-UCR-6, T-UCR-7, T-UCR-8, T-UCR-9, and T-UCR-10.",
    "llama-7b_fact_raw": "1. T-UCR-1 has been implicated in gastric cancer.\n2. T-UCR-2 has been implicated in gastric cancer.\n3. T-UCR-3 has been implicated in gastric cancer.\n4. T-UCR-4 has been implicated in gastric cancer.\n5. T-UCR-5 has been implicated in gastric cancer.",
    "llama-7b_fact": [
      "T-UCR-1 has been implicated in gastric cancer.",
      "T-UCR-2 has been implicated in gastric cancer.",
      "T-UCR-3 has been implicated in gastric cancer.",
      "T-UCR-4 has been implicated in gastric cancer.",
      "T-UCR-5 has been implicated in gastric cancer."
    ],
    "llama-7b_judge_raw": "UNKNOWN\n\nThe statements provided refer to T-UCRs, which likely stands for \"Transcribed Ultra-Conserved Regions.\" These are a specific subset of DNA sequences that are highly conserved across different species and are believed to have important regulatory functions. Some T-UCRs have been implicated in various forms of cancer, including gastric cancer. However, without specific information about T-UCR-1 through T-UCR-5, it is impossible to determine the veracity of these statements. More detailed information or a specific scientific context is required to assess whether each of these T-UCRs has been implicated in gastric cancer.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-7b_response": "The Lupus Severity Index (LSI) is a tool used to measure the severity of systemic lupus erythematosus (SLE) in patients. It was developed by the National Institutes of Health (NIH) in 1992 and is based on a combination of clinical and laboratory criteria. The LSI takes into account the patient's overall health, the number and severity of organ involvements, and the presence of disease flares. A higher score on the LSI indicates a more severe form of lupus.",
    "llama-7b_fact_raw": "1. The Lupus Severity Index (LSI) is used to measure the severity of systemic lupus erythematosus (SLE) in patients.\n2. The LSI was developed by the National Institutes of Health (NIH) in 1992.\n3. The LSI is based on a combination of clinical and laboratory criteria.\n4. The LSI considers the patient's overall health, the number and severity of organ involvements, and the presence of disease flares.\n5. A higher score on the LSI indicates a more severe form of lupus.",
    "llama-7b_fact": [
      "The Lupus Severity Index (LSI) is used to measure the severity of systemic lupus erythematosus (SLE) in patients.",
      "The LSI was developed by the National Institutes of Health (NIH) in 1992.",
      "The LSI is based on a combination of clinical and laboratory criteria.",
      "The LSI considers the patient's overall health, the number and severity of organ involvements, and the presence of disease flares.",
      "A higher score on the LSI indicates a more severe form of lupus."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no widely recognized tool called the Lupus Severity Index (LSI) developed by the National Institutes of Health (NIH) in 1992. The NIH has been involved in lupus research, but the specific development of an index called the LSI in that year is not documented. The SLE Disease Activity Index (SLEDAI) is a commonly used tool to measure disease activity in SLE patients.\n3. TRUE: While the statement about the LSI is based on a misunderstanding, it is true that tools used to measure SLE severity, such as the SLEDAI, are based on a combination of clinical and laboratory criteria.\n4. TRUE: Again, while the LSI is not a recognized tool, this statement is generally true for SLE severity scoring systems, which consider overall health, organ involvement, and disease flares.\n5. TRUE: For SLE severity scoring systems, a higher score typically indicates more severe disease activity. However, this statement is made in the context of the LSI, which is not a recognized tool, but the concept applies to other tools like the SLEDAI.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-7b_response": "De novo mutations in ZSWIM6 have been linked to the development of certain genetic disorders, including autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), Friedreich's ataxia (FRDA), and spinocerebellar ataxia type 6 (SCA6). ARSACS is a neurodegenerative disorder characterized by progressive spasticity and ataxia. FRDA is an autosomal recessive disorder that causes progressive damage to the heart, liver, and other organs. SCA6 is an autosomal dominant ataxia that results in progressive loss of coordination and balance.",
    "llama-7b_fact_raw": "1. De novo mutations in ZSWIM6 are linked to the development of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).\n2. De novo mutations in ZSWIM6 are associated with Friedreich's ataxia (FRDA).\n3. De novo mutations in ZSWIM6 are connected to spinocerebellar ataxia type 6 (SCA6).\n4. ARSACS is characterized by progressive spasticity and ataxia.\n5. FRDA causes progressive damage to the heart, liver, and other organs.",
    "llama-7b_fact": [
      "De novo mutations in ZSWIM6 are linked to the development of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).",
      "De novo mutations in ZSWIM6 are associated with Friedreich's ataxia (FRDA).",
      "De novo mutations in ZSWIM6 are connected to spinocerebellar ataxia type 6 (SCA6).",
      "ARSACS is characterized by progressive spasticity and ataxia.",
      "FRDA causes progressive damage to the heart, liver, and other organs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: De novo mutations in SACS gene, not ZSWIM6, are linked to the development of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).\n2. FALSE [correction]: Friedreich's ataxia (FRDA) is typically associated with mutations in the FXN gene, not ZSWIM6.\n3. FALSE [correction]: Spinocerebellar ataxia type 6 (SCA6) is caused by mutations in the CACNA1A gene, not ZSWIM6.\n4. TRUE\n5. FALSE [correction]: FRDA primarily causes progressive damage to the nervous system and heart, not the liver.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-7b_response": "The Koos Classification is used to classify infective endocarditis, which is an inflammation of the lining of the heart caused by bacterial infection.",
    "llama-7b_fact_raw": "1. The Koos Classification is used to classify infective endocarditis.\n2. Infective endocarditis is an inflammation of the lining of the heart.\n3. Infective endocarditis is caused by bacterial infection.",
    "llama-7b_fact": [
      "The Koos Classification is used to classify infective endocarditis.",
      "Infective endocarditis is an inflammation of the lining of the heart.",
      "Infective endocarditis is caused by bacterial infection."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Duke Criteria is used to classify infective endocarditis, not the Koos Classification.\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-7b_response": "AZD8601 is a potent and selective inhibitor of the c-Met receptor tyrosine kinase, which is over-expressed in many types of cancer. In vivo studies have shown that AZD8601 can reduce tumor growth and metastasis in mouse models of cancer, as well as reduce the number of circulating tumor cells in patients with metastatic cancer. Additionally, AZD8601 has been shown to improve overall survival and progression-free survival in patients with advanced cancer.",
    "llama-7b_fact_raw": "1. AZD8601 is an inhibitor of the c-Met receptor tyrosine kinase.\n2. The c-Met receptor tyrosine kinase is over-expressed in many types of cancer.\n3. In vivo studies indicate that AZD8601 can reduce tumor growth and metastasis in mouse models of cancer.\n4. AZD8601 has been shown to reduce the number of circulating tumor cells in patients with metastatic cancer.\n5. AZD8601 has been associated with improved overall survival and progression-free survival in patients with advanced cancer.",
    "llama-7b_fact": [
      "AZD8601 is an inhibitor of the c-Met receptor tyrosine kinase.",
      "The c-Met receptor tyrosine kinase is over-expressed in many types of cancer.",
      "In vivo studies indicate that AZD8601 can reduce tumor growth and metastasis in mouse models of cancer.",
      "AZD8601 has been shown to reduce the number of circulating tumor cells in patients with metastatic cancer.",
      "AZD8601 has been associated with improved overall survival and progression-free survival in patients with advanced cancer."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: AZD8601 is not an inhibitor of the c-Met receptor tyrosine kinase; it is actually an mRNA-based therapy designed to encode for vascular endothelial growth factor A (VEGF-A) as a novel treatment for heart disease.\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe correction for statement 1 is based on the knowledge that AZD8601 is a developmental drug for heart disease, not a c-Met inhibitor for cancer. Statements 3, 4, and 5 cannot be verified without specific data or results from clinical trials regarding AZD8601's effects on cancer, which is not its primary indication.",
    "llama-7b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-7b_response": "SAHFS are created through a process called synthesis, which involves the combination of two or more molecules to form a new compound with different properties. The molecules used in synthesis can be organic compounds, inorganic compounds, or other molecules containing carbon. During synthesis, the molecules are typically heated in the presence of a catalyst, which helps to speed up the reaction and increase the yield of the desired product.",
    "llama-7b_fact_raw": "1. SAHFS are created through a process called synthesis.\n2. Synthesis involves the combination of two or more molecules to form a new compound.\n3. The molecules used in synthesis can be organic compounds, inorganic compounds, or other carbon-containing molecules.\n4. During synthesis, the molecules are typically heated.\n5. A catalyst is used during synthesis to speed up the reaction and increase the yield of the product.",
    "llama-7b_fact": [
      "SAHFS are created through a process called synthesis.",
      "Synthesis involves the combination of two or more molecules to form a new compound.",
      "The molecules used in synthesis can be organic compounds, inorganic compounds, or other carbon-containing molecules.",
      "During synthesis, the molecules are typically heated.",
      "A catalyst is used during synthesis to speed up the reaction and increase the yield of the product."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. FALSE [correction]: During synthesis, the molecules may be heated, but heating is not a requirement for all synthesis reactions.\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-7b_response": "The PDZ domain of SATB1 is a protein-protein interaction domain that binds to the PDZ domains of other proteins. This interaction is important for the formation of the SATB1 protein complex, which is involved in the transcriptional regulation of genes involved in cell growth and development.",
    "llama-7b_fact_raw": "1. The PDZ domain of SATB1 is a protein-protein interaction domain.\n2. The PDZ domain of SATB1 binds to the PDZ domains of other proteins.\n3. The interaction of PDZ domains is important for the formation of the SATB1 protein complex.\n4. The SATB1 protein complex is involved in the transcriptional regulation of genes.\n5. The genes regulated by the SATB1 protein complex are involved in cell growth and development.",
    "llama-7b_fact": [
      "The PDZ domain of SATB1 is a protein-protein interaction domain.",
      "The PDZ domain of SATB1 binds to the PDZ domains of other proteins.",
      "The interaction of PDZ domains is important for the formation of the SATB1 protein complex.",
      "The SATB1 protein complex is involved in the transcriptional regulation of genes.",
      "The genes regulated by the SATB1 protein complex are involved in cell growth and development."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: SATB1 does not contain a PDZ domain; it contains a CUT domain and a homeodomain that are involved in DNA binding.\n2. FALSE [correction]: Since SATB1 does not have a PDZ domain, it does not bind to the PDZ domains of other proteins through a PDZ domain.\n3. FALSE [correction]: The interaction of PDZ domains is not relevant to SATB1 as it does not contain a PDZ domain. However, protein-protein interactions are important for the formation of protein complexes in general.\n4. TRUE: The SATB1 protein complex is indeed involved in the transcriptional regulation of genes.\n5. TRUE: The genes regulated by the SATB1 protein complex are involved in various processes including cell growth and development.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-7b_response": "The BLISS technique is based on the principles of behaviorism, which states that behavior can be modified through the use of positive and negative reinforcement. The BLISS technique uses positive reinforcement to encourage desired behaviors and negative reinforcement to discourage undesired behaviors. Positive reinforcement can come in the form of praise, rewards, or other forms of recognition, while negative reinforcement can take the form of timeouts, removal of privileges, or other forms of punishment.",
    "llama-7b_fact_raw": "1. The BLISS technique is based on the principles of behaviorism.\n2. Behaviorism states that behavior can be modified through the use of positive and negative reinforcement.\n3. The BLISS technique uses positive reinforcement to encourage desired behaviors.\n4. The BLISS technique uses negative reinforcement to discourage undesired behaviors.\n5. Positive reinforcement in the BLISS technique can include praise, rewards, or other forms of recognition.",
    "llama-7b_fact": [
      "The BLISS technique is based on the principles of behaviorism.",
      "Behaviorism states that behavior can be modified through the use of positive and negative reinforcement.",
      "The BLISS technique uses positive reinforcement to encourage desired behaviors.",
      "The BLISS technique uses negative reinforcement to discourage undesired behaviors.",
      "Positive reinforcement in the BLISS technique can include praise, rewards, or other forms of recognition."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nWithout specific context or a clear definition of what the \"BLISS technique\" is, it's difficult to accurately confirm or deny statements 1, 3, and 4. The term \"BLISS technique\" is not a widely recognized term in behaviorism or psychology, to my knowledge as of the cutoff in 2023. Therefore, without additional information, the truth of these statements cannot be determined. However, statement 2 is a general principle of behaviorism and is true, and statement 5 describes common forms of positive reinforcement, which is also true.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-7b_response": "Three NK3R antagonists are aprepitant, fosaprepitant, and rolapitant.",
    "llama-7b_fact_raw": "1. Aprepitant is an NK3R antagonist.\n2. Fosaprepitant is an NK3R antagonist.\n3. Rolapitant is an NK3R antagonist.",
    "llama-7b_fact": [
      "Aprepitant is an NK3R antagonist.",
      "Fosaprepitant is an NK3R antagonist.",
      "Rolapitant is an NK3R antagonist."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Aprepitant is an NK1 receptor antagonist.\n2. FALSE [correction]: Fosaprepitant is a prodrug of aprepitant and thus is also an NK1 receptor antagonist.\n3. FALSE [correction]: Rolapitant is an NK1 receptor antagonist.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-7b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is known as dapagliflozin. It was developed by Bristol-Myers Squibb and was approved by the FDA in 2014 for the treatment of type 2 diabetes.",
    "llama-7b_fact_raw": "1. Dapagliflozin is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Dapagliflozin was developed by Bristol-Myers Squibb.\n3. The FDA approved dapagliflozin in 2014.\n4. Dapagliflozin is used for the treatment of type 2 diabetes.",
    "llama-7b_fact": [
      "Dapagliflozin is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Dapagliflozin was developed by Bristol-Myers Squibb.",
      "The FDA approved dapagliflozin in 2014.",
      "Dapagliflozin is used for the treatment of type 2 diabetes."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Dapagliflozin is not a ghrelin receptor inverse agonist; it is an SGLT2 inhibitor used in the treatment of diabetes.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-7b_response": "The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be approximately 86%. This means that if 100 people receive the vaccine, approximately 86 of them will be protected against the disease.",
    "llama-7b_fact_raw": "1. The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be approximately 86%.",
    "llama-7b_fact": [
      "The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be approximately 86%."
    ],
    "llama-7b_judge_raw": "UNKNOWN\n\nWithout additional context or a reliable source to confirm the specific efficacy rate of Vaxchora (a vaccine for cholera), I cannot verify the accuracy of the statement. The efficacy of vaccines can vary based on different studies and conditions, so the provided percentage would need to be referenced against current and credible scientific data.",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-7b_response": "The first cholera vaccine to be approved in the United States was Dukoral, which was approved in 2014. Dukoral is a live attenuated vaccine that is administered orally and is approved for use in adults and children aged two years and older. It is approved for the prevention of cholera caused by Vibrio cholerae serogroups O1 and O139.",
    "llama-7b_fact_raw": "1. Dukoral was the first cholera vaccine to be approved in the United States.\n2. Dukoral was approved in the United States in 2014.\n3. Dukoral is a live attenuated vaccine.\n4. Dukoral is administered orally.\n5. Dukoral is approved for use in adults and children aged two years and older.",
    "llama-7b_fact": [
      "Dukoral was the first cholera vaccine to be approved in the United States.",
      "Dukoral was approved in the United States in 2014.",
      "Dukoral is a live attenuated vaccine.",
      "Dukoral is administered orally.",
      "Dukoral is approved for use in adults and children aged two years and older."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Dukoral was not the first cholera vaccine to be approved in the United States; Vaxchora was the first approved cholera vaccine in the U.S. in 2016.\n2. FALSE [correction]: Dukoral has not been approved for use in the United States; it is approved in other countries.\n3. FALSE [correction]: Dukoral is not a live attenuated vaccine; it is an inactivated vaccine containing killed cholera bacteria and recombinant cholera toxin B subunit.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is adenosine deaminase deficiency (ADA-SCID). ADA-SCID is caused by mutations in the ADA gene, which codes for the enzyme adenosine deaminase. This enzyme is essential for the normal development and function of B and T cells, which are key components of the immune system. As a result, individuals with ADA-SCID have severely compromised immune systems and are vulnerable to a wide range of infections.",
    "llama-7b_fact_raw": "1. Adenosine deaminase deficiency (ADA-SCID) is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. ADA-SCID is caused by mutations in the ADA gene.\n3. The ADA gene codes for the enzyme adenosine deaminase.\n4. Adenosine deaminase is essential for the normal development and function of B and T cells in the immune system.\n5. Individuals with ADA-SCID have severely compromised immune systems.",
    "llama-7b_fact": [
      "Adenosine deaminase deficiency (ADA-SCID) is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "ADA-SCID is caused by mutations in the ADA gene.",
      "The ADA gene codes for the enzyme adenosine deaminase.",
      "Adenosine deaminase is essential for the normal development and function of B and T cells in the immune system.",
      "Individuals with ADA-SCID have severely compromised immune systems."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Adenosine deaminase deficiency (ADA-SCID) is not the most common cause of common variable immunodeficiency (CVID) in Europeans. ADA-SCID is a separate and distinct form of severe combined immunodeficiency (SCID).\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-7b_response": "The IFIT1 gene plays a role in the development of Systemic Lupus Erythematosus (SLE) by regulating the production of interferon-alpha. Interferon-alpha is an important antiviral and antiproliferative cytokine that helps to regulate the immune system and is important in the pathogenesis of SLE. Mutations in the IFIT1 gene have been linked to an increased risk of developing SLE.",
    "llama-7b_fact_raw": "1. The IFIT1 gene regulates the production of interferon-alpha.\n2. Interferon-alpha is an antiviral and antiproliferative cytokine.\n3. Interferon-alpha helps to regulate the immune system.\n4. Interferon-alpha is important in the pathogenesis of Systemic Lupus Erythematosus (SLE).\n5. Mutations in the IFIT1 gene have been linked to an increased risk of developing SLE.",
    "llama-7b_fact": [
      "The IFIT1 gene regulates the production of interferon-alpha.",
      "Interferon-alpha is an antiviral and antiproliferative cytokine.",
      "Interferon-alpha helps to regulate the immune system.",
      "Interferon-alpha is important in the pathogenesis of Systemic Lupus Erythematosus (SLE).",
      "Mutations in the IFIT1 gene have been linked to an increased risk of developing SLE."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The IFIT1 gene is involved in the interferon response, but it does not regulate the production of interferon-alpha. It is induced by interferon and has antiviral activities.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-7b_response": "The Liverpool Elbow Score is a diagnostic tool used to assess the severity of an elbow injury. It is based on the patient's symptoms and physical examination findings, and provides a quick and easy way to assess the likelihood of a fracture or other serious injury. A high score indicates a greater likelihood of a fracture or other serious injury, while a low score indicates a less serious injury.",
    "llama-7b_fact_raw": "1. The Liverpool Elbow Score is used to assess the severity of an elbow injury.\n2. It is based on the patient's symptoms and physical examination findings.\n3. The score helps to assess the likelihood of a fracture or other serious injury.\n4. A high Liverpool Elbow Score indicates a greater likelihood of a fracture or serious injury.\n5. A low Liverpool Elbow Score indicates a less serious injury.",
    "llama-7b_fact": [
      "The Liverpool Elbow Score is used to assess the severity of an elbow injury.",
      "It is based on the patient's symptoms and physical examination findings.",
      "The score helps to assess the likelihood of a fracture or other serious injury.",
      "A high Liverpool Elbow Score indicates a greater likelihood of a fracture or serious injury.",
      "A low Liverpool Elbow Score indicates a less serious injury."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Explanation]: Without specific medical knowledge about the Liverpool Elbow Score or a reference to validate these statements, it is not possible to determine the accuracy of these claims. The Liverpool Elbow Score is not a widely recognized medical scoring system in the public domain as of my knowledge cutoff date, and it may be a specialized or less commonly used tool. Therefore, without additional context or information, the truthfulness of these statements cannot be ascertained.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-7b_response": "The 100,000 Genomes Project is a UK-based project that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases. As part of the project, researchers have been studying sarcoma, a type of cancer that affects the soft tissues and bones. Through the project, researchers have been able to identify new genetic variants associated with sarcoma, which can help inform diagnosis and treatment decisions. Additionally, the project has enabled researchers to develop a better understanding of the genetic basis of the disease and to identify potential targets for new therapies.",
    "llama-7b_fact_raw": "1. The 100,000 Genomes Project is a UK-based initiative that sequences whole genomes from NHS patients with cancer and rare diseases.\n2. Sarcoma, a type of cancer affecting soft tissues and bones, is one of the conditions being studied under the 100,000 Genomes Project.\n3. Researchers involved in the 100,000 Genomes Project have identified new genetic variants associated with sarcoma.\n4. The project has contributed to a better understanding of the genetic basis of sarcoma.\n5. Potential targets for new therapies have been identified through the 100,000 Genomes Project's research on sarcoma.",
    "llama-7b_fact": [
      "The 100,000 Genomes Project is a UK-based initiative that sequences whole genomes from NHS patients with cancer and rare diseases.",
      "Sarcoma, a type of cancer affecting soft tissues and bones, is one of the conditions being studied under the 100,000 Genomes Project.",
      "Researchers involved in the 100,000 Genomes Project have identified new genetic variants associated with sarcoma.",
      "The project has contributed to a better understanding of the genetic basis of sarcoma.",
      "Potential targets for new therapies have been identified through the 100,000 Genomes Project's research on sarcoma."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe first two statements are factual and pertain to the objectives and scope of the 100,000 Genomes Project. The last three statements would require specific and current knowledge about the project's findings and impacts, which are not provided in the context. Therefore, without additional information, the truthfulness of statements 3, 4, and 5 cannot be determined.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-7b_response": "Yes, protein ALEX1 contains armadillo repeats. It is a member of the Armadillo family of proteins, which are characterized by the presence of repetitive structures called armadillo repeats. These repeats are composed of approximately 60 amino acids and are found in the C-terminal region of ALEX1.",
    "llama-7b_fact_raw": "1. Protein ALEX1 contains armadillo repeats.\n2. ALEX1 is a member of the Armadillo family of proteins.\n3. Armadillo repeats are composed of approximately 60 amino acids.\n4. Armadillo repeats are found in the C-terminal region of ALEX1.",
    "llama-7b_fact": [
      "Protein ALEX1 contains armadillo repeats.",
      "ALEX1 is a member of the Armadillo family of proteins.",
      "Armadillo repeats are composed of approximately 60 amino acids.",
      "Armadillo repeats are found in the C-terminal region of ALEX1."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-7b_response": "Enzymes that remove histone modifications include histone deacetylases (HDACs), histone methyltransferases (HMTs), and histone demethylases (HDMLs).",
    "llama-7b_fact_raw": "1. Histone deacetylases (HDACs) are enzymes that remove histone modifications.\n2. Histone methyltransferases (HMTs) are enzymes that remove histone modifications.\n3. Histone demethylases (HDMLs) are enzymes that remove histone modifications.",
    "llama-7b_fact": [
      "Histone deacetylases (HDACs) are enzymes that remove histone modifications.",
      "Histone methyltransferases (HMTs) are enzymes that remove histone modifications.",
      "Histone demethylases (HDMLs) are enzymes that remove histone modifications."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Histone methyltransferases (HMTs) are enzymes that add methyl groups to histones, not remove them.\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-7b_response": "The evidence suggests that head CT scans may increase the risk of developing a brain tumor. Studies have shown that repeated exposure to radiation from CT scans can cause changes in the cells of the brain, which can lead to the development of a tumor. Additionally, CT scans can cause inflammation in the brain, which can also increase the risk of developing a tumor. For these reasons, it is recommended that CT scans be used only when absolutely necessary.",
    "llama-7b_fact_raw": "1. Head CT scans may increase the risk of developing a brain tumor.\n2. Repeated exposure to radiation from CT scans can cause changes in the cells of the brain.\n3. Changes in brain cells due to radiation from CT scans can lead to the development of a tumor.\n4. CT scans can cause inflammation in the brain.\n5. It is recommended that CT scans be used only when absolutely necessary.",
    "llama-7b_fact": [
      "Head CT scans may increase the risk of developing a brain tumor.",
      "Repeated exposure to radiation from CT scans can cause changes in the cells of the brain.",
      "Changes in brain cells due to radiation from CT scans can lead to the development of a tumor.",
      "CT scans can cause inflammation in the brain.",
      "It is recommended that CT scans be used only when absolutely necessary."
    ],
    "llama-7b_judge_raw": "1. TRUE: Head CT scans involve exposure to radiation, which has been associated with an increased risk of developing cancer, including brain tumors, although the risk is generally considered small.\n2. TRUE: Repeated exposure to radiation, such as from CT scans, can cause changes in cells that may increase the risk of cancer.\n3. TRUE: Changes in brain cells due to radiation exposure can potentially lead to the development of a tumor, although this is a complex process and the risk is generally low.\n4. UNKNOWN: While radiation can cause various biological effects, the statement about CT scans causing inflammation in the brain is not specific enough without additional context or scientific evidence to support it.\n5. TRUE: Medical guidelines generally recommend that CT scans and other forms of medical imaging that involve radiation be used judiciously and only when the benefits outweigh the risks, which is consistent with the principle of using such procedures only when absolutely necessary.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-7b_response": "Otx2 is associated with the embryonic stem cell pluripotency.",
    "llama-7b_fact_raw": "1. Otx2 is associated with embryonic stem cell pluripotency.",
    "llama-7b_fact": [
      "Otx2 is associated with embryonic stem cell pluripotency."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-7b_response": "Approximately 200 DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region.",
    "llama-7b_fact_raw": "1. There are approximately 200 DNaseI hypersensitive sites marking the murine beta globin locus region.",
    "llama-7b_fact": [
      "There are approximately 200 DNaseI hypersensitive sites marking the murine beta globin locus region."
    ],
    "llama-7b_judge_raw": "UNKNOWN\n\nThe statement provides a specific number of DNaseI hypersensitive sites for the murine beta globin locus region. Without access to current and specific scientific literature or data on the murine beta globin locus, it is not possible to verify the accuracy of this number. The number of DNaseI hypersensitive sites can vary based on the methods used to identify them and advancements in genomic research. Therefore, without additional context or reference, the truthfulness of this statement cannot be determined.",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-7b_response": "There are several European influenza vaccines available, including Fluarix (GlaxoSmithKline), FluLaval (Sanofi Pasteur), Fluvirin (Novartis), and Fluzone (Sanofi Pasteur).",
    "llama-7b_fact_raw": "1. Fluarix is an influenza vaccine produced by GlaxoSmithKline.\n2. FluLaval is an influenza vaccine produced by Sanofi Pasteur.\n3. Fluvirin is an influenza vaccine produced by Novartis.\n4. Fluzone is an influenza vaccine produced by Sanofi Pasteur.",
    "llama-7b_fact": [
      "Fluarix is an influenza vaccine produced by GlaxoSmithKline.",
      "FluLaval is an influenza vaccine produced by Sanofi Pasteur.",
      "Fluvirin is an influenza vaccine produced by Novartis.",
      "Fluzone is an influenza vaccine produced by Sanofi Pasteur."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: FluLaval is an influenza vaccine produced by GlaxoSmithKline.\n3. FALSE [correction]: Fluvirin was an influenza vaccine originally produced by Novartis, but as of my knowledge cutoff in 2023, the influenza vaccine business of Novartis was acquired by CSL's Seqirus.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-7b_response": "Yes, the Paramyxovirus geneome segmented, negative-sense RNA.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-7b_response": "Roflumilast Cream is effective for treating chronic obstructive pulmonary disease (COPD).",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-7b_response": "Several tools have been developed for identifying and visualising ncRNA promoters. These include the Promoter Analysis Tool (PAT), the NcRNA Promoter Analysis Tool (N-PAT), the Non-Coding RNA Promoter Finder (NCRPF), the Non-Coding RNA Promoter Analysis Tool (NC-PAT), and the Non-Coding RNA Promoter Visualization Tool (NCRVT). All of these tools are designed to help researchers identify and visualise the promoters of non-coding RNAs.",
    "llama-7b_fact_raw": "1. The Promoter Analysis Tool (PAT) is a tool developed for identifying and visualising ncRNA promoters.\n2. The NcRNA Promoter Analysis Tool (N-PAT) is a tool developed for identifying and visualising ncRNA promoters.\n3. The Non-Coding RNA Promoter Finder (NCRPF) is a tool developed for identifying and visualising ncRNA promoters.\n4. The Non-Coding RNA Promoter Analysis Tool (NC-PAT) is a tool developed for identifying and visualising ncRNA promoters.\n5. The Non-Coding RNA Promoter Visualization Tool (NCRVT) is a tool developed for identifying and visualising ncRNA promoters.",
    "llama-7b_fact": [
      "The Promoter Analysis Tool (PAT) is a tool developed for identifying and visualising ncRNA promoters.",
      "The NcRNA Promoter Analysis Tool (N-PAT) is a tool developed for identifying and visualising ncRNA promoters.",
      "The Non-Coding RNA Promoter Finder (NCRPF) is a tool developed for identifying and visualising ncRNA promoters.",
      "The Non-Coding RNA Promoter Analysis Tool (NC-PAT) is a tool developed for identifying and visualising ncRNA promoters.",
      "The Non-Coding RNA Promoter Visualization Tool (NCRVT) is a tool developed for identifying and visualising ncRNA promoters."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe correctness of these statements depends on the existence and naming of specific bioinformatics tools, which are not common knowledge and cannot be verified without additional context or access to current databases of such tools.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-7b_response": "SWIM tool has identified and down-regulated several genes in glioblastoma, including PTEN, PDCD4, CDKN2A, and SMAD4.",
    "llama-7b_fact_raw": "1. The SWIM tool has identified the PTEN gene as being down-regulated in glioblastoma.\n2. The SWIM tool has identified the PDCD4 gene as being down-regulated in glioblastoma.\n3. The SWIM tool has identified the CDKN2A gene as being down-regulated in glioblastoma.\n4. The SWIM tool has identified the SMAD4 gene as being down-regulated in glioblastoma.",
    "llama-7b_fact": [
      "The SWIM tool has identified the PTEN gene as being down-regulated in glioblastoma.",
      "The SWIM tool has identified the PDCD4 gene as being down-regulated in glioblastoma.",
      "The SWIM tool has identified the CDKN2A gene as being down-regulated in glioblastoma.",
      "The SWIM tool has identified the SMAD4 gene as being down-regulated in glioblastoma."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific data or results from the SWIM tool (Subnetwork Integration for Multidimensional omics), it is not possible to verify the accuracy of these statements regarding the regulation of the PTEN, PDCD4, CDKN2A, and SMAD4 genes in glioblastoma. The SWIM tool is used for analyzing omics data, and the results can vary depending on the dataset and parameters used.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-7b_response": "Several R packages have been developed for studying TADs. These include: \n\n1. TADs: A package for the analysis of TADs.\n2. TADplot: A package for the visualization of TADs.\n3. TADview: A package for the interactive exploration of TADs.\n4. TADtrack: A package for the tracking of TADs.\n5. TADtrackR: A package for the tracking of TADs in a R environment.\n6. TADstack: A package for the analysis of TADstacks.\n7. TADstackR: A package for the analysis of TADstacks in a R environment.\n8. TADmatrix: A package for the analysis of TADmatrices.\n9. TADmatrixR: A package for the analysis of TADmatrices in a R environment.",
    "llama-7b_fact_raw": "1. TADs is an R package developed for the analysis of TADs.\n2. TADplot is an R package developed for the visualization of TADs.\n3. TADview is an R package developed for the interactive exploration of TADs.\n4. TADtrack is an R package developed for the tracking of TADs.\n5. TADstack is an R package developed for the analysis of TADstacks.",
    "llama-7b_fact": [
      "TADs is an R package developed for the analysis of TADs.",
      "TADplot is an R package developed for the visualization of TADs.",
      "TADview is an R package developed for the interactive exploration of TADs.",
      "TADtrack is an R package developed for the tracking of TADs.",
      "TADstack is an R package developed for the analysis of TADstacks."
    ],
    "llama-7b_judge_raw": "1. TRUE: TADs (Topologically Associating Domains) is indeed a term related to genomic research, and there are R packages developed for the analysis of TADs, such as \"TADbit\" and others that could be referred to as \"TADs\" in a colloquial sense.\n2. FALSE [correction]: There is no specific R package named \"TADplot\" known for the visualization of TADs. However, visualization of TADs is a common feature in various R packages designed for genomic data analysis, such as \"TADbit\" or \"HiCExplorer.\"\n3. UNKNOWN: Without more information, it is unclear whether \"TADview\" is an actual R package. There are various tools for interactive exploration of TADs, but \"TADview\" may not be a recognized package.\n4. UNKNOWN: \"TADtrack\" is not a well-known R package for tracking TADs, and without further context, it is difficult to verify its existence or purpose.\n5. UNKNOWN: \"TADstack\" is not a recognized term in the context of R packages for genomic analysis, and without additional information, the existence of such a package cannot be confirmed.",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-7b_response": "The bioconductor tool that has been developed for accessing bacterial regulatory networks is the Bacterial Regulatory Networks (BRN) package. This package provides an interface for exploring and analyzing bacterial regulatory networks. It allows users to query, visualize, and analyze bacterial regulatory networks from a variety of species, including E. coli, Salmonella, and Staphylococcus aureus. The package also provides tools for predicting the effects of mutations on bacterial regulatory networks.",
    "llama-7b_fact_raw": "1. The Bacterial Regulatory Networks (BRN) package is a bioconductor tool developed for accessing bacterial regulatory networks.\n2. The BRN package provides an interface for exploring and analyzing bacterial regulatory networks.\n3. The BRN package includes features for querying, visualizing, and analyzing bacterial regulatory networks.\n4. The BRN package covers a variety of species, including E. coli, Salmonella, and Staphylococcus aureus.\n5. The BRN package offers tools for predicting the effects of mutations on bacterial regulatory networks.",
    "llama-7b_fact": [
      "The Bacterial Regulatory Networks (BRN) package is a bioconductor tool developed for accessing bacterial regulatory networks.",
      "The BRN package provides an interface for exploring and analyzing bacterial regulatory networks.",
      "The BRN package includes features for querying, visualizing, and analyzing bacterial regulatory networks.",
      "The BRN package covers a variety of species, including E. coli, Salmonella, and Staphylococcus aureus.",
      "The BRN package offers tools for predicting the effects of mutations on bacterial regulatory networks."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about the Bacterial Regulatory Networks (BRN) package, it is not possible to verify the accuracy of these statements. They could be true if such a package exists and has these features, but without access to the relevant documentation or publication, the truthfulness of these statements cannot be confirmed.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-7b_response": "The end products of the shikimate pathway are aromatic compounds such as aromatic amino acids, aromatic alcohols, and aromatic acids. These compounds are important building blocks for the synthesis of proteins, lipids, and other molecules in plants and some bacteria.",
    "llama-7b_fact_raw": "1. The shikimate pathway produces aromatic compounds.\n2. Aromatic amino acids are end products of the shikimate pathway.\n3. Aromatic alcohols are produced by the shikimate pathway.\n4. Aromatic acids are among the end products of the shikimate pathway.\n5. The shikimate pathway is present in plants and some bacteria.",
    "llama-7b_fact": [
      "The shikimate pathway produces aromatic compounds.",
      "Aromatic amino acids are end products of the shikimate pathway.",
      "Aromatic alcohols are produced by the shikimate pathway.",
      "Aromatic acids are among the end products of the shikimate pathway.",
      "The shikimate pathway is present in plants and some bacteria."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The shikimate pathway primarily produces aromatic amino acids, not aromatic alcohols. While some intermediates of the pathway or their derivatives might be converted to aromatic alcohols in some organisms, aromatic alcohols are not typically considered direct end products of the shikimate pathway.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-7b_response": "Yes, cabergoline is used for the treatment of Nelson's syndrome, which is a rare condition that occurs when a patient with a pituitary adenoma develops a prolactin-secreting tumor. Cabergoline is a dopamine agonist that is used to reduce prolactin levels and decrease the size of the tumor.",
    "llama-7b_fact_raw": "1. Cabergoline is used for the treatment of Nelson's syndrome.\n2. Nelson's syndrome is a rare condition associated with a pituitary adenoma.\n3. In Nelson's syndrome, a patient develops a prolactin-secreting tumor.\n4. Cabergoline is a dopamine agonist.\n5. Cabergoline is used to reduce prolactin levels and decrease the size of the tumor.",
    "llama-7b_fact": [
      "Cabergoline is used for the treatment of Nelson's syndrome.",
      "Nelson's syndrome is a rare condition associated with a pituitary adenoma.",
      "In Nelson's syndrome, a patient develops a prolactin-secreting tumor.",
      "Cabergoline is a dopamine agonist.",
      "Cabergoline is used to reduce prolactin levels and decrease the size of the tumor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Cabergoline is not typically used for the treatment of Nelson's syndrome. It is used for conditions associated with hyperprolactinemia, such as prolactinomas.\n2. TRUE\n3. FALSE [correction]: In Nelson's syndrome, a patient develops ACTH (adrenocorticotropic hormone) secreting pituitary adenomas after bilateral adrenalectomy for Cushing's disease, not a prolactin-secreting tumor.\n4. TRUE\n5. TRUE (in the context of prolactin-secreting pituitary tumors, not specifically Nelson's syndrome)",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-7b_response": "The main manifestation of Liebenberg syndrome is a painful, red, and swollen joint, usually the knee. Other symptoms may include fever, stiffness, and limited mobility.",
    "llama-7b_fact_raw": "1. The main manifestation of Liebenberg syndrome is a painful, red, and swollen joint.\n2. The knee is usually the joint affected by Liebenberg syndrome.\n3. Symptoms of Liebenberg syndrome may include fever.\n4. Stiffness can be a symptom of Liebenberg syndrome.\n5. Liebenberg syndrome may cause limited mobility.",
    "llama-7b_fact": [
      "The main manifestation of Liebenberg syndrome is a painful, red, and swollen joint.",
      "The knee is usually the joint affected by Liebenberg syndrome.",
      "Symptoms of Liebenberg syndrome may include fever.",
      "Stiffness can be a symptom of Liebenberg syndrome.",
      "Liebenberg syndrome may cause limited mobility."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Liebenberg syndrome is not characterized by a painful, red, and swollen joint. It is a rare congenital condition that typically involves the abnormal development of the elbow and forearm, resembling a limb malformation.\n2. FALSE [correction]: Liebenberg syndrome does not usually affect the knee. It typically involves the upper limbs, particularly the elbow and forearm.\n3. UNKNOWN: Without specific information on Liebenberg syndrome symptoms related to systemic manifestations like fever, it is difficult to determine the accuracy of this statement.\n4. UNKNOWN: While stiffness could be a symptom associated with many musculoskeletal syndromes, there is no specific information provided about stiffness in relation to Liebenberg syndrome.\n5. TRUE: Liebenberg syndrome may cause limited mobility due to the abnormal development and malformation of the limbs, particularly the elbow and forearm.",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-7b_response": "Orally bioavailable MPS1 kinase inhibitors include sorafenib, pazopanib, and sunitinib.",
    "llama-7b_fact_raw": "1. Sorafenib is an orally bioavailable MPS1 kinase inhibitor.\n2. Pazopanib is an orally bioavailable MPS1 kinase inhibitor.\n3. Sunitinib is an orally bioavailable MPS1 kinase inhibitor.",
    "llama-7b_fact": [
      "Sorafenib is an orally bioavailable MPS1 kinase inhibitor.",
      "Pazopanib is an orally bioavailable MPS1 kinase inhibitor.",
      "Sunitinib is an orally bioavailable MPS1 kinase inhibitor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Sorafenib is an orally bioavailable kinase inhibitor, but it is not specific to MPS1; it targets several tyrosine protein kinases, such as VEGFR, PDGFR, and Raf kinases.\n2. FALSE [correction]: Pazopanib is an orally bioavailable kinase inhibitor used to treat kidney cancer and soft tissue sarcoma, but it is not specific to MPS1; it mainly targets VEGFR, PDGFR, and c-Kit.\n3. FALSE [correction]: Sunitinib is an orally bioavailable kinase inhibitor used to treat renal cell carcinoma and gastrointestinal stromal tumor, but it is not specific to MPS1; it targets multiple receptor tyrosine kinases, including PDGFR, VEGFR, and c-Kit.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-7b_response": "Golimumab has not been tested specifically for the treatment of diabetes. However, it has been studied in clinical trials for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, and the safety and efficacy of golimumab in patients with diabetes has not been established.",
    "llama-7b_fact_raw": "1. Golimumab has not been tested specifically for the treatment of diabetes.\n2. Golimumab has been studied in clinical trials for the treatment of rheumatoid arthritis.\n3. Golimumab has been studied in clinical trials for the treatment of ankylosing spondylitis.\n4. Golimumab has been studied in clinical trials for the treatment of psoriatic arthritis.\n5. The safety and efficacy of golimumab in patients with diabetes has not been established.",
    "llama-7b_fact": [
      "Golimumab has not been tested specifically for the treatment of diabetes.",
      "Golimumab has been studied in clinical trials for the treatment of rheumatoid arthritis.",
      "Golimumab has been studied in clinical trials for the treatment of ankylosing spondylitis.",
      "Golimumab has been studied in clinical trials for the treatment of psoriatic arthritis.",
      "The safety and efficacy of golimumab in patients with diabetes has not been established."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-7b_response": "No, progeria is not caused by an autosomal recessive gene. Progeria is a rare genetic disorder that is caused by a mutation in the lamin A gene on the short arm of chromosome 18. This mutation is dominant, meaning that one copy of the mutated gene is sufficient to cause the disorder.",
    "llama-7b_fact_raw": "1. Progeria is not caused by an autosomal recessive gene.\n2. Progeria is a rare genetic disorder.\n3. Progeria is caused by a mutation in the lamin A gene.\n4. The lamin A gene is located on the short arm of chromosome 18.\n5. The mutation that causes progeria is dominant.",
    "llama-7b_fact": [
      "Progeria is not caused by an autosomal recessive gene.",
      "Progeria is a rare genetic disorder.",
      "Progeria is caused by a mutation in the lamin A gene.",
      "The lamin A gene is located on the short arm of chromosome 18.",
      "The mutation that causes progeria is dominant."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The lamin A gene (LMNA) is located on the long arm of chromosome 1, not the short arm of chromosome 18.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-7b_response": "Common variants at 12q14 and 12q24 are associated with an increased risk of developing schizophrenia and bipolar disorder, respectively.",
    "llama-7b_fact_raw": "1. Variants at 12q14 are associated with an increased risk of developing schizophrenia.\n2. Variants at 12q24 are associated with an increased risk of developing bipolar disorder.",
    "llama-7b_fact": [
      "Variants at 12q14 are associated with an increased risk of developing schizophrenia.",
      "Variants at 12q24 are associated with an increased risk of developing bipolar disorder."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\nThe association of specific genetic variants with diseases like schizophrenia and bipolar disorder is a topic of ongoing research. Without specific references to scientific studies or consensus in the scientific community, it is not possible to confirm the accuracy of these statements. Genetic associations can be complex and may involve multiple genes and environmental factors. Therefore, without additional context or sources, the truth of these statements cannot be determined.",
    "llama-7b_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-7b_response": "The ligands of the Roundabout (Robo) receptors are Slit, Robo1, Robo2, and Robo3.",
    "llama-7b_fact_raw": "1. Slit is a ligand of the Roundabout (Robo) receptors.\n2. Robo1 is a ligand of the Roundabout (Robo) receptors.\n3. Robo2 is a ligand of the Roundabout (Robo) receptors.\n4. Robo3 is a ligand of the Roundabout (Robo) receptors.",
    "llama-7b_fact": [
      "Slit is a ligand of the Roundabout (Robo) receptors.",
      "Robo1 is a ligand of the Roundabout (Robo) receptors.",
      "Robo2 is a ligand of the Roundabout (Robo) receptors.",
      "Robo3 is a ligand of the Roundabout (Robo) receptors."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Robo1 is not a ligand but rather a member of the Roundabout (Robo) family of receptors that bind to the Slit ligand.\n3. FALSE [correction]: Robo2 is not a ligand but rather a member of the Roundabout (Robo) family of receptors that bind to the Slit ligand.\n4. FALSE [correction]: Robo3 is not a ligand but rather a member of the Roundabout (Robo) family of receptors that bind to the Slit ligand.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-7b_response": "Yes, TFII-I plays an important role in megakaryopoiesis. TFII-I is a transcription factor that is essential for the formation of megakaryocytes, a type of blood cell that produces platelets. TFII-I binds to the promoter region of genes involved in the formation of megakaryocytes and activates their transcription. Without TFII-I, megakaryopoiesis cannot occur.",
    "llama-7b_fact_raw": "1. TFII-I is a transcription factor.\n2. TFII-I is essential for the formation of megakaryocytes.\n3. Megakaryocytes are a type of blood cell that produces platelets.\n4. TFII-I binds to the promoter region of genes involved in megakaryocyte formation.\n5. TFII-I activates the transcription of genes involved in the formation of megakaryocytes.",
    "llama-7b_fact": [
      "TFII-I is a transcription factor.",
      "TFII-I is essential for the formation of megakaryocytes.",
      "Megakaryocytes are a type of blood cell that produces platelets.",
      "TFII-I binds to the promoter region of genes involved in megakaryocyte formation.",
      "TFII-I activates the transcription of genes involved in the formation of megakaryocytes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements regarding TFII-I's specific role in megakaryocyte formation and its binding to the promoter region of genes involved in that process are not common knowledge and would require specific scientific literature to confirm or refute. Therefore, without additional context or sources, the truthfulness of statements 2, 4, and 5 cannot be determined.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-7b_response": "Yes, atenolol is metabolized by the cytochrome P450 enzyme CYP2D6. CYP2D6 is responsible for the majority of the metabolism of atenolol, with additional metabolism by other enzymes, including CYP1A2, CYP3A4, and CYP4A11. CYP2D6 is an important enzyme in the metabolism of many drugs, including other beta-blockers, and genetic variations in the CYP2D6 gene can affect the metabolism of atenolol and other drugs.",
    "llama-7b_fact_raw": "1. Atenolol is metabolized by the cytochrome P450 enzyme CYP2D6.\n2. CYP2D6 is responsible for the majority of the metabolism of atenolol.\n3. Other enzymes, including CYP1A2, CYP3A4, and CYP4A11, also contribute to the metabolism of atenolol.\n4. CYP2D6 is an important enzyme in the metabolism of many drugs, including other beta-blockers.\n5. Genetic variations in the CYP2D6 gene can affect the metabolism of atenolol and other drugs.",
    "llama-7b_fact": [
      "Atenolol is metabolized by the cytochrome P450 enzyme CYP2D6.",
      "CYP2D6 is responsible for the majority of the metabolism of atenolol.",
      "Other enzymes, including CYP1A2, CYP3A4, and CYP4A11, also contribute to the metabolism of atenolol.",
      "CYP2D6 is an important enzyme in the metabolism of many drugs, including other beta-blockers.",
      "Genetic variations in the CYP2D6 gene can affect the metabolism of atenolol and other drugs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Atenolol is not significantly metabolized by the cytochrome P450 enzyme system, including CYP2D6.\n2. FALSE [correction]: Since atenolol is not significantly metabolized by the cytochrome P450 enzyme system, CYP2D6 is not responsible for the majority of its metabolism.\n3. FALSE [correction]: Atenolol is primarily eliminated unchanged in the urine and is not significantly metabolized by liver enzymes, including CYP1A2, CYP3A4, and CYP4A11.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-7b_response": "There are several versions of ExpansionHunter available, including the free version, the premium version, the pro version, and the ultimate version. Each version offers different features and benefits, such as increased storage capacity, more powerful tools, and access to exclusive content.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-7b_response": "Adamts18 is a metalloprotease that is involved in the regulation of hormone receptor signaling. It has been shown to play a role in the activation of estrogen and androgen receptors, as well as the inactivation of progesterone receptors. Adamts18 has also been found to be involved in the regulation of cell proliferation, migration, and invasion in breast cancer cells.",
    "llama-7b_fact_raw": "1. Adamts18 is a metalloprotease.\n2. Adamts18 is involved in the regulation of hormone receptor signaling.\n3. Adamts18 plays a role in the activation of estrogen and androgen receptors.\n4. Adamts18 is involved in the inactivation of progesterone receptors.\n5. Adamts18 has been found to be involved in the regulation of cell proliferation, migration, and invasion in breast cancer cells.",
    "llama-7b_fact": [
      "Adamts18 is a metalloprotease.",
      "Adamts18 is involved in the regulation of hormone receptor signaling.",
      "Adamts18 plays a role in the activation of estrogen and androgen receptors.",
      "Adamts18 is involved in the inactivation of progesterone receptors.",
      "Adamts18 has been found to be involved in the regulation of cell proliferation, migration, and invasion in breast cancer cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statement that Adamts18 is a metalloprotease is true; ADAMTS (A Disintegrin And Metalloproteinase with Thrombospondin Motifs) are a family of metalloproteases. However, the specific roles of Adamts18 in hormone receptor signaling, activation of estrogen and androgen receptors, inactivation of progesterone receptors, and its involvement in the regulation of cell proliferation, migration, and invasion in breast cancer cells are not widely established or may vary based on recent research. Without specific context or references, it is difficult to confirm the accuracy of these statements.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-7b_response": "Thiazovivin is a chemotherapy drug that works by inhibiting the enzyme thiazole dioxygenase, which is involved in the biosynthesis of folate. By inhibiting this enzyme, thiazovivin prevents the production of tetrahydrofolate, an essential component of the folate pathway. This disruption of the folate pathway leads to cell death, which is the primary mode of action of Thiazovivin.",
    "llama-7b_fact_raw": "1. Thiazovivin is a chemotherapy drug.\n2. Thiazovivin works by inhibiting the enzyme thiazole dioxygenase.\n3. Thiazole dioxygenase is involved in the biosynthesis of folate.\n4. Inhibition of thiazole dioxygenase by Thiazovivin prevents the production of tetrahydrofolate.\n5. Disruption of the folate pathway by Thiazovivin leads to cell death.",
    "llama-7b_fact": [
      "Thiazovivin is a chemotherapy drug.",
      "Thiazovivin works by inhibiting the enzyme thiazole dioxygenase.",
      "Thiazole dioxygenase is involved in the biosynthesis of folate.",
      "Inhibition of thiazole dioxygenase by Thiazovivin prevents the production of tetrahydrofolate.",
      "Disruption of the folate pathway by Thiazovivin leads to cell death."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Thiazovivin is not a chemotherapy drug; it is a small molecule inhibitor used to enhance the survival of various cells, including stem cells, during cell culture.\n2. FALSE [correction]: Thiazovivin does not work by inhibiting the enzyme thiazole dioxygenase. It acts by inhibiting the Rho-associated kinase (ROCK), which is involved in cell adhesion and survival.\n3. UNKNOWN: The statement about thiazole dioxygenase being involved in the biosynthesis of folate is specific, and without additional context or information, it is difficult to verify its accuracy.\n4. FALSE [correction]: Since Thiazovivin does not inhibit thiazole dioxygenase, it does not prevent the production of tetrahydrofolate by this mechanism. Thiazovivin's known mechanism of action is the inhibition of ROCK, not related to the folate pathway.\n5. UNKNOWN: The statement about the disruption of the folate pathway leading to cell death may be true in a general sense for certain drugs that target the folate pathway, but it is not applicable to Thiazovivin, which does not disrupt the folate pathway as part of its mechanism of action.",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  }
]